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ABSTRACT 
COMPOSITE NETWORK OF ACTIN AND MICROTUBULE FILAMENTS, 






Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Jennifer Ross 
 
Actin and microtubule filaments, with their auxiliary proteins, enable the cytoskeleton to 
perform vital processes in the cell by tuning the organizational, mechanical properties 
and dynamics of the network. Despite their critical importance and interactions in cells, 
we are only beginning to uncover information about the composite network. Here, I use 
florescence microscopy to explore the role of filaments characteristics, interactions and 
activities in the self-organization and steady-state dynamics of the composite network of 
filaments. First, I discuss active self-organization of semiflexible actin and rigid 
microtubule filaments in the 2D composite network while myosin II and kinesin-1 motor 
proteins propel actin and microtubule filaments, respectively. Second, I studied the 
steady-state mobility of the 3D composite network is studied when the interactions of 
filaments are regulated by the varying amount of crosslinkers. In a composite network 
where only actin filaments crosslinked using biotin-NeutrAvidin molecules, microtubule 
mobility is tuned by actin crosslinking and displays non-monotonic dependence on the 
amount of actin crosslinkers. Third, I included antiparallel microtubule crosslinkers, 
MAP65, as well as biotin-NeutrAvidin actin crosslinkers to reveal the different roles of 
these crosslinkers in the structure and mobility of the composite network. While actin 
crosslinkers dictated the mobility, microtubule crosslinkers control the co-localization of 
filaments. Finally, I worked on an active composite network of actin, microtubule, and 
myosin II motor proteins. The structural changes in the contractile composite network is 
characterized using correlation length measurements. These results provide a valuable 
insight into the cytoskeletal filaments interactions and their vital roles in various 
biological processes in cells. Furthermore, this knowledge could enable us to design 
autonomous bioinspired materials with tunable mechanical properties.  
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fractions: 0.0008, 0.008, 0.010, 0.013, 0.015.  The microtubules (blue markers) 
where used at three different concentrations: 0.5 μM, 2.5 μM, and 5 μM 
corresponding to the following filament densities (filaments/μm2): 0.03, 0.17, 0.34 
and the following dimensionless area fractions: 0.004, 0.02, 0.04.  For each 
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be seen through the actin channel due to high signal and imperfect dichroic glass. 
xvii 
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crosslinker motifs (None, Actin, Microtubule, Both, Co-linked, Both 2x) described 
in the text. The calculated length between crosslinkers for each motif is listed under 
each cartoon, where lc,a is the length between crosslinkers along an actin filament, 
lc,m is the length between crosslinkers along a microtubule, and lc is the length 
between crosslinkers when actin and microtubules are linked to each other. 
(B)Two-color laser scanning confocal micrograph of 5.8 μM Co-linked actin-
microtubule composite with ~3% of microtubules and actin labeled with rhodamine 
(red) and Alexa-488 (green), respectively. Standard deviation projections of a 60 s 
video taken at 1 fps for the microtubule (red) and actin (green) channels. Scale bar 
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Figure 3. 2 Schematic of experiments to probe the role that crosslinking plays in the 
mechanics and mobility of actin crosslinked actin-microtubule composites. (A) 
Cartoon of composites of microtubules (red) and actin (green) with increasing 
concentrations of actin crosslinkers (blue) defined as the crosslinker:actin ratio R. 
(B) Two-color laser scanning confocal image of 5.8 μM total actin-microtubule 
composite with R = 0.08. For visualization of filaments, ~3% of tubulin and actin 
are labeled with rhodamine (red channel) and Alexa-488 (green), respectively. 
Standard deviation projections of a 60 s time series taken at 1 fps for the 
microtubule (red) and actin (green) channels. Scale bar is 20 µm. ..........................69 
Figure 3. 3 Differences between crosslinking motifs have minimal impact on the steady-state 
filament mobility in actin-microtubule composites.  (A) For each composite, 
a 128×128 image shows the standard deviation of intensity values for each pixel 
over time for actin (green) and microtubules (red) in a 60 s time series.  Scale bar is 
10 µm and applies to all images. (B) Box-whisker plot of the steady-state mobility, 
determined by computing the average standard deviation of pixel intensities <> 
normalized by the overall average pixel intensity <I> for each time series (as 
described in Methods). For each composite type, <>/<I> is calculated separately 
for actin (cross-hatched) and microtubules (solid) and each data point is computed 
from 10-12 time series each collected in different regions of the sample chambers of 
two different samples. As shown, microtubules are less mobile than actin filaments 
in all composites. Further, while crosslinking reduces the mobility of both 
filaments, the specific crosslinking motif has little effect. .......................................73 
Figure 3. 4 Mobility analysis from time series with 62.5 ms time windows. Box-whisker plot 
of the steady-state mobility determined by computing the average standard 
deviation of pixel intensities <δ> normalized by the overall average pixel intensity 
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<I> for each time series. Here, we use a time resolution of 62.5 ms (1 frame) 
compared to 1 s (16 frames averaged together) shown in Fig 3.3. As shown, the 
dependence of the mobility of both actin and microtubules on crosslinking motif is 
robust to varying time windows used for analysis. However, for smaller time 
windows the mobility values and spread in the mobility distributions for both actin 
and microtubules are enhanced due to noise. ............................................................74 
Figure 3. 5 Microtubule mobility is tuned by actin crosslinking and dictates the non-
monotonic mechanics of composites. (A) Projection images of the standard 
deviation of pixel intensity values in actin (green) and microtubules (red) channels 
for a 60 s time series. Time series are acquired using a Nikon A1R laser scanning 
confocal microscope with 60 - 1.4 NA objective. Numbers in bottom left of each 
image correspond to crosslinking ratio R. Colors outlining images match color 
scheme in (B). Scale bar is 25 μm. (B) Box whisker plot of mobility calculated by 
computing the standard deviation of pixel intensities over time and space <δ>, 
normalized by the average pixel intensity for each time series <I> as described in 
Methods. As shown, the mobility as well as the distribution of fluctuations for 
microtubules decreases until R= 0.02 after which the mobility increases, with 
microtubules becoming more mobile than the actin filaments. ................................77 
Figure 3. 6 Mesoscale force response of actin-microtubule composites shows non-monotonic 
dependence of stiffness on actin crosslinking. (A) Force, F(x) composites exert to 
resist constant speed (v = 10 µm/s) microsphere displacement of 10 µm. Grey lines 
are linear fits to the data from 0.25 to 10 µm. (B) Average force over the full 10 µm 
bead displacement with error bars denoting standard error across all trials. Colors 
match the legend in A and black line and grey panel are average and error for R = 0. 
(C) Average composite stiffness <K> = <dF/dx> determined from slopes of the 
linear fits shown in A. R = 0 is the solid line 162. ......................................................78 
 
Figure 4. 1 Image examples for actin filaments in the composite network of actin and 
microtubule with NeutrAvidin molecules and MAP65 as actin and microtubule 
crosslinkers, respectively. A pair of images is shown for each of 0%, 3%, and 10% 
MAP65 and R = 0, 0.02, 0.04, and 0.08 for NeutrAvidin molecules. The % 
represents the percentage of tubulin dimers that are bound to MAP65 crosslinkers, 
while R is NeutrAvidin:actin molar ratio.  Each pair consists of projection image of 
standard deviation of pixel intensity value (STD) and projection image of average 
of pixel intensity value (AVG). Spatial averaging of STD and AVG images 
generates <δ> and <I>, respectively. These values were used to form <δ>/<I> 
ratio for each time series. Scale bar is 20 μm and applies to all of the images. ........88 
Figure 4. 2 Image examples for microtubule filaments in the composite network of actin and 
microtubule with NeutrAvidin molecules and MAP65 as actin and microtubule 
crosslinkers, respectively. A pair of images is shown for each of 0%, 3%, and 10% 
MAP65 and R = 0, 0.02, 0.04, and 0.08 for NeutrAvidin molecules. The % 
xix 
represents the percentage of tubulin dimers that are bound to MAP65 crosslinkers, 
while R is NeutrAvidin:actin molar ratio.  Each pair consists of projection image of 
standard deviation of pixel intensity value (STD) and projection image of average 
of pixel intensity value (AVG). Spatial averaging of STD and AVG images 
generates <δ> and <I>, respectively. These values were used to form <δ>/<I> 
ratio for each time series. Scale bar is 20 μm and applies to all of the images. ........89 
Figure 4. 3 Composite networks of microtubule and actin filaments without actin 
crosslinkers. (A) Representative images of (i, iv, vii) microtubules, (ii, v, viii) actin 
filaments, and (iii, vi, ix) merge channels with microtubules (cyan) and actin (red) 
for 0%, 3%, and 10% MAP65 without actin crosslinking (R = 0). Colors outlined 
correspond to the colors in part (B). Scale bar is 20 µm. (B) The standard deviation 
of pixel intensity over time and space, <δ>, was calculated and normalized by the 
average of pixel intensity over time and space, <I>. Box-whisker plot for <δ>/<I> 
ratio for 0%, 3%, and 10% MAP65 (N = 7, 8, 6 independent time series) is shown 
separately for actin (hashed) and microtubule (solid) networks. ..............................93 
Figure 4. 4 Cross correlation of microtubule and actin channels. (A) Representative image of 
(i) microtubule and (ii) actin networks in the same location for R = 0 and 10% 
MAP65. Scale bar is 20 µm. Bright regions in the microtubule channel (arrow) are 
not observed in the actin channel, implying bleed-through is not present. (B) 
Calculated cross-correlation maps for the same microtubule and actin images from 
(A) for different window sizes, d, when d = 1, 5, 10, 15 (i-vi). Optimal window size 
was chosen to be d = 5 (n = 121 pixels) and used throughout to compare different 
experiments. (C) Box-whisker plots of the average cross correlations between 
microtubule and actin channels averaged over the entire cross-correlation map 
created with window size d = 5 pixels for networks with no actin crosslinking (R = 
0) and increasing MAP65 0%, 3%, 10%. (N = 8, 9, 8 independent time series) ......97 
Figure 4. 5 Cross-correlation between actin and microtubule channels. (A) Heat map plot 
shows the mean of normalized cross-correlation values for all composite networks 
measured with various R and MAP65 percent bound. Color scale indicates 
quantitative cross-correlation. (B) Representative merged images of microtubule 
(cyan) and actin (red) for all experimental parameters with various R and MAP65 
percent bound. Scale bar is 20 µm. (N = 8 – 10 independent measurements) ..........99 
Figure 4. 6 High intensity microtubule aggregates do not appear in the actin channels. 
Representative images of microtubules (i, iii, v, vii, ix, xi) and actin (ii, iv, vi, viii, 
x, xii) for the same region in the experimental chamber at different percentages of 
MAP65 and R. Arrows denote regions where there is high fluorescence in the 
microtubule channel, which are caused by aggregates, without bleed-through into 
the actin channel. Scale bar is 20 μm. .......................................................................99 
Figure 4. 7 Actin and MAP65 do not interact without microtubules. (A) Actin network with 
10% MAP65. Scale bar is 20 µm. (B) Representative image of (i) actin and (ii) 
GFP-MAP65. Scale bar is 10 µm. (C) (i) Large, thick bundle of microtubules in the 
xx 
presence of 10% MAP65. (ii) Actin filaments co-localized within the bundle. (iii) 
Merge of microtubules (cyan) and actin (red). Scale bar is 10 µm. (D) Temporal 
color code of a 1-minute time series of (i) microtubules and (ii) actin shows that 
actin within the microtubule bundle does not fluctuate as much as actin outside of 
the bundles. Temporal color code scale uses the spectrum color scale from 0 – 123 
s.. .............................................................................................................................102 
Figure 4. 8 Filament fluctuations depend on actin crosslinking. (A) Representative images of 
microtubules (i, iv, vii, x) and actin (ii, v, viii, xi). Merged images (iii, vi, ix, xii) 
display microtubules (cyan) and actin (red) networks as the actin crosslinking is 
increased R = 0, 0.02, 0.04, 0.08 in the absence of microtubule crosslinkers (N = 7, 
6, 8, 5 independent time series for increasing R). Colors outlined correspond to the 
colors in part (B). Scale bar is 20 μm. Arrows denote regions where there is high 
fluorescence in one channel without bleed-through into the other fluorescence 
channel. (B) The mobility of the networks was quantified using the <δ>/<I> ratio 
where <δ> is the standard deviation of pixel intensity that was averaged over time 
and space and then normalized by the mean of pixel intensity, <I>, for (i) 
microtubules and (ii) actin as a function of actin crosslinking ratio. ......................107 
Figure 4. 9 Co-localization of microtubule and actin filaments at 10% MAP65. (A) 
Representative images of microtubules (i, iv, vii, x), actin (ii, v, viii, xi), and merge 
(iii, vi, ix, xii) with microtubules (cyan) and actin (red) composite networks created 
in the presence of 10% MAP65 with different actin crosslinking ratios: R = 0, 0.02, 
0.04, and 0.08. Bundles of microtubules and co-localization of actin are obvious for 
all networks. Color outlines correspond to the data represented in (B) and (C). Scale 
bar is 20 μm. (B) Cross correlation of microtubule and actin channels were 
computed and displayed in a box-whisker plot. There was no significant difference 
in the actin-microtubule co-localization as a function of R (N =8, 8, 10, 10). (C) The 
mobility of the (i) microtubules and (ii) actin of composite networks was quantified 
using the <δ>/<I> ratio where <δ> is the standard deviation of pixel intensity that 
was averaged over time and space and then normalized by the mean of pixel 
intensity, <I>, for networks with increasing actin crosslinkers, R (N = 6, 6, 8, 9 
independent time series). ........................................................................................110 
Figure 4. 10 Mobility of composite networks of microtubule and actin filaments with varying 
crosslinkers. (A) Example three-color image of a network with (i) microtubules and 
(ii) actin crosslinked with (iii) 10% GFP-MAP65, and NeutrAvidin R = 0.02. 
Three-color image merge showing microtubules (blue), MAP65 (green), and actin 
(red). Scale bar is 10 μm. (B) Example mobility of the images from (A) using 
ImageJ/FIJI temporal color code function shows (i) microtubules, (ii) actin, and (iii) 
MAP65. Microtubules and act both do not move, which a subset of actin does move 
outside of the bundles. (C) All mobility measurements for microtubules (i – iv) and 
actin (v- viii) as a function of actin crosslinking (R) and MAP65 binding show an 
overall dependence on actin crosslinking but not on MAP65 binding (N = 5 - 10 
independent time series). Horizontal gray bars denote control data of only one type 
of filament in the network. ......................................................................................114 
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Figure 4. 11 Microtubules in the presence of actin crosslinkers. Representative image of 
microtubules in the presence of actin crosslinkers, NeutrAvidin, at R = 0.08 does 
not show any structure or any evidence of crosslinking. Scale bar is 20 μm. ........114 
        
Figure 5. 1 Correlation measurement. (A) A confocal microscopy image of actin network in 
an active actin-microtubule composite network. It is 180×180 pixel or 
149μm×149μm. Scale bar is 20 μm. (B) Color-coded map of 2D spatial correlation 
function, g (𝒓), obtained from the image. The spatial correlation function is depicted 
for 360×360 pixels. (C) 1D spatial correlation function calculated by angular 
averaging for each r value. The normalized result is plotted versus r (μm)............120 
Figure 5. 2 Actin filaments in a 3D active contractile composite network. (A) Four different 
confocal microscopy images of time series i, ii, iii are displayed. The frames 
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the 
activated myosin motors initiate the contraction in the composite network. Colors 
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all 
the images. (B) Correlation length values of actin network for each of the four 
frames of time series i, ii, iii are shown. Myosin activities move and rearrange actin 
filaments and forms a denser network with smaller correlation length over the 
course of 6 minutes. ................................................................................................123 
Figure 5. 3 Microtubule filaments in a 3D contractile composite network. (A) Four different 
confocal microscopy images of time series i, ii, iii are displayed. The frames 
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the 
activated myosin motors initiate the contraction in the composite network. Colors 
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all 
the images. (B) Correlation length values of microtubule network for each of the 
four frames of time series i, ii, iii are shown. Although, myosin only binds to actin 
filaments, the microtubule network moves accordingly. This rearrangement of 
microtubules forms a network with smaller correlation length. .............................124 
Figure 5. 4 Actin filaments in a 3D active actomyosin network. (A) Four different confocal 
microscopy images of time series i, ii, iii are displayed. The frames correspond to 
20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the activated 
myosin motors initiate the contraction in the actin network. Colors outlined 
correspond to the colors in part (B). Scale bar is 40 μm and applies to all the 
images. (B) Correlation length values of actin network for each of the four frames 
of time series i, ii, iii are shown. Structural changes fueled by myosin activity forms 
bundles of actin filaments that enter and exit the plane of view. The correlation 
measurements correspond to the rearrangement of these bright areas, while an 









Biophysics is a bridging field that employs physics and mathematics concepts and 
methods to explore complex biological systems. Many physical and chemical principals 
could be applied directly to understand and quantify the governing behavior of biological 
organization in the cell and molecular scales. In addition, new methods and techniques 
have been developed using physical principles and engineering. Various types of imaging 
techniques, like fluorescence imaging that have extensively been used in this thesis, 
enable us to visualize biological structures and perform quantitative measurements.  
  Biological systems could be studied through observation, measurements, and 
manipulation of its component in vivo (performed in a living organism) as well as in vitro 
(performed outside of a living organism). Molecular biophysicists often examine 
biological processes as systems of interacting subcomponents. To reveal the underlying 
mechanism that govern these complex systems, it is essential to determine which features 
and subcomponents have a key role in a certain biological process. Then, proper 
experiments are designed to study these phenomena in living cells or in reconstituted 
systems that are assembled from biological building blocks.  Reconstitution experiments 
provide a powerful platform to determine minimal requirements for a certain biological 
system. Hence, the role of individual components and the interplay between them could 




This thesis focuses on reconstituted composite networks of cytoskeletal filaments, 
actin and microtubules, in vitro. This minimal system enables us to investigate the 
organization and dynamics of this composite network while other well-defined 
components could be introduced in a controlled manner. Figure 1.1 shows the three main 
control parameters in the present work that contribute to the crosstalk of actin and 
microtubule filaments.   
The stiffness of actin and microtubule filaments is their key characteristic that has 
a significant role in their various biological functions. To regulate the mechanical 
properties of the composite network, we used filaments with different stiffnesses and 
lengths. Here, the persistence length (rigidity) of the filaments remained fixed. 
Microtubules are more rigid compared to actin filaments. In chapter 2, the length of the 
pre-polymerized actin and microtubule filaments were controlled, while filament length 





Figure 1. 1 Phase diagram parameters for studying composite network of actin and 
microtubule filaments. Particle properties in the composite network of filaments, 
such as stiffness and the length of the filaments could tune the characteristics of the 
network. Interaction of filaments could be regulated by the type and amount of 
crosslinkers and crowding agent used for imaging. Activity of the composite could 
be controlled by the type and amount of the crosslinkers, while ATP concentration 
could also affect the activity of motor proteins and the composite network. 
 
To tune the interaction of actin and microtubule filaments, different types of 
crosslinkers and crowding agents could be employed. The structure and organization of 
the network of filaments could be determined by various types of crosslinkers that bind to 
them and form higher order structures. In chapter 3, biotin-Neutravidin molecules create 
isotopically crosslinked networks of actin and microtubules. In other studies, in chapter 3 
and 4, these molecules bind to actin filaments to link them while MAP65 molecules form 
bundles of microtubules. Another interesting work in chapter 2 indicates that crowding 
agents that are used to facilitate imaging near a surface in a sample could also affect the 
way that filaments “talk” to each other.  
Activity of the composite network could be provided by different kinds of motor 
proteins that constantly consume energy and generate force in the system. In chapter 2, I 
used kinesin-1 and myosin II motors to observe the self-organization of filaments in the 
2D composite network. Chapters 3 and 4 explore the steady-state dynamics of the 
composite network where no motor protein has been used. Myosin II motor activities in a 
3D composite network of actin and microtubule are discussed in chapter 5. This active 
composite network undergoes contraction motion that leads to structural changes in the 
network of filaments. 
The actin-microtubule composite networks were examined systematically while 




The amount and the type of each factor, such as the amount of crosslinker or motor 
protein, enable us to study the phase diagram at these limits. To visualize the formed 
composite network at each data point, I used epi-fluorescence (chapter 2, 4) or scanning 
confocal (chapter 3, 5) microscopy. The results of each study are discussed and analyzed 
accordingly.  
1.2 Biological background 
Cells organize their interior and interact effectively with their environment. A 
complex interacting network of filaments, the cytoskeleton, empower the cell to carry out 
vital functions. The essential roles of the cytoskeleton are to facilitate morphological 
changes in cell division and migration. It shapes the cell and enables it to maintain its 
integrity while responding to stress caused by changing environment. The cytoskeleton is 
composed of three different types of protein filaments: microtubules, actin filaments, and 
intermediate filaments. Each of them has certain mechanical properties, dynamics, and 
biological roles. Each of these filaments has a large set of specific accessory proteins as 
well as motor proteins. To execute key processes, cell requires effective cooperation and 
interaction between these filaments and accessory proteins.  
Here, the biological background of two main cytoskeletal filaments actin and 
microtubules will be reviewed.  The characteristics of some of their associate motor 
proteins, myosin II and kinesin-1 as well as crosslinkers such as MAP65 and biotin-




1.2.2 Cytoskeletal filaments 
1.2.2.1 Actin filaments 
 
Actin filaments are helical biopolymers with the diameter of 5-9 nm while the 
helix repeats every 37 nm (Fig 1.2.A). Filamentous actin, also known as F-actin, 
polymerizes from noncovalently bound globular actin monomers, G-actin that has a 
molecular mass of 42 kDa. These weak noncovalent bonds between subunits enable the 
actin filaments to assemble and disassemble rapidly with no need of forming or breaking 
covalent bonds 1. X-ray crystallography shows that globular actin consists of two lopes 
separated by a cleft. This cleft is a binding site for adenosine triphosphate (ATP) 
or adenosine diphosphate (ADP) associated with a Mg2+ ion 2,3. These G-actin monomers 
assemble head-to-tail to generate actin filaments.  
The actin filament is called a polar structure because the orientation of the 
asymmetric subunits forms a filament with two distinct ends that have different structure 
and dynamics. Hence, actin filament has a fast-growing end, the “plus end”, and slow a 
growing end, the “minus end”. These ends are also called the barbed and pointed ends, 
respectively. The latter terminology refers to the electron microscopic images of actin 
filaments decorated with myosin motors that show arrowhead configuration, where the 
shaft is the actin and the fletching is the myosin. The end of the filament without any 
protruding myosin is called pointed end and the other end is barbed end 4–6.  In the steady 
state, the net assembly rate at the plus end equals the net disassembly rate at the minus 
end. This phenomenon is called treadmilling that maintains the length of actin filaments 
constant in steady-state condition, although there is a flux of G-actin monomers along the 




Actin polymerization is a non-equilibrium process due to constant energy 
consumption. ATP hydrolysis process starts shortly after an ATP-bound monomer 
incorporates to a filament. Thus, ADP-bound actin monomers are formed and remained 
trapped in the filaments, while the free phosphate group, Pi, releases slowly from each 
monomer. Consequently, two different ATP-bound and ADP-bound G-actin could be 
found in the filament structure. At fast elongation rates of actin filaments, a transient cap 
of ATP-bound subunits exists at the plus end, while at steady state, it turns to stabilizing 
ADP-Pi cap at the fast-growing end of actin polymer. However, phosphate release leads 
to conformational changes of the actin subunit that destabilize the intermolecular bounds 
between the monomers and result in structural and dynamics changes 8–10. 
Actin is a relatively flexible filament, as quantified by persistence length 
measurements carried out both on in vitro and in vivo such as thermal fluctuation analysis 
11–14 and mechanical properties studies with optical tweezers 15. The results indicate the 
persistence length in the order of 10 - 20 μm 14,16–18. In vitro F-actin polymerization can 
form filaments in range of 1-20 μm, while the distribution of filament length depends on 
the initial G-actin concentration 19,20. As the results, in most of the in vitro studies, F-actin 
could be considered a semiflexible polymer due to its comparable length distribution to 
the persistence length.  
Actin filaments form higher order structures using accessory proteins that regulate 
their mechanics and dynamics 21–23. In muscle cells, aligned actin filaments and myosin 
motor proteins generate force and ultimately muscle contraction. During cell mitosis, 




provides structural support to the cell interior during mitosis. It allows the cell motility by 
generating protrusive and retractive forces at the front and rear of the cell 1. 
 
 
Figure 1. 2 (A) Structure of an actin filament: Actin is a double helix filament that is 
made of globular actin monomers. This biofilament has the diameter of 5-9 nm 
when the length of the half a period is around 37 nm. (B) Structure of a microtubule 
filament: Microtubule is a hollow cylinder with the inner diameter of 17 nm and 
outer diameter of 25 nm. Tubulin dimers are subunits of a microtubule filament. 
 
1.2.2.2 Microtubule filaments  
Microtubules are formed from protein subunits called tubulin. Each tubulin is a 
heterodimer that is made of two globular proteins, α and β tubulin that are tightly bound 
noncovalently. Each α and β subunit weights 55 kDa and has a binding site for a GTP 
molecule. The GTP that is bound to α tubulin is physically trapped and never hydrolyzed 
or exchanged. In contrast, the GTP in the β tubulin could be hydrolyzed to GDP, and it is 
exchangeable.  That hydrolysis cause conformational changes in the microtubule subunits 




Tubulins assemble into a hollow cylinder structure with inner diameter of 17 and 
outer diameter of 25 nm, that is composed of 13 protofilaments 25 (Fig 1.2.B). The 
longitudinal contact occurs between α and β subunit while lateral contacts are between α - 
α and β - β subunits 26. All of the subunits in a protofilaments point in a same direction, 
while the protofilaments are aligned in parallel along the microtubule polymer. As a 
result, microtubule filaments have two distinct ends with different polymerization 
dynamics. They have fast-growing “plus end” and slow-growing “minus ends” where the 
β tubulins and α tubulins are exposed, respectively 27,28.  
Tubulins bind and hydrolyze GTP to GDP. This process is important in 
microtubule polymerization dynamics as well as stability. The GTP hydrolysis only 
occurs at the β tubulin, while the GTP that binds to α tubulin is never hydrolyzed. The 
hydrolysis causes conformational changes within the tubulin as it leads to compaction 
that rearranges and tilts the interaction between α and β tubulins 29,30. 
Microtubules go through a stochastic process of switching between growing and 
shrinking called dynamic instability. This phenomenon allows the microtubules to form 
new structures and rearrange the interior of the cell accordingly. When the rate of 
assembly of subunits is faster than the hydrolysis of the GTP, a stabilizing GTP cap 
forms on the microtubule end that tends to grow fast. However, if hydrolysis proceeds 
faster than the subunit addition, the cap is lost and depolymerization happens. The 
transition from growth to rapid shrinking is called catastrophe, while the change to 
growth is called rescue 1,27.  
The structure of the microtubule forms a stiff filament that withstands mechanical 




as thermal fluctuation measurements 31, flow 32,33, or optical tweezers 33–35. The 
persistence length of the microtubule corresponds to 1 mm 14,18,36,37  which is larger than 
the average size of eukaryotic cell (5 – 15 μm) 38. This explains how these filaments 
maintain the structure of the cell. Microtubules provide a platform for intracellular 
transport by making tracks for cargo-carrying motor proteins. Microtubules also have a 
vital role in forming the mitotic spindle while the dynamic instability allows 
reorganization of these filaments during cell division.  
1.2.3 Motor proteins  
One of the important associated proteins of the cytoskeleton are motor proteins. 
Each type of filament has specific motor proteins that can bind, hydrolyze ATP, and 
move along these structurally polarized polymers. A superfamily of myosin motors with 
different structures bind to actin filaments and generate motion. For microtubules, more 
that fourteen families of kinesin in the kinesin superfamily were found that can bind to 
microtubules. Each type of motor protein walks along in certain direction of filaments. 
Using these polar tracks, they carry organelles, such as Golgi complexes and secretory 
vesicles, to various locations in the cell. Motor proteins also can generate force by sliding 
filaments against each other and exerting tension in the cell that facilitate muscle 
contraction and ciliary beating. 
The immobilized motor proteins can propel their associate filaments in a gliding 
assay experiment. In chapter 3, I use both myosin and kinesin to simultaneously drive 
actin and microtubule filaments in a gliding assay. In the last chapter, I explore the 
organization of a 3D contractile actin-microtubule composite network when myosin II 






Figure 1. 3 Structure of (A) Myosin II: Myosin motor protein bind to actin filaments 
and generate movement by ATP hydrolysis. It consists of head, neck and tail parts. 
The head domains bind to the actin filament (2012 Pearson Education). (B) Kinesin- 
1: It is the associate motor protein of microtubule filaments. Kinesin also has head, 
neck, and tail parts. The head binds to microtubule and generate force by 
hydrolyzing ATP 39. 
 
 
1.2.3.1 Myosin motor  
Myosin is a superfamily of motor proteins that walks along actin filament and 
could be found in almost all eukaryotes. Myosin protein is composed of head domain, 
neck and elongated tail part. The head domain is the force generative machinery that 
binds to actin filaments (Fig 1.3.A). Each myosin head binds and hydrolyzes ATP to 
move toward the plus end of the actin filaments.  
Skeletal muscle myosin was the first identified motor protein, called conventional 
myosin or myosin II due to its two head domains. Myosin II motors generate force and 
displacement through a power stroke mechanism empowered by ATP hydrolysis. The 




hydrolysis, while myosin is tightly binding to actin. This release results in conformational 
change in myosin motor and generates force. Then, the head of myosin loses its bound 
ADP molecule while locked tightly to actin filament in rigor configuration.  Binding to a 
new ATP, reduces the affinity of the head to actin, hence the myosin motor releases the 
actin filament. The hydrolysis of a new ATP molecule followed by phosphate releasing 
leads to myosin binding to actin again and repeating this cycle 40–42. 
Myosin II plays an important role in contractile activities in both muscle and non-
muscle cells.  In muscle cells, individual myosin II motors joint together and form the 
thick filament of sarcomere, which is a vital structure for muscle contraction 1. In non-
muscle cells, myosin II motors and actin filaments build stress fibers. These actin bundles 
facilitate cell contractility by providing force during various cell functions such as cell 
adhesion, migration and morphogenesis 42,43.  
1.2.3.2 Kinesin motor 
Kinesin is a microtubule-associate motor protein powered by ATP hydrolysis and 
walks along the microtubule toward the plus end (Fig 1.3.B). Kinesin is structurally 
similar to myosin II and consists of two globular head motor domains, an elongated tail, 
and a neck. These head domains work in a coordinated manner that enable the kinesin to 
step forward. Once a head domain is bound to the microtubule, ATP binding causes 
conformational changes in the neck linker part of the motor that leads to movement 
toward the plus end of microtubule. After hydrolyzing ATP and releasing the phosphate, 
the head detaches from the microtubule. By exchanging the ADP for a new ATP, the 




Like myosin, kinesin belongs to a large superfamily. Kinesin motors transport 
large cargos to desire destination in the cell by their unidirectional movement along 
microtubules. They have been known for fast movement of mitochondria and fast axonal 
transport. Additionally, many types of kinesin motors are in charge of mitotic and meiotic 
spindle formation as well as chromosome separation during cell division 1. 
1.2.4 Crosslinkers 
Cells regulate their morphology, dynamics, and mechanics of the cytoskeletal. To 
control higher order structures of actin and microtubules, the cell accurately adjusts the 
interaction between the cytoskeletal filaments in different positions. A wide range of 
accessory proteins for each type of filament, governs filament bundling and crosslinking. 
I discuss in chapter 3 that in in vitro studies the presence of crowding agents could also 
modify the interaction of microtubule-microtubule filaments, as well as actin-actin and 
actin-microtubule filaments. In this thesis, I employed two different types of crosslinkers, 
MAP65 and biotin-NeutrAvidin molecules. 
1.2.4.1 Biotin-NeutrAvidin  
NeutrAvidin is a tetramer that weighs around 60 kDa. It has a strong affinity to 
biotin, KD = 10 
-15 M. Biotin-NeutrAvidin complex molecules are generic and strong 
crosslinkers that are employed to form isotropic crosslinked network of filaments 45. 
Different desirable crosslinking motifs could be made using preassembled NeutrAvidin 
with biotinylated actin and/or tubulin. In addition, different amounts of these crosslinkers 




1.2.4.2 MAP65 molecules 
Proteins that bind along the side of microtubule filaments are called microtubule-
associated proteins or MAPs. Various types of MAPs are identified to be responsible for 
different functions such as stabilizing and crosslinking microtubules. MAP65 molecules, 
are a family of MAPs that weight 65 kDa and form antiparallel crosslinked microtubules. 
They could be found in plants, and are analogous to PRC1 in animal cells and Asep1 in 
yeast cells 46. It has been shown that purified MAP65 forms microtubule bundling in vitro 
while the spacing between adjacent microtubules is around 25 nm 46–49.  MAP65 
molecules have a binding affinity of KD = 1.2 μM 
50. Hence, they weakly crosslink 
microtubules in vitro. However, great number of these transient crosslinkers can 
guarantee the formation of more stable bundles of microtubule filaments. 
In this thesis, I explore the composite network of actin and microtubule filaments. 
To control the interaction of these filaments, different types of crosslinkers or crowding 
agents were employed. The steady-state dynamics of the composite network due to 
thermal fluctuations were measured. The mobility of the active composite networks was 
quantified while motor proteins actively organize the structure of the networks. 
Investigating the active self-organization and dynamics of the composite network of 
filaments could reveal the underlying mechanism that leads to crosstalk between actin 
and microtubule filaments in the cytoskeleton in the presence of their numerous auxiliary 








ACTIVE SELF-ORGANIZATION OF THE 2D COMPOSITE NETWORK OF 
ACTIN AND MICROTUBULES  
2.1 Abstract 
Spontaneous self-organization of active matter has been demonstrated in a 
number of biological systems including bacteria, cells, and cytoskeletal filaments. 
Cytoskeletal filaments act as active polar rods when they are propelled along a glass 
surface via motor proteins. Actin has previously been shown to display polar or nematic 
ordering, whereas microtubules have been shown to create large vortices. For the first 
time, I combine both the actin and microtubule gliding into a composite active system.  In 
the absence of actin filaments, microtubule filament organization transitions from 
isotropic to nematic to polar as a function of filament density. I find that the presence of a 
crowder, methylcellulose, is essential for this transition. In the absence of actin, 
microtubules transition from isotropic to nematic. In combination, microtubules are 
affected by the presence of actin and the overall density of the filaments, becoming 
entrained with the nematic alignment of actin. Actin filaments are not as affected by the 
presence of microtubules. These results serve as a first step in exploring the rich 
emergent behavior that can result from composite active matter system with tunable 





Active materials are a recently demarcated class of non-equilibrium systems that 
are characterized by energy input at the microscale that results in emergent steady states 
at long length scales. Being inherently out of equilibrium due to the microscopic drive, 
the basic mechanisms that lead to emergent behavior provide a pathway to design 
materials that have properties prohibited thermodynamically in traditional systems 51 and 
identify design principles for directed self-assembly 52. Further, active materials serve as 
a useful theoretical paradigm to understand biochemomechanical functionality in 
biological systems ranging from sub-cellular 53–55 to tissues 56–58.  
From a fundamental point of view, it is useful to categorize active materials based 
on the symmetry of the active drive and the interactions among particles 59,60. The most 
common realization of activity is self-propulsion, a self-replenishing velocity along one 
direction of the body axis of the particles that compose the material. This could arise 
either due to flagellar swimming in the case of bacteria 61,62 or due to cytoskeletal 
motility as in the case of epithelial cells 63,64, due to chemical catalysis in the case of 
synthetic systems 65,66 or due to the activity of a motor protein carpet as in the case of 
motility assays 67–69. The symmetry of this form of drive is called “polar” in that there is a 
specific direction in the particle coordinates in which the driving acts. The emergent 
properties of self-propelled particle systems are determined by the symmetry of the 
interaction. The most well studied case is that of isotropic (non-aligning) excluded 
volume interactions. Isotropic active fluids have proved fruitful to describe synthetic self-




athermal phase separation 71, rectification in the presence of barriers 72, and boundary 
effects 73.  
Another realization of interactions among self-propelled particles is nematic 
alignment, where the body axes of two interacting particles along which their self-
propulsion axes are equally likely to be aligned parallel or anti-parallel with respect to 
each other. This is a well-studied model theoretically, using microscopic 74–78, statistical 
mechanics 79–81, and continuum theory 82–85. Spectacular phenomenology predicted from 
the theoretical investigations include the existence of anomalous Giant Number 
fluctuations and phase separation into bands, and instability of the bands leading to a 
chaotic inhomogeneous steady state. The experimental investigations into this rich 
parameter space have been more limited. A vibrated monolayer of granular rods have 
been used as an experimental test bed for some of these ideas 86,87  while this theoretical 
paradigm has been used to understand some emergent behavior in B. Subtilis 61,62,88 and 
myxobacteria colonies 89–91.  Further, to date, most active matter systems explored 
experimentally, have been composed of a single species of active particle, while 
theoretical work on self-propelled  particles with varying motility has shown segregation 
behavior in bulk 92 and under confinement 93. 
In this work, I create a new, composite system composed of both microtubules 
and actin filaments as rods propelled by their respective motor proteins, kinesin-1 and 
myosin II. I build upon past work with actin systems 51,67,94,95 and our research group’s 
prior work with microtubule systems 96–98. The theory above describes actin ordering 
from isotropic to nematic, but prior experimental reports have shown that actin can also 




67,99. The same theories apply to microtubule systems, but microtubule ordering has often 
been difficult to observe, especially in kinesin-driven filament gliding assays. In our 
previously published works, I used microtubule-gliding assays with kinesin-1 motors to 
examine the effects of both filament density and crosslinkers on self-organization of 
microtubules 96–98. I found that two microtubules do not interact at low concentration 96,97, 
often crossing each other as if the other filament was not in the path. When taken to 
higher filament densities, I found that there was no long-range order, instead small, single 
microtubule loops form (46). Other microtubule motors, such as axonemal dynein, have 
been shown to create arrays of large vortices of gliding microtubules 68. In this 
manuscript, I report a method for creating microtubule self-organization for the first time. 
Microtubules are capable of nematic and polar order at high densities. Interesting, the 
same experimental parameters cause actin filaments to lose their polar order, although 
they can still exhibit nematic ordering. 
In this work, I take self-organization a step forward by creating a new, composite 
system composed of both microtubules and actin filaments as self-propelled rods. This 
system can serve as a model to explore the emergent behavior of composite self-
propelled particles with aligning interactions and variable motility and particle properties. 
The actin and microtubule composite is also biologically interesting because 
microtubules and actin filaments make up part of the essential cytoskeletal network of 
cells. Microtubules serve as long-range support structures and the long-distance highway 
system for intracellular transport in the cell 100. Actin filaments serve as active force 
generators for cell motility and cellular contraction, as well as the short-range, local road 




into important architectures within cells, and are presumed to interact, yet little is known 
about those interactions. Recent work has illustrated that microtubule-associated proteins 
and actin binding proteins can serve as the intermediary between these two networks to 
drive co-organization during simultaneous co-polymerization 101,102. The cytoskeletal 
structure is active, using the energy of ATP (actin) or GTP (microtubules) hydrolysis to 
rearrange itself as needed based on the cell’s life cycle state, cell cycle state, or local 
environment. The cell has no internal intelligence prescribing the cytoskeletal 
architecture. Instead, the microtubule and actin networks must self-organize using 
physical and chemical cues. The work presented here is an important step in 
understanding how actin and microtubules could self-organize and coordinate in the cell 
using only physical (steric) interactions.  
In the experiments reported here, I find that actin alone changes from isotropic to 
nematic organizations with increasing filament density while microtubules exhibit 
isotropic, nematic, and polar ordering. When mixed together, I find that the actin can 
inhibit microtubule polar order, and the filaments can affect each other to cause 
entrainment. I find that the effect is stronger for actin affecting microtubule organization, 
but not as effective for microtubules on actin alignment. These results serve as a first step 
in exploring the rich emergent behavior that can result from this composite active matter 





2.3 Materials and Method 
2.3.1 Actin Polymerization 
Actin was purified from acetone powder of chicken pectoralis muscle as 
previously described 103. Briefly, G-actin was extracted from the actetone powder in a 
low salt buffer (2 mM Tris base, 0.2 mM CaCl2, 0.005% NaN3, at pH 8.0) on ice in a cold 
room (4°C).  Actin filaments were then polymerized in a solution including 1 mM ATP, 
10 mM imidazole, 50 mM KCl, 1 mM MgCl2, and 1 mM DTT, pH 7.5. Labeled actin 
filaments were polymerized in the same buffer from a combination of rhodamine-labeled 
globular actin (Cytoskeleton) and unlabeled actin at a ratio of 1:2. To polymerize 
filaments, actin solution was incubated on ice for 30 minutes and then at room 
temperature for another 30 minutes. Unlabeled phalloidin (Thermo Fisher Science) in 
methanol was added to stabilize the actin filaments with a final concentration of 16 µM. 
After the addition of phalloidin, filaments were incubated on ice for another hour.  
2.3.2 Microtubule Polymerization 
Microtubules were polymerized from 5 mg/ml tubulin dimers (Cytoskeleton) in 
adding PEM-100 (100 mM PIPES, 1 mM EGTA, 1 mM MgSO4, pH 6.8). Labeled 
microtubules were polymerized by mixing Dylight-650 tubulin (Cytoskeleton) or Alexa-
647 tubulin (PUR Solutions) at a 1:8 ratio tubulin with unlabeled tubulin. After mixing 
tubulin in PEM-100, dimers were centrifuged at 360,000xg at 4°C for 10 minutes to 
pellet aggregated dimers. The supernatant was removed and used for polymerization. 
GTP was added to the solution at 1 mM. Tubulin was incubated at 37°C for 20 minutes. 




stabilize microtubules. The Taxol binding was equilibrated by incubating at 37°C for 
another 20 minutes. 
2.3.3 Myosin II preparation 
Whole skeletal muscle myosin (myosin II) was purified from chicken pectoralis 
muscle as previously described 104. It was subsequently cut by chymotryptic digestion 
into heavy meromyosin (HMM) and further purified as described 104. HMM was stored in 
-20°C in 50% glycerol and a low salt myosin buffer (25 mM imidazole, 300 mM KCl, 1 
mM EGTA, 10 mM DTT, 4 mM MgCl2 at pH 7.4.) for up to 4 weeks when being used in 
gliding assays. Prior to use in filament gliding assays, the final purification steps for 
HMM were performed to remove any enzymatically dead myosin motors. Myosin stock 
is diluted in myosin buffer to final concentration of 180 µg/ml myosin, 100 µg /ml 
unlabeled F-actin, and 1 mM ATP. The myosin and actin were centrifuged for 20 minutes 
at 95,000 rpm and 4°C. Enzymatically dead myosins bind and do not release from actin 
filaments, and therefore pellet during centrifugation. Use of myosin remaining in the 
supernatant ensures the best activity of the motors and the removal of dead motors 
reduces additional drag on these active motors in these motility assays.  
2.3.4 Kinesin-1 Preparation 
Truncated kinesin-1, 560 amino acids in length, with a 6x His tag and GFP at the 
amino terminus (AddGene) was transfected into BL21 bacteria cells for protein 
expression and purification, as previously described 105,106. Kinesin was aliquoted and 




gliding assays, kinesin-1 was clarified by centrifugation at 360,000 xg for 10 minutes at 
4°C. 
2.3.5 Filament Gliding Assay 
Filament gliding assays to accommodate both actin and microtubule gliding were 
modified from microtubule and actin gliding assays (Fig 2.1). Coverslips were coated 
with 0.1% nitrocellulose diluted in amylacetate using a spin coater at 3,500 rpm for 30 
seconds. Coverslips were used to create experimental chambers using double stick tape to 
create a flow path between a slide and the coverslip. Chambers were 10 μl in volume. 
Myosin (530 nM) and kinesin (58 nM) motors were mixed, added to the chamber, and 
incubated for 5 minutes to allow them to adhere to the surface. The surfaces were blocked 
by adding 0.5 mg/ml BSA in actin buffer (25 mM imidazole, 25 mM KCl, 1 mM EGTA, 
10 mM DTT, 4 mM MgCl2 at pH 7.4). Cytoskeletal filaments were added to the chamber 
and allowed to adhere. Actin filaments were diluted in actin buffer with oxygen 
scavenging system (0.016 μM glucose oxidase, 0.12 mg/ml catalase) and microtubule 
filaments were diluted in PEM-100 and 20 μM Taxol with the same oxygen scavenging 
system. Finally, motility solution (50 mM KCl, 2.5 mM ATP, 10 mM DTT, 30 μM 
Taxol, 0.6% methylcellulose in actin buffer) is added to initiate the gliding activity. 
In order to vary the density of the cytoskeletal filaments for each experiment, I 
adjusted the concentration of the filaments that were added to the chamber. The 
concentration was described by the concentration of the tubulin or G-actin subunits 






Figure 2. 1 Composite driven active rod experiments.  (A) The drive rods are 
composed of microtubule and actin filaments, which are polymerized from tubulin 
dimers and globular actin monomers, respectively. (B) Microtuules are driven by 
the ATP turn-over of kinesin-1 motor proteins. Actin filaments are driven by the 
ATP turn-over of myosin II motor proteins. Both motors are truncated forms. 
Kinesin-1 is truncated at amino acid 560 and expressed in bacteria. Myosin-II is 
enzymatically cleaved to make heavy meromyosin (HMM) and purified from chick 
muscles. (C) Active rod experiments performed in a filament gliding assay. Kinesin-
1 and myosin II are both adhered to the cover glass. Microtubules and actin 
filaments are added to the chamber where they bind to the motors and are propelled 
via ATP. Methylcellulose is added to keep actin and microtubule filaments crowded 
to the surface. 
 
using the median length measurement (Fig 2.2) of each filament, assuming that all the 
filaments were this median contour length, Lc. The contour length was used to find the 




filament. For microtubules, the number of subunits per filaments was approximated by 
assuming that the microtubules had 13 protofilaments around and a dimer was 8 nm in 
length. For an actin filament, there were two protofilaments and each monomer was 5 nm 
in length. The molar concentration was converted to the number of filaments using the 
estimation of the number of subunits per filament. The contour length was also used to 
find the volume of an individual filament, and the volume was converted to the surface 
area of the filament by raising it to the 2/3rds power. These estimations were used to 
change the concentration of tubulin or G-actin subunits into the number of filaments in 
the chamber and the surface density of filaments in the chamber, as reported. Because 
actin and microtubules are filaments, and they are polymerized at high density, they have 
the ability to be entangled networks in the test tube. This filament entanglement was the 
largest source of variation in our experimental system because the local filament density 
could change when entangled. When pipetting the filaments to dilute them, the entangled 
filaments could result in pulling out more or fewer filaments than expected. Further, the 
final chamber wash, which included methylcellulose had to be pipetted gently to prevent 









Figure 2. 2 Filament characterization. (A) Filament contour lengths were measured 
for actin filaments and microtubule filaments. (i) Probability distribution functions 
(PDFs) of actin filaments (red circles, N = 1070) and microtubules (blue squares, N = 
865) were binned with 0.25 μm sized bins and normalized. Data was fit to a 
lognormal function for actin (dark red line) and microtubules (dark blue line). See 
supplemental information for fit equation and supplemental table 1 for all fit 
parameters with uncertainty and goodness of fits. (ii) Cumulative distribution 
functions (CDFs) of the same data for actin filaments (red circles, N = 1070), and 
microtubules (blue squares, N = 865). CDFs were normalized and fit with the error 
function appropriate for lognormally distributed data for actin filaments (dark red 
line) and microtubules (dark blue line). See supplemental information for fit 
equation and supplemental table 2 for all fit parameters with uncertainty and 
goodness of fits. (iii) Using the fit parameters from the CDF data, I found the 
median contour lengths for both actin filaments (red bars) and microtubules (blue 
bars). Error bars represent the uncertainty of the fits parameter for the median. (B) 
Filament velocities were measured for actin and microtubule filaments separately. 
(i) PDFs of actin filament velocities (red circles, N = 276) and microtubules (blue 
squares, N = 167) were binned with 0.05 μm/s sized bins and normalized. Data was 
fit to a lognormal function for actin (dark red line) and microtubules (dark blue 
line). See supplemental information for fit equation and supplemental table 3 for all 
fit parameters with uncertainty and goodness of fits. (ii) Cumulative distribution 
functions (CDFs) of the same data for actin filaments (red circles, N = 276), and 
microtubules (blue squares, N = 167). CDFs were normalized and fit with the error 
function appropriate for lognormally distributed data for actin filaments (dark red 
line) and microtubules (dark blue line). See supplemental information for fit 
equation and supplemental table 4 for all fit parameters with uncertainty and 
goodness of fits. (iii) Using the fit parameters from the CDF data, we found the 
median filament velocities for both actin filaments (red bars) and microtubules 
(blue bars). Error bars represent the uncertainty of the fits parameter for the 
median. 
 
In order to mitigate these issues and increase the reproducibility of our 
experiments, I performed the following steps for each experiment. First, microtubules 
were sheared 3 times using a Hamilton syringe to purposely break up entangled networks 
and to create microtubules that were relatively short (Lc ~ 5 µm, Fig 2.2). Actin filaments 
were polymerized to be short (Lc ~ 1 µm, Fig 2.2), but they were still entangled at high 
concentration. In order to mix the labeled with unlabeled actin filaments, labeled 




pipette tip. The actin filaments were never pipetted excessively nor were they vortexed to 
mix, as this would cause shearing and reduction of the length of the filaments. All 
chambers were visually inspected to determine if the filament density was similar from 
chamber to chamber for the same experimental parameters. If a chamber did not appear 
to have a similar or expected density or either actin or microtubules, it was not used for 
analysis.  
Another source of uncertainty of the experiments was the labile nature of the 
isolated kinesin-1 or myosin II motors. These motors were fairly stable when stored but 
would sometimes prematurely expire and no longer function. If either the microtubules or 
actin filaments did not bind to the surface or did not glide, the chamber was discarded, 
and a new preparation of kinesin-1 or myosin II was purified. During this study, two 
different myosin II preparations from chicken and three different kinesin-1 preparations 
from bacteria were prepared. The majority of the data reported was from a single 
preparation of both kinesin-1 and myosin II.  
As described above, the final purification step for myosin II motors was 
performed each day prior to using the myosin II motors to remove myosin II motors that 
may have expired in storage. In this step, the myosin was bound to actin filaments and 
released using a high concentration of ATP. Despite all these procedures, I still had some 
enzymatically dead myosin II motors bound to the surface in the experiment. In typical 
actin gliding assays, one would add in unlabeled actin filaments to block these dead 
motors in the chamber. In this work, such additional filaments would increase the 




some labeled filaments at the lowest actin concentration that would bind to dead myosin-
II molecules and be immobile.  
2.4 Imaging and Image analysis 
For all assays, gliding filaments were visualized using epi-fluorescence imaging 
on a Nikon Ti-E inverted microscope with either a 60x water immersion objective (NA = 
1.38) or a 60x oil-immersion objective (NA = 1.49). Rhodamine actin (excitation: 530 
nm, emission: 560 nm) and Dylight 650 (excitation: 650 nm, emission: 700 nm) or 
rhodamine microtubules (emission: 530 nm, excitation 560 nm) were imaged using 
sequential imaging for 2 minutes to 60 minutes and recorded using Nikon Elements. 
Images were projected onto the detector of a Scientific-CMOS camera (Zyla, Andor), 
recorded, and saved as .nd2 files (compressionless tif files) with the metadata. Image data 
was imported into ImageJ/Fiji using the Bioformats Imager. The pixel size was 108 
nm/pixel. The diffraction limit for the fluorescence image was approximately 300 nm, 
which corresponded to about 3 pixels. All experiments were performed at room 
temperature (23°C) in a temperature-controlled room with year-round heating and air 
conditioning. 
Determination of the state of the filament gliding system were performed by 
creating standard deviation z-projections of the time series movie data using ImageJ/Fiji. 
The standard deviation images were inspected manually and classified initially in that 
manner. In order to reduce human bias, I also used two different ImageJ/FIJI plugins to 
characterize the global organization of the filaments. The programs were “Directionality” 
107 or “OrientationJ” 108. Both of these systems can use either a nearest neighbor approach 




gradient of the intensity in a local vicinity corresponds to the local orientation. I found 
that both of these systems worked well for identifying the regions where filaments were 
aligned and the orientation of the aligned regions. Global alignment could be visually 
inspected using a color-coding. Histograms of the angles represented within the image 
were plotted (Fig 2.3). When the image was globally isotropic, the angles were evenly 
distributed, with no or very little peak at the alignment angle. For aligned images, there 
was one dominant or characteristic angle in the histogram between -90 and 90 degrees, as 
would be expected for aligned filaments. Using this analysis, I could verify in a non-
biased way, when the standard deviation images revealed alignment for most of the data 
(Fig 2.3 A).  
I found that the ImageJ/FIJI plugins or programs had some difficulty with certain 
data sets. I show two difficult data sets in the supplement (Fig 2.3 B). The reasons for the 
uncertainty were sometimes due to the fact that there were very few filaments, such as in 
the most dilute regimes. Other times, the images had non-motile, background aggregates 
that showed up in fluorescence. Although these aggregates should be round, if the movie 
displayed thermal drift, the points would be analyzed as orientation in the data. I 
attempted to correct this using drift correction plugin (StackReg) but was not able to drift 
correct all the data sets. Finally, sometimes the data appeared isotropic to our eyes, but 
appeared to have some overall orientation. This may have been due to the fact that the 
goal of the program is to seek out and report orientation based on intensity gradients. 
Samples with low signal-to-noise, which some of our data had due to photobleaching, 




when the Directionality or OrientationJ analysis did not report the overall arrangement of 
the filaments as clearly (Fig 2.3 B). 
Another analysis that could be employed to characterize the type of alignment in 
the network is spatial correlation measurements. Briefly, I used a MATLAB code that 
uses Fast Fourier Transform, FFT, to compute pair autocorrelation function 109. The 2D 
correlation function map 𝑔(𝑟, 𝜃) =  
𝐹𝐹𝑇−1( |𝐹𝐹𝑇 (𝐼)|2 )
𝐹𝐹𝑇−1( |𝐹𝐹𝑇 (𝑊)|2)
  was calculated for an image, I. 
Here, FFT-1 is a revers Fast Fourie Transform, while r and θ are distance and angle, 
respectively. Also, W is a mask that has the same size as the image where all pixels have 
a value of 1 inside the measurement area and was used for normalization purposes. The 
2D correlation map of example images with nematic and isotropic organization for actin 
and microtubule channels are displayed in Fig 2.4 and Fig 2.5. To calculate the 1D 
correlation function G(r) for an image, g(r,θ) was averaged over all the angels θ for 
different r values. Then, 1D correlation function, 
G(r) − 1
𝐺𝑚𝑎𝑥(𝑟)−1
 , was plotted versus r (μm) 
while Gmax(r) has the greatest value of the 1D correlation function (Fig 2.4 v, vi and Fig 
2.4 v,vi). The 2D correlation map of the nematic microtubule and actin images (Fig 2.4 
iii, iv) indicates that g(r,θ) map highly depends on θ angles, where the repetitive 
structures are formed along the alignment axes for filaments. However, isotropic 
microtubule and actin images (Fig 2.5 iii, iv) display radially symmetric g(r,θ) maps as 
predicted 110. However, although the 2D correlation maps show angular dependent 
patterns for nematically ordered filaments, it seems that it is not the optimum method to 





After all, in order to assess if bundles of microtubules or actin filaments were 
displaying nematic or polar alignment, I used kymographs (space-time plots). The 
location of the linear region of interest for the kymograph was determined using the 
standard deviation z-projections of the movies, which represented the tracks of filaments 
over time. The linear region of interest was moved to the movie and created using the 
MultiKymograph plugin in ImageJ/FIJI. The linear region of interest was expanded to 
three pixels, which is a diffraction-limited region for our microscope. Kymographs 
displayed the number of filaments and the direction of the filaments that moved along the 






Figure 2. 3 Example images and angle analysis using Directionality plugin in 
ImageJ/Fiji. (A) Filaments that were well-aligned (nematic or polar) for (i) 
microtubules or (ii) actin are displayed as a standard deviation compression over 
movie. The angular distribution for (iii) microtubules and (iv) actin of the images in 
(i) and (ii), respectively. Nematic or polar alignment results in an asymmetric 
distribution peaked at one angle. (B) Filaments that are not well-aligned (isotropic) 
for (i) or (ii) actin are displayed as a standard deviation compression over the time 
series of the movie. The angular distribution for (iii) microtubules and (iv) actin of 
the images in (i) and (ii), respectively. Isotropic alignment results in an almost flat 
distribution, which some edge effects. Some of the angle distributions were more 








Figure 2. 4 Example images and correlation analysis for nematic/polar organization 
of filaments. (i, ii) Nematic organization for microtubule (i) and actin (ii) filaments 
displayed as an intensity compression over movie. Each image is 1429×1429 pixel or 
154.81 μm×154.81 μm. Scale bar is 20 μm and applies to both images. (iii, iv) 2D 
spatial correlation g(r,θ) is displayed for microtubule (iii) and actin (iv) filaments 
versus pixels. (v, vi) 1D spatial correlation is plotted versus short range distance, 
r(μm), for microtubules (v) and actin filaments (vi). The results calculated after 
angular averaging of g(r,θ) and then normalization. Correlation values 1 and 0 






Figure 2. 5 Example images and correlation analysis for isotropic organization of 
filaments. (i, ii) Isotropic organization for microtubule (i) and actin (ii) filaments 
displayed as an intensity compression over movie. Each image is 1429×1429 pixel or 
154.81 μm×154.81 μm. Scale bar is 20 μm and applies to both images. (iii, iv) 2D 
spatial correlation g(r,θ) is displayed for microtubule (iii) and actin (iv) filaments 
versus pixels. (v, vi) 1D spatial correlation is plotted versus short range distance, 
r(μm), for microtubules (v) and actin filaments (vi). The results calculated after 
angular averaging of g(r,θ) and then normalization. Correlation values 1 and 0 






2.5.1 Filament and gliding characteristics 
    I systematically studied active matter composite systems of actin and microtubule 
filaments propelled by myosin II and kinesin-1 motors, respectively. Immobilized myosin 
and kinesin proteins adhered to a nitrocellulose-coated coverslip through non-specific 
interaction as it was described previously 69. Methylcellulose, a macromolecular 
crowding agent routinely used in actin gliding assays was added (0.6%, 88,000 MW) to 
keep the filaments close to the surface 100,111 (Fig 2.1). 
Actin and microtubule filaments have different bending stiffnesses that make their 
composite networks a unique and interesting system to study. The persistence length of 
actin filaments is around 16 μm 14, and microtubules are more rigid with the persistence 
length of 1 mm 14,36,37. I measured the counter length of actin and microtubule filaments 
to assure they were in a regime that act as rigid rods. I found that their contour length 
distributions were log normal as it was expected for polymerization reactions 112. I plotted 
the probability distribution function (PDF) and cumulative distribution function (CDF) 
for contour lengths of both filaments (Fig 2.2.A).  
Normalized probability distributions were fit to lognormal distributions of the 
form: 
 







)         Eq 2.1 
Where A is an amplitude, x0 and σ are the mean and standard deviation of the normal 
distribution of log(x). For normalized data, the amplitude should equal the inverse of the 
square root of 2π, but we cannot discount the possibility of undercounting the data. I found 




The best fit parameters for the filament contour length probability distribution functions 
can be found in Table 2.1. 
 
Table 2. 1 Best fit parameters for filament contour length probability distribution 
functions 
Data Set A x0 σ R2 
Actin 0.101 ± 0.004 -0.09 ± 0.02 0.65 ± 0.02 0.989 
Microtubules 0.099 ± 0.002 1.59 ± 0.02 0.79 ± 0.02 0.969 
 
Normalized cumulative distributions were fit to the error function very well, 
which is the expected fit for a cumulative distribution function of a lognormal 
distribution of the form: 






 erf ( 
ln (𝑥)− 𝑥0 
√2𝜎
 )      Eq 2.2 
When x0 and σ are as mentioned above. Here, an amplitude is not required, so it has one 
less fitting parameter. The best fit parameters for the filament contour length cumulative 
distribution functions can be found in Table 2.2. 
Table 2. 2 Best fit parameters for filament contour length cumulative distribution 
functions 
Data Set x0 σ R2 
Actin -0.2045 ± 0.0005 0.5403 ± 0.0009 0.999 
Microtubules 1.6196 ± 0.0008 0.778 ± 0.001 0.999 
 
I found the median contour length for the actin filaments was 0.980 ± 0.001 μm 




Another important characteristic in a gliding assay is the propulsion speed of the 
filaments (Fig 2.2.B). First, I directly measured the velocity of self-propelled filaments at 
low densities of actin and microtubule filaments. Normalized probability distributions 
were fit to lognormal distributions using equation 2.1. The best fit parameters for the 
propulsion speed probability distribution functions can be found in Table 2.3. 
Table 2. 3 Best fit parameters for propulsion speed probability distribution 
functions 
Data Set A x0 σ R2 
Actin 0.021 ± 0.001 -1.07 ± 0.07 0.94 ± 0.05 0.961 
Microtubules 0.025 ± 0.004 -0.9 ± 0.2 1.0 ± 0.1 0.840 
 
Also, normalized cumulative distributions were fit to equation 2.2. The best fit 
parameters for the propulsion speed probability distribution functions can be found in 
Table 2.4. 
Table 2. 4 Best fit parameters for propulsion speed cumulative distribution 
functions 
Data Set x0 σ R2 
Actin -1.077 ± 0.001 0.805 ± 0.002 0.999 
Microtubules -1.131 ± 0.005 0.726 ± 0.009 0.995 
 
I find that the velocity distributions are almost identical when plotted as 
probability distribution histograms (Fig. 2.2.B i). Using the Kolmogorov-Smirnov 
statistical test, I find that the probability that these two distributions are distinct is 16% (p 
= 0.161), so I conclude that the distributions are identical to our ability to measure it. 




functions (Fig 2.B ii) are very similar for actin (0.341 ± 0.001 μm/s) and microtubules 
(0.323 ± 0.004 μm/s) (Fig 2.2.B iii). 
2.5.2 Methylcellulose enhances microtubule-microtubule interactions 
Given our past results and long-time experience with microtubule gliding 96–98, we were 
surprised to see that microtubules became well-ordered at high density when we 
performed experiments as described here. The buffers and protein constituents are 
different in the current assays compared to prior work, so we examined what might cause 
the difference. We discovered that the presence of methylcellulose in the experiment was 
capable of inducing microtubule-microtubule interactions that result in the formation of 
large-scale bundles (Fig. 2.6.B). Methylcellulose is a crowding agent used in both actin 
gliding and microtubule dynamic instability assays to force the filaments to stay close to 
the surface during the assay. We added it here in the attempt to create a composite assay 
between microtubule and actin gliding. Excitingly, it enhanced the microtubule 
interactions, such that they were able to form self-organized bundles during gliding. 
Further, these bundles appear to be polar – all moving in the same direction. Thus, not 
only is the methylcellulose allowing the microtubules to sterically interact with each 
other, the microtubules are likely engaged closely and without lubrication, as has been 





Figure 2. 6 Methylcellulose increases microtubule interactions. (A) Time series of 
gliding microtubules in a chamber with kinesin-1 motors only without 
methylcellulose. Microtubules do not exhibit long-range interaction. Microtubules 
do create small loops. Time between frames is 100 s. (B) Time series of gliding 
microtubules in a chamber with kinesin motors and 0.3% methylcellulose, as used 
in our composite assays. Microtubules begin in a nematic phase, which is aligned 
and transition to a polar phase. Time between frames is 100 s. For all images, the 
scale bar is 10 μm. 
 
2.5.3 Microtubules exhibit Isotropic, Nematic, and Polar states 
Using the composite experimental system including kinesin, myosin, and 
methylcellulose, I observed microtubules alone can alter their self-organization as a 
function of filament density. At low filament density, the organization of microtubules in 
the chamber is isotropic. I displayed the motion of individual filaments by overlaying 
images of microtubules as different colors to represent different times (Fig 2.7.A). The 








Figure 2. 7 Steady states of microtubule organization as a function of increasing 
microtubule filament density.  (A) Color time overlays where each frame of a time 
series is overlaid as a different color, as indicated by the color scale bar. (i) Lowest 
concentrations of microtubules display an isotropic phase with filaments pointing in 
all directions.  The concentration (c) is 0.5 μM tubulin dimers. The filament density 
(ρ) is 0.0267 filaments per μm2. The surface area fraction of filaments (ϕ) is 0.033. 
The color time scale for this image is from 0 to 180 s. (ii) The intermediate 
concentration of microtubules displays a nematic phase with filaments co-aligning 
locally and moving in antiparallel directions within the high density regions.  The c 
is 2.5 μM tubulin dimers. The ρ is 0.133 filaments per μm2. The ϕ is 0.0167. The 
color time scale for this image is from 0 to 40 s. (iii) The highest concentration of 
microtubules displays a polar phase with filaments co-aligning globally and moving 
in the same directions within the high density regions.  The c is 5 μM tubulin 
dimers. The ρ is 0.267 filaments per μm2. The ϕ is 0.033. The color time scale for this 
image is from 0 to 120 s. (B) In order to determine the direction of the filaments 
within the high-density regions of the images, I created kymographs where the 
image along the linear region of interest is sequentially layered for each time step. 
The time dimension is portrayed on the y-axis. The space dimension along the 
filament is portrayed along the x-direction. (i) For the lowest density of filaments, 
visible tracks in the color time overlays were used to create kymographs. These 
tracks were deposited by single filaments, as evidenced by the single trail of intensity 
in the kymographs. (ii) For intermediate densities of filaments, the dense regions of 
the color-time overlay were used to create kymographs. The filaments moving in the 
high density regions were moving in both directions, as evidenced by the diagonal 
lines in both directions. (iii) For high density filaments, the high density regions of 
the color-time overlays were used to create the kymograph. All the filaments appear 
to move in the same direction implying that the high density region has polar-
aligned filaments. All scale bars in the x-direction are 5 μm for all images. All scale 




gliding trajectory of individual filaments (Fig 2.7.A i). Using these tracks, I created 
kymographs (space-time diagrams) of the moving filaments to reveal the direction and 
speed of each filament as it glided (Fig 2.7.B). The intensity of the filament was 
displayed with distance along the track on the x-axis, and time along the track in the y-
direction. The diagonal lines indicated motion of the filaments parallel to the track. For 
low densities, the kymographs showed one filament gliding in only one direction (Fig 




At intermediate filament densities, the tracks in the time color overlay image were 
mixed because many filaments were overlapping in a condensed, active stream of 
filaments (Fig 2.7.A ii). The condensed streams that appeared in the overlay image were 
used to create a kymograph to reveal the velocity and direction of filaments in the stream. 
In the kymograph, tracks moved in both directions (left and right). The width of the line 
used to create the kymograph was ~300 nm, which was approximately the diffraction 
limit of the microscope. The fact that multiple filaments with opposing directions were 
observed within the same diffraction-limited region of the stream implies that these 
filaments were organized into a nematic within the stream.  
At higher concentrations, the time color overlay was also a mix of colors, appearing 
white in some regions, because they were present over almost the entire imaging time 
(Fig 2.7.A iii). The condensed streams at higher concentration appeared a bit wider and 
better condensed than those at intermediate concentration. Creating a kymograph from 
these condensed stream regions, I observed that there are still multiple filaments within a 
diffraction-limited region. Unlike the intermediate filament density, I observed that all 
the filaments were proceeding in the same direction, creating a polar array of filaments 
(Fig 2.7.B iii). Thus, in our system, the microtubules self-organize into nematic or polar 
streams as a function of the filament density. 
2.5.4 Actin filaments exhibit Isotropic and Nematic states 
Using the same time color overlays and kymographs, I examined the direction and 
velocity of actin filaments (Fig 2.8). As for microtubules, low actin filament densities 
resulted in individual trajectory traces that correspond to the motion of individual actin 




persistence length of actin filaments. Prior work has demonstrated that the persistence 
length of gliding trajectories of actin and microtubules are equivalent to the persistence 
length of the filaments 114. When I created kymographs from the trajectories, I found that 
some filaments moved slower and had frequent pauses (Fig 2.8.B i, top), likely due to 
inactive myosin II in the chamber, as described in the methods. Other trajectories moved 
faster and did not pause (Fig 2.8.B i, bottom). 
At higher actin filament densities, I again saw condensed streams using the time-
color overlay. When the concentration of actin filaments was higher, the persistence of 
the trajectories increased significantly, and the direction of the filaments became aligned 
(Fig 2.8.A ii). Over time, the filaments in the chamber became more condensed, which 
could be seen in comparing color time overlays for an early movie with one from a later 
movie in the same chamber. The density of filaments increased within the streams, and 
streams coalesced and became more defined (Fig 2.8.A ii Early and Late).  
Using kymographs, it was clear that the condensed streams contained filaments 
moving in both directions, implying that they were nematic in organization (Fig 2.8.B ii). 
Both the early and late movies showed nematic ordering with filaments moving both 
directions within the same diffraction-limited region. The main difference was the density 
of filaments. Early movies had a fewer filaments within a diffraction-limited region, but 
late time kymographs showed more filaments, again implying that the filament density 








Figure 2. 8 Steady states of actin filament organization as a function of increasing 
actin filament density. (A) Color time overlays where each frame of a time series is 
overlaid as a different color, as indicated by the color scale bar. (i) Lowest 
concentrations of actin filaments display an isotropic phase with filaments pointing 
in all directions.  The concentration (c) is 0.5 μM actin monomers. The filament 
density (ρ) is 0.2 filaments per μm2. The surface area fraction of filaments (ϕ) is 
0.0008. The color time scale for this image is from 0 to 120 s. (ii) The highest 
concentration of actin filaments displays a nematic phase with filaments co-aligning 
globally and moving in antiparallel directions throughout the space.  The c is 10 μM 
tubulin dimers. The ρ is 3.0 filaments per μm2. The ϕ is 0.015. Filament alignment 
occurs rapidly, but the local density of the aligned filaments changes over time. 
Early images of these samples do not show density fluctuations – only global 
alignment. Later imaging of the same sample shows the accumulation of high-
density regions. The color time scale for these time series are from 0 to 120 s. (B) In 
order to determine the direction of the filaments within the high-density regions of 
the images, I created kymographs where the image along the linear region of 
interest is sequentially layered for each time step. The time dimension is portrayed 
on the y-axis. The space dimension along the filament is portrayed along the x-
direction. (i) For the lowest density of filaments, visible tracks in the color time 
overlays were used to create kymographs. These tracks were deposited by single 
filaments, as evidenced by the single trail of intensity in the kymographs. Some 
filaments were observed to pause because of interactions with some dead myosins 
(top). When unlabeled actin filaments were also included, all filaments were 
observed to move without pausing (bottom). (ii) For high densities of filaments, the 
denser regions of the color-time overlay were used to create kymographs. For early 
time movies, a single diffraction-limited region used for the kymograph still 
displayed filaments moving in both directions, even though the density was not as 
high. For the late time movies, the regions of high density show motion in both 
directions and a significantly higher number of filaments passing parallel to the 
diffraction-limited region. All scale bars in the x-direction are 5 μm for all images. 
All scale bars in the y-direction were 1 min in time for all kymographs. 
 
2.5.5 Actin-Microtubule Composite Active Matter Velocity Distributions 
I next combined the actin and microtubules together in the same assay to 
determine the interplay between the filaments. I performed a series of experiments with 
varying actin and microtubule concentrations and assessed the state of the system at late 
times (after allowing the system to evolve into steady state). A particularly interesting 
observation was that the velocity of the actin filaments was faster at higher density (Fig 




within streams, but I was able to track some filaments, and used those for this analysis. I 
quantified velocities for actin at 10 µM without microtubules or at 10 µM with 5 µM 
microtubules. Interestingly, I found that actin filaments were propelled significantly 
faster at the highest actin densities when compared to actin filaments at low density, 0.5 
µM without microtubules (Fig 2.2.B, 2.9.A). Using the KS test for significance, the 
probability that these velocity distributions were the same is less than 0.01% (p < 
0.0001). This was true for both actin alone and in the presence of microtubules.  
For actin filaments at low and high densities, normalized probability distributions 
were fit to lognormal distributions using equation 2.1. The best fit parameters for the 
propulsion speed probability distribution functions can be found in Table 2.5.  
 
Table 2. 5 Best fit parameters for actin propulsion speeds probability distribution 
functions 
Data Set A x0 σ R2 
Actin 0.5 µM Alone 0.021 ± 0.001 -1.07 ± 0.07 0.94 ± 0.05 0.961 
Actin 10 µM Alone 0.045 ± 0.004 -0.07 ± 0.06 0.62 ± 0.05 0.861 
Actin 10 µM with    5 
µM Microtubules 
0.040 ± 0.003 -0.18 ± 0.04 0.41 ± 0.04 0.854 
 
Also, normalized cumulative distributions for action filaments were fit to equation 
2.2. The best fit parameters for the propulsion speed probability distribution functions can 






Table 2. 6 Best fit parameters for actin propulsion speed cumulative distribution 
functions 
Data Set x0 σ R2 
Actin 0.5 µM Alone -1.077 ± 0.001 0.805 ± 0.002 0.999 
Actin 10 µM Alone -0.175 ± 0.003 0.532 ± 0.005 0.995 
Actin 10 µM with    5 µM 
Microtubules 
-0.262 ± 0.003 0.407 ± 0.005 0.985 
 
When I quantified the velocities of microtubules at 5 µM without actin or at 5 µM 
with 10 µM actin, I found minimal changes to the microtubule velocity (Fig 2.2.B, 
2.9.B). Comparing 0.5 µM to 5 µM microtubules, both without actin, the probability that 
they were the same is 4% (KS test, p = 0.04). Comparing 0.5 µM without actin to 5 µM 
microtubules with 10 µM actin, the probability that they were the same is 3.5% (KS test, 
p = 0.035). Although these results could be significant, more data would need to be taken 
to increase the confidence in these differences.  
For microtubules at low and high densities, normalized probability distributions 
were fit to lognormal distributions using equation 2.1. The best fit parameters for the 




Table 2. 7 Best fit parameters for microtubule propulsion speed probability 
distribution functions 
Data Set A x0 σ R2 
Microtubules 0.5 µM Alone  0.0220 ± 0.002 -1.0 ± 0.1 0.94 ± 0.08 0.836 
Microtubules 5 µM Alone 0.043 ± 0.005 -0.9 ± 0.1 0.74 ± 0.09 0.846 
Microtubules  5 µM with 10 
µM Actin 
0.041 ± 0.003 -0.96 ± 0.04 0.46 ± 0.04 0.927 
 
Also, normalized cumulative distributions for microtubules were fit to equation 
2.2. The best fit parameters for the propulsion speed probability distribution functions can 
be found in Table 2.8. 
Table 2. 8 Best fit parameters for microtubule propulsion speed cumulative 
distribution functions 
Data Set x0 σ R2 
Microtubules 0.5 µM 
Alone  
-1.131 ± 0.005 0.726 ± 0.009 0.990 
Microtubules  5 µM 
Alone 
-0.905 ± 0.009 0.70 ± 0.01 0.982 
Microtubules  5 µM with 
10 µM Actin 
-1.040 ± 0.006 0.41 ± 0.01 0.985 
 
 The median velocities for the actin and microtubules show that the velocity is 
strikingly increased for actin filaments compared to microtubules (Fig 2.9.C). Such an 








Figure 2. 9 Velocity of actin filaments increases with polymer concentration. (A) 
Actin velocities with crowding. (i) Probability distribution functions of the velocity 
of trackable actin filaments gliding in the myosin and kinesin gliding assay at 0.5 
µM without microtubules (red filled circles), 10 µM without microtubules (blue 
filled circles), or 10 µM with 5 µM microtubules (green filled circles). Fits to the 
data are lognormal fit equation (Equation 2.1) for 0.5 µM without microtubules 
(dark red line), 10 µM without microtubules (dark blue line), or 10 µM with 5 µM 
microtubules (dark green line). (ii) Cumulative probability distribution functions of 
the velocity of trackable actin filaments gliding in the myosin and kinesin gliding 
assay at 0.5 µM without microtubules (red filled circles), 10 µM without 
microtubules (blue filled circles), or 10 µM with 5 µM microtubules (green filled 
circles). Fits to the data are lognormal fit equation (Equation 2.2) for 0.5 µM 
without microtubules (dark red line), 10 µM without microtubules (dark blue line), 
or 10 µM with 5 µM microtubules (dark green line). (B) Microtubules velocities with 
crowding. (i) Probability distribution functions of the velocity of trackable 
microtubule filaments gliding in the myosin and kinesin gliding assay at 0.5 µM 
without actin (red filled squares), 5 µM without actin (blue filled squares), or 5 µM 
with 10 µM actin (green filled squares). Fits to the data are lognormal fit equation 
(Equation 2.1) for 0.5 µM without actin (dark red line), 5 µM without actin (dark 
blue line), or 5 µM with 10 µM actin (dark green line). (ii) Cumulative probability 
distribution functions of the velocity of trackable microtubule filaments gliding in 
the myosin and kinesin gliding assay at 0.5 µM without actin (red filled squares), 5 
µM without actin (blue filled squares), or 5 µM with 10 µM actin (green filled 
squares). Fits to the data are lognormal fit equation (Equation 2.2) for 0.5 µM 
without actin (dark red line), 5 µM without actin (dark blue line), or 5 µM with 10 
µM actin (dark green line). (C) Median velocities from the fits to the cumulative 
distribution functions for actin (filled bars) and microtubules (outlined bars). Actin 
data from 0.5 µM without microtubules (red filled bar), 10 µM without 
microtubules (blue filled bar), or 10 µM with 5 µM microtubules (green filled bar). 
Microtubule data from 0.5 µM without actin (red filled bar), 5 µM without actin 
(blue filled bar), or 5 µM with 10 µM actin (green filled bar). Error bars represent 
the uncertainty of the median velocity fit parameter from Equation 2.2. See Tables 
2.5–2.8 for all fit parameters with uncertainty and goodness of fits. 
 
2.5.6 Actin-Microtubule Composite Active Matter Phase Diagram 
Using the same parameters described above for actin or microtubules alone, I 
assessed if each system displayed isotropic, nematic, or polar order in either the 
microtubule or actin organizations. I created a phase diagram of the emergent behavior I 




In the low-density regions on the phase diagram, both microtubules and actin 
were isotropic, which would be expected. The density of each was too low to have 
interaction among the same filaments, and the total polymer mass was also very low. For 
the highest microtubule and actin filament densities, both filaments became co-aligned 
and nematic (Fig 2.10.B). At the highest density, I observed individual, fluorescently-
labeled actin filaments, which were added at a ratio of one fluorescent filament to 99 
unlabeled filaments. The labeled actin, serving as tracers, glided along paths of high 
microtubule density (Fig 2.10.B). The microtubule bundles were visible within the actin 
channel due to imperfect dichroic glass and the high density resulting in high signal.  
At low densities of actin, I found that the presence of the actin disrupted the 
microtubules’ polar order. Examining the last column of the diagram, when no actin was 
present, the microtubules exhibited polar order. When even the lowest density of actin 
was introduced to the system, the microtubules were no longer polar, but rather nematic. 
This implied that the microtubule-microtubule interactions that cause  
polar ordering were disrupted when actin filaments were present, implying that 
the microtubules “sense” the presence of the actin filaments. This could mean that the 
microtubule-microtubule interactions that lead to polar order are sensitive to even minor 








Figure 2. 10 State diagram for actin and microtubule composite gliding assays. (A) 
The actin filaments (red markers) were used at five different concentrations: 0.5 
μM, 5 μM, 6.7 μM, 8.8 μM, and 10 μM corresponding to the following filament 
densities (filaments per μm2): 0.2, 1.5, 2.0, 2.7, 3.0 and the following dimensionless 
area fractions: 0.0008, 0.008, 0.010, 0.013, 0.015.  The microtubules (blue markers) 
where used at three different concentrations: 0.5 μM, 2.5 μM, and 5 μM 
corresponding to the following filament densities (filaments/μm2): 0.03, 0.17, 0.34 
and the following dimensionless area fractions: 0.004, 0.02, 0.04.  For each 
concentration pair observed, I used the definitions of isotropic, nematic, and polar 
described in figure 2.7 and 2.8 to describe the organization of actin filaments or 
microtubules. Isotropic organizations are denoted with a filled circle. Polar 
organizations are denoted with a single-headed arrow. Nematic organizations are 
denoted with a double headed arrow. Some organizational states were difficult to 
determine or showed different organizations in different chambers. These were 
mixed between isotropic and nematic and are denoted with a double headed wide 
arrow. For each location on the state diagram, 2-5 different chambers were made 
and 4-9 different 2-5 minute movies were recorded over one hour, as described. (B) 
Example alignment of actin and microtubules. (i) Images from a time series of actin 
gliding at 10 µM in the presence of (ii) 5 µM microtubules. (iii) Images are overlaid 
with actin in red and microtubules in cyan. Short actin filaments that glide along 
microtubule bundles are highlighted with an arrow head. Microtubule channel can 
be seen through the actin channel due to high signal and imperfect dichroic glass. 
Time between frames in second is given under the images, approximately 3 s apart. 
Scale bar is 10 µm. 
 
Both actin and microtubules can become entrained with the other filament’s 
nematic order. For example, very high concentrations of actin (10 μM) were nematic. 
When combined with a low concentration (0.5 μM) of microtubules, the very few, sparse 
density of microtubules were observed to co-align with the actin filaments. They did not 
form dense streams of microtubules, but rather were recruited by the nematic streams of 
actin and co-aligned with them. Another example was when actin was at 5 μM, it was 
typically isotropic. Yet, at the highest microtubule density (5 μM), the actin became 
entrained in the microtubule nematic streams (Fig 2.10.B).  
Interestingly, the entrainment and co-alignment is not perfectly reciprocal – actin 




type of filament was aligned, but the other stayed isotropic. For instance, at the lowest 
actin concentration (0.56 μM), the actin filaments never co-aligned with microtubules, 
despite excellent microtubule nematic ordering. I saw the same effect for actin at 5 μM 
with microtubules at 2.5 μM. Microtubules were aligned, but actin was isotropic.  
Although the actin organization was less sensitive to the microtubule 
organization, there was some actin entrainment with microtubules. Examining the 5 μM 
actin concentration row, the actin alone preferred to be isotropic. Yet, at the highest 
microtubule density, the actin did co-align with the microtubules to participate in the 
nematic organization. These results implied that the filaments could sense each other to 
cause co-alignment, but only when they were at the highest concentrations. 
2.6 Discussion 
Here, I present a proof of principle for a composite active matter system 
composed of actin-microtubule filament gliding assay. I found that the presence of other 
motors on the surface that could not engage the filament of interest had no effect on the 
gliding ability of the filaments, making the system potentially useful for future studies 
(Fig 2.2). Further, I found a composite buffer condition that allows both actin and 
microtubules to glide simultaneously and at about the same velocity. Excitingly, I also 
found that methylcellulose has the ability to enable microtubules to interact to drive 
alignment into nematic and polar order (Fig 2.6). A recent publication previously showed 
that microtubules became nematic with higher methylcellulose but did not report polar 
order, as I observe here 115. During the review of this manuscript, another publication 
reported that methylcellulose was able to induce large-scale chiral vortices, which would 




within the chamber, such as air bubbles 116. These studies appear to be seeing a similar 
phenomenon as I present for microtubules, although they did not characterize their 
directionality. I found that the methylcellulose was not simply able to align filaments, but 
cause polar ordering, similar to that observed with actin in the absence of crowders 
previously 67.  The effect of methylcellulose on microtubule active matter offers an 
opportunity for control and a tuneability not previously controllable for this system.  
One of the results of our experiments is the identification of the concentration of 
polymer at which the system begins to exhibit orientationally ordered streams. I find that 
this transition occurs between concentrations of 0.5 and 2.5 μM for microtubules and 5 
and 10 μM for actin. These concentrations correspond to filament densities of 0.03 – 0.17 
filaments/μm2 for microtubules and 1.5 – 3 filaments/μm2 for actin. Using this transition 
density as a measure of the isotropic-nematic transition point, I find that it is indeed lower 
than the Onsager estimate for long thin rods of the corresponding lengths (ρC = 3π / 2LC
2)  
117 which would be 4.7 filaments/μm2 or 15.5 μM for actin and 0.18 filaments/μm2 or 2.7 
μM for microtubules if I use the median length of the filaments to make the estimates. 
Our findings are consistent with theoretical results on self-propelled rod models 79 and 
simulations of filaments on motility assays 118, both of which predict an enhancement of 
nematic order and hence a lowering of the transition density due to the self-propulsion of 
the filaments. In order to make a quantitative comparison of experiments and the theory 
as presented in 79, future work needs to be performed at different filament lengths and 
different self-propulsion speeds.  
Another interesting, yet unexplained result is that the actin filaments were 




present, is less pronounced and therefore reported with lower confidence for 
microtubules. It is not clear why the filaments would be able to glide faster at high 
densities. One possibility is the saturation of inactive myosins on the surface at high 
density. At low density, I often observed filaments moored at locations of inactive 
myosin. It is possible that at high density, all such locations were blocked, and the 
filaments could move faster. Another possibility is that the actin filaments were straighter 
and effectively stiffer when they are at higher density. Straight actin might enhance the 
ATP turn-over through increasing the rate of ADP release, increasing the efficiency of 
mechanochemical coupling in the actin-myosin system. Future studies could probe the 
mechanism of this phenomenon by reducing the motor number, but maintaining high 
density of actin filaments to see if velocity stays high when the filament trajectories are 
straighter.  
Prior simulations use the motor density on the coverslip as a measure of the self-
propulsion or activity in the system 118.  In our assays, I used 58 nM kinesin-1 and 530 
nM myosin II non-specifically adhered to the surface. I estimated the motor density in 
two ways. To find the maximal motor density, I assumed all the motors inserted in the 
chamber adhered to the available cover glass on the top and bottom. This estimate 
resulted in 1,600 kinesin/μm2 and 15,000 myosin/μm2. These estimates are still less than a 
saturating level of ~60,000 motors/μm2, assuming the motors each take up 16 nm2 on the 
glass surface. At the lower end, I assume that the concentration of motors in the chamber 
was constant and estimated the surface density from the given volume density of motors. 
Using this second approximation scheme, I estimate the motor density to be 11 




prior works 67,96,119. At these motor densities, using the width of the filament as the motor 
capture radius, the simulations predict that the transition should occur at 5x10-5 
microtubules/μm2 and 0.05 actin filaments/μm2  118, which is much lower than the values I 
find in our experiments. There are many possible reasons why these predicted transition 
locations do not match our results, including our estimates of motors on the surface, 
estimates of the radius of capture for the filaments, and the length distributions of the 
filaments and their inherent semi-flexibility. Future experiments will aim to quantify the 
origins of these discrepancies. 
A second main result of our experiments is a first look into the emergent 
phenomenology when self-propelled filaments of different lengths and stiffnesses interact 
with each other. Microtubules appear more susceptible to entrainment by actin in this 
system, but actin filaments are not as affected by microtubule polymer. There are a 
number of locations on the state diagram where the total polymer mass (microtubules and 
actin combined) should be more than enough to cause actin filament alignment, yet the 
actin does not align. For instance, actin alone shows nematic ordering when the area 
fraction is above 0.015. Yet, when the total polymer mass is above 0.015, such as when 
the microtubules are at 2.5 μM, the actin still does not align. Thus, the total polymer mass 
is not a good order parameter for actin ordering. On the other hand, the total polymer area 
fraction is a good order parameter for microtubule ordering into the nematic phase. In 
fact, whenever the total polymer mass is above 0.02, microtubules appear to be ordered in 
the system – whether that density to due to actin or microtubules. One plausible reason 




which will significantly change their interparticle interactions. Future experiments will 
explore this hypothesis by changing the length of the filaments.  
Understanding the physical mechanisms that lead to the phenomenology observed 
in the model composite active matter system requires an exploration of the interplay 
between self-propulsion speed, length and stiffness of a mixture of two species of self-
propelled rods. While the parameter space of different speeds has been explored in the 
literature, and shown to produce unexpected segregation and density fluctuations, the 
influence of relative lengths of the active nematogen and their stiffness is as yet 
unexplored territory. Given the inherently non-equilibrium nature of the system, I have 
no a priori way of predicting the consequence of these properties on the emergent 
behavior. I expect that the development of this model experimental system can spur 
theoretical investigations into these questions in the context of composite active 
materials. 
Given the importance of the microtubule and actin cytoskeletal networks in live 
cells, it is interesting to speculate on how the work presented here might inform on these 
complex processes. I found that the actin appeared to be less influenced by the 
microtubules. Although that could mean that the actin ignores the microtubule 
cytoskeleton in the cell. The experiments presented here took advantage of steric 
interactions, likely enhanced by the crowding agents. In addition, depletion force has a 
key role in bundle formation for actin and microtubule filaments. Interestingly, its 
corresponding interactions between actin filaments is different from microtubules. The 
depletion force forms nematic bundles of actin filaments meaning the resulted 




the depletion force affects microtubules interactions differently. It is sensitive to the 
structural polarity of microtubules and could lead to nematic as well as polar ordering in 
microtubule bundles. Also, methylcellulose is a negatively charged molecule that could 
affect charge interaction between filaments. Within the cell, there are likely a number of 
chemical interactions between the filaments. Indeed, a number of recent in vitro 
experiments have shown that microtubule or actin associated proteins can actually bind to 
the other cytoskeletal filament as well 101,102. These papers have demonstrated that actin 
and microtubule filaments can interact during polymerization at dilute concentrations 
101,102. It would be an interesting further step to repeat these experiments in dense systems 
with many more filaments of each type to observe the large-scale co-polymerization and 
co-organization.  
In summary, I have described first experiments in a composite active matter 
system of self-propelled filaments. The phase space available for exploration in this 
system includes particle properties (length of filaments, stiffness), activity (modifying 
motor concentrations), interactions (altered crowders, ionic strength buffers, and 
crosslinkers), and concentration of the different component particles. This system can 
serve as a test bed for theoretical ideas that have been proposed in the context of aligning 
self-propelled active fluids and serve to play the same role as Janus colloids have played 









DYNAMICS OF THE 3D COMPOSITE NETWORK OF ACTIN AND 
MICROTUBULE WITH NEUTRAVIDIN CROSSLINKERS 
3.1 Abstract 
The cytoskeleton is able to precisely tune its structure and mechanics through 
interactions between semiflexible actin filaments, rigid microtubules and crosslinker 
proteins. However, the role that each of these components, as well as the interactions 
between them, plays in the dynamics of the composite cytoskeleton remains an open 
question. Here, I investigate the effect of interaction of actin and microtubule filaments in 
the steady-state dynamics of this composite using generic, strong biotin-NeutrAvidin 
crosslinkers. I analyzed the data collected by our collaborators using fluorescence 
confocal microscopy to reveal the mechanisms in which crosslinking tunes the mobility 
of actin–microtubule composites. We show that varying crosslinking motifs have little 
impact on the microscale mobility and mechanics. We further examine the role of actin 
crosslinking and find non-monotonic dependence of microtubules steady-state dynamics 
on actin crosslinking. In fact, the microtubule mobility – dictated by crosslinker-driven 
rearrangements of actin filaments –controls composite stiffness. The microrheology 
measurements from our collaborators show similar non-monotonic dependence of the 
stiffness on the actin crosslinking, corroborating our findings about the dynamics of the 
actin-microtubule composites and implying a link between the mechanics and mobility of 





Functional dynamic properties of the cytoskeleton are determined by the crosstalk 
of biopolymers, actin and microtubule, when physical interaction of these filaments 
mediated by auxiliary proteins such as crosslinking proteins. Actin filaments are 
semiflexible filaments with a persistence length of 10 µm 17,18, microtubules are rigid 
with of 1 mm 14,18,36,120,121. Networks of semiflexible actin filaments play critical roles in 
cell polarity and contractile and migratory processes 122,123; while microtubules enable 
intracellular trafficking and transport, chromosomal dynamics, and mitotic spindle 
alignment during cell division 122,124. Synergistic interactions between these two 
filaments, which are mediated by steric and chemical interactions (i.e. entanglements and 
crosslinking) 17,123,125,126, establish essential cell asymmetries and enable proliferation, 
differentiation, and migration 17,123,127–129 . While crosslinking of both filaments is 
ubiquitous in cells, serving important roles in locomotion, membrane reinforcement, and 
intercellular cargo transport 120,123,129 there is mounting evidence of crosslinking between 
actin and microtubules, mediated by proteins such as tau, MAP2, APC, profilin, and 
plectin 88,101,123,130–136. Specifically, actin-microtubule co-crosslinking has been shown to 
be important to cortical flow, wound healing, neuronal cone growth, cell migration, and 
muscle contraction 122–124,129,131,133,137–140.  
To understand the role of actin crosslinking in cells, numerous studies have 
investigated the mechanical properties of crosslinked actin networks in vitro 45,126,141–143. 
These studies have shown that the majority of crosslinking proteins form isotropic 
networks of crosslinked filaments at low and intermediate crosslinker:actin monomer 




these structural changes, increasing crosslinker concentrations have been shown to 
directly correlate with increased network stiffness and elasticity 16,45,142–144,146–149. 
Despite the growing evidence of the importance of actin and microtubule 
interactions to cytoskeleton dynamics, mechanics, and function 126,150–154  and its 
application in designing biomimetic materials, few studies have investigated composite 
networks of actin and microtubules 126,155–157. Here, we use fluorescence microscopy to 
examine the steady-state dynamics of crosslinked composite network of equimolar actin 
and microtubule filaments. First, we study the effect of varying crosslinking motifs, and 
show that it has minor impact on the microscale mobility while all crosslinking motifs 
reduce filament mobility. The subtle effect of actin crosslinking on composite mechanics 
that this study reveals begs the question as to the role of actin crosslinking in dynamics 
and mechanics and its dependence on the crosslinking concentration. We demonstrate 
non-monotonic dependence of mobility of the microtubules on the degree to which actin 
filaments are crosslinked. Microtubule mobility is slowed the most when the actin 
network that scaffolds microtubules is both rigidly crosslinked and sufficiently dense. 
Too much crosslinking leads to actin bundling, thereby increasing the actin scaffold mesh 
size and thus allowing for more microtubule mobility. Conversely, too few crosslinks 
confer a dense but floppy scaffold that is insufficient to markedly suppress microtubule 
fluctuations. This careful balance demonstrates the elegant ways that actin crosslinking 
can modulate the interactions between actin and microtubules within the cytoskeleton to 
enable a myriad of different mechanical responses and processes in cells. More generally, 




showing that modest changes to filament interactions can lead to dramatic improvements 
in toughness and elasticity. 
3.3 Material and Methods 
Here I explain the materials and methods for actin microtubule composite 
network. Two sets of experiments were conducted by our collaborators on the crosslinked 
composite network of actin and microtubule filaments. In all the experiments, the total 
amount of equimolar actin and microtubule proteins was held fixed at 5.8 μM. First, a 
constant amount of crosslinkers were employed to crosslink different filaments. Then, 
different amount of actin crosslinkers were added to the composite while microtubules 
were not crosslinked. The steady-state dynamics of these composite networks were 
studied using fluorescence confocal microscopy. 
3.3.1 Materials for varying crosslinking motifs in actin-microtubule composite 
network 
 
Rabbit skeletal actin, biotinylated actin and Alexa-488-labeled actin were 
purchased from Cytoskeleton (AKL99, AB07) and Thermofisher (A12373) and stored at 
−80 °C in a Ca buffer (2 mM Tris (pH 8.0), 0.2 mM ATP, 0.5 mM DTT, 0.1 mM CaCl2) 
Porcine brain tubulin, biotinylated tubulin, and rhodamine-labeled tubulin were 
purchased from Cytoskeleton (T240, T33P, TL590M) and stored at −80 °C in PEM-100 
(100 mM PIPES (pH 6.8), 2 mM MgCl2, and 2 mM EGTA). 
Crosslinked networks were formed using preassembled biotin-NeutrAvidin 
complexes optimized previously for stable, isotropic crosslinking of actin networks 45. As 




either side by biotinylated actin and/or tubulin, depending on the desired crosslinking 
motif. We incorporated crosslinkers into previously established protocols to form co-
entangled actin-microtubule composites 155. In short, actin monomers, tubulin dimers, and 
crosslinker complexes were added to PEM-100 supplemented with 1 mM ATP, 1 mM 
GTP, and 5 μM Taxol. To image composites, 0.13 μM of Alexa-488-labeled actin 
filaments and rhodamine-labeled microtubules, as well as oxygen scavenging agents [4.5 
mg/ml glucose, 0.5% β-mercaptoethanol, 4.3 mg/ml glucose oxidase, 0.7 mg/ml catalase] 
were added (Fig 3.1). The solution was then mixed, pipetted into a ~20 μL sample 
chamber, and allowed to incubate at 37 °C for 30 minutes to co-polymerize both proteins. 
We prepared six different composite types that varied in their crosslinking motif 
as follows (Fig 3.1.A): (1) no crosslinkers are present (None); (2) actin filaments in the 
composite are crosslinked to each other (Actin); (3) microtubules in the composite are 
crosslinked to each other (Microtubule); (4) both actin and microtubules are crosslinked 
but they cannot crosslink to each other (Both); (5) actin and microtubules are crosslinked 
to each other but not to themselves (Co-linked); and (6) a composite similar to Both but 
in which the densities of actin-actin and microtubule-microtubule crosslinks are both 
doubled (Both 2x). 
For all presented data at the first part, total protein concentration was held fixed at 
5.8 μM with an equimolar ratio of actin to tubulin, and the molar ratio of crosslinker to 




        Eq. 3.1 
The mesh size of actin and microtubule networks comprising each composite are a = 
0.3/ca




actin and tubulin concentrations in units of mg/ml 158–160. From these mesh sizes we 
calculated the effective composite mesh as ξ = (m -3  + a -3 ) -1/3 = 0.81 μm 155. We 
estimated the length between crosslinkers for all three types of crosslinking used in 
composites (actin crosslinking, microtubule crosslinking, and actin-microtubule co-
linking) as follows (Fig 3.1.A). The length between crosslinkers along an actin filament 
was determined by lc,a = ½lmon × R
−1 where lmon = 2.7 nm is the length that each actin 
monomer adds to an actin filament. The ½ prefactor takes into account that each 
crosslinker is shared between two filaments. Similarly, the length between crosslinkers 
along a microtubule was calculated by lc,m = ½(lring/13) × R
−1 where every 13 tubulin 
dimers adds lring = 7.8 nm in length to the microtubule. For Actin and Microtubule 
composites, lc,a = 67.5 nm and lc,m = 15 nm. In the composite where crosslinkers are 
equally distributed between actin-actin links and microtubule-microtubule links (Both), R 
remains fixed so there are half as many crosslinkers available to each network. Thus, lc,a 
and lc,m both double (i.e. lc,a = 135 nm, lc,m = 30 nm). For composites in which both 
networks are linked but R is doubled (Both 2x) lc,a and lc,m remain the same as in the Actin 
and Microtubule cases. For Co-linked composites, the length between crosslinkers that 
link actin to microtubules was computed as lc,a-m = (lc,a×lc,m)
1/2 = 31 nm.  
A Nikon A1R laser scanning confocal microscope with a 60x 1.4 NA objective 
and QImaging QICAM CCD camera were used to collect 2D time series of composites. 
The microscope is outfitted with 488 nm and 561 nm lasers and simultaneously records 
separate images for each laser channel (green and red) to separately visualize 
Alexa-488-actin (green) and rhodamine-tubulin (red) (Figs 3.1.B, 3.2). Time series of 512 




For each composite type, two different samples were imaged with 3–5 time series taken 
for each sample. 
Time series from each channel (green and red) were analyzed separately to 
determine the mobility of actin and microtubules in the composites, as previously 
described 155. In brief, every 16 frames in the time series were averaged together to create 
time series with 1 second frames 155. As demonstrated and described previously 155, we 
selected 1 second frames to average out the frame-to-frame shot noise that obscured the 
images of the filaments, enhancing the signal to noise without altering the trends in the 
data (Fig 3.4); and because the filaments do not significantly change position over that 
time (within the resolution of the measurement). From these averaged time series, we 
used FIJI/ImageJ to create a single collapsed image for each channel that represented the 
standard deviation of each pixel over time (Fig 3.1.B). The average standard deviation 
over all pixels was then calculated to give a single standard deviation value for the entire 
time series <δ>. This value, which represents the variation in intensity values for each 
pixel over time, is a measure of the extent to which filaments in the network fluctuate 
over time. To account for differences in overall intensity among different time series, we 
also computed the average intensity over all pixels and frames for each time series <I>, 
and normalized each standard deviation by this value. The resulting metric <δ>/<I>, 
which quantifies the mobility of actin and microtubules in each time series, is presented 
in Fig 3.3. We carried out this analysis for all time series collected for each composite 
type. We used the Kolmogorov-Smirnov statistical test (KS-Test, 





Figure 3. 1 Schematic of experiments to probe the role that crosslinking plays in the 
mechanics and mobility of crosslinked actin-microtubule composites. (A) Cartoon of 
molecular components comprising actin-microtubule composites with varying 
crosslinker motifs (None, Actin, Microtubule, Both, Co-linked, Both 2x) described in 
the text. The calculated length between crosslinkers for each motif is listed under 
each cartoon, where lc,a is the length between crosslinkers along an actin filament, 
lc,m is the length between crosslinkers along a microtubule, and lc is the length 
between crosslinkers when actin and microtubules are linked to each other. (B)Two-
color laser scanning confocal micrograph of 5.8 μM Co-linked actin-microtubule 
composite with ~3% of microtubules and actin labeled with rhodamine (red) and 
Alexa-488 (green), respectively. Standard deviation projections of a 60 s video taken 







From KS-tests, we computed probability values p for finding overlapping data and use 
the accepted value of p < 0.05 as the cutoff for determining when two data sets were 
significantly different. 
3.3.2 Materials for varying actin crosslinking in actin-microtubule composite 
network 
For the second set of experiments, Rabbit skeletal actin monomers (G-actin), 
biotinylated G-actin and Alexa-488-labeled G-actin are purchased from Cytoskeleton 
(AKL99, AB07) and Thermofisher (A12373) and suspended at 1 mg/ ml,  2 mg/ml and 
1.5  mg/ml,  respectively,  in  Ca buffer G (2 mM Tris pH 8.0, 0.2 mM ATP, 0.5 mM 
DTT, 0.1 mM CaCl2) and stored at -80°C. Lyophilized porcine brain tubulin, biotinylated 
tubulin, and rhodamine-labeled tubulin are purchased from Cytoskeleton (T240, T33P, 
TL590M). Porcine tubulin and biotinylated tubulin are suspended to 5 mg/ml in PEM-
100 [100 mM PIPES (pH 6.8), 2 mM MgCl2, 2 mM EGTA] and stored at 80 °C. 
Rhodamine-labeled tubulin is suspended to 5  mg/ml  using a  1 : 10  ratio of rhodamine-
tubulin : unlabeled- tubulin in PEM-100 and stored at -80 °C. 
To crosslink actin filaments within co-entangled actin–microtubule composites, 
we incorporate biotin–NeutrAvidin crosslinker complexes prepared using well-
established and validated protocols described previously 45,141,161. Crosslinker complexes, 
tubulin dimers, and G-actin are added to PEM-100 supplemented with 1 mM ATP, 1 mM 
GTP, and 5 μM Taxol. To determine filament mobility within composites, 0.13 μM of 
Alexa-488-labeled actin filaments and rhodamine-labeled microtubules are added to the 
solution 155. To inhibit photobleaching of labeled filaments, oxygen scavenging agents 




catalase] are included. The final mixture is pipetted into a 20 μl sample chamber made 
from a glass slide and coverslip separated by 100 μm of double-stick tape and sealed with 
epoxy. To polymerize filaments and form the crosslinked network, the sample is 
incubated for 30 minutes at 37 °C.  
For all presented data, we fix the total protein concentration to 5.8 μM with an 
equimolar ratio of actin monomers to tubulin dimers. We vary the crosslinker 
concentration to examine actin crosslinker molar ratios of R = 0, 0.005, 0.01, 0.02, 0.04 




          Eq. 3.2 
The mesh sizes of the actin network and microtubule network within composites are the 
same as the previous part.  
To determine filament mobility, we use a Nikon A1R laser scanning confocal 
microscope with a 60x 1.4 NA objective and QImaging QICAM CCD camera to collect 
2D time series of composites. The microscope is outfitted with 488 nm and 561 nm lasers 
that simultaneously record separate images in the green and red channels to visualize 
Alexa-488-actin (green) and rhodamine-tubulin (red) (Fig 3.2.B). For each crosslinker 
ratio, 3–5 time series of 512 x 512 images (0.41 μm /pixel) in each channel are recorded 
at 1 fps for 60 seconds for two different samples. 
Using FIJI/ImageJ, each time series channel (green and red) is separately 
analyzed to determine the mobility of actin and microtubules in the composites, as 
previously described 141,161. In short, we create a single projection image of the standard 
deviation of each pixel over time. We calculate the average standard deviation over all 




time series <δ>. This value represents the variation in intensity values for each pixel over 
time and is thus a measure of the extent to which filaments in the composite fluctuate 
over time. In order to account for differences in the overall intensity among different time 
series, we normalize each standard deviation value by the average intensity over all pixels 
and frames for each time series <I>. The resulting metric, <δ>/<I>, quantifies the 
mobility of actin and microtubules in each time series. 
 
 
Figure 3. 2 Schematic of experiments to probe the role that crosslinking plays in the 
mechanics and mobility of actin crosslinked actin-microtubule composites. (A) 
Cartoon of composites of microtubules (red) and actin (green) with increasing 
concentrations of actin crosslinkers (blue) defined as the crosslinker:actin ratio R. 
(B) Two-color laser scanning confocal image of 5.8 μM total actin-microtubule 
composite with R = 0.08. For visualization of filaments, ~3% of tubulin and actin are 
labeled with rhodamine (red channel) and Alexa-488 (green), respectively. Standard 
deviation projections of a 60 s time series taken at 1 fps for the microtubule (red) 





3.4 Results and discussion 
3.4.1 Steady-state mobility of varying crosslinking motifs in actin-microtubule 
composite network 
To systematically investigate the role that crosslinking plays in composites of 
actin and microtubules we design actin-microtubule composites with four distinct 
crosslinking motifs. We use our previously established protocols 155  to create equimolar 
co-entangled actin-microtubule composites. We then incorporate biotin-NeutrAvidin 
complexes into composites to selectively crosslink the filamentous proteins, keeping the 
crosslinker:protein ratio fixed at R = 0.02 155 . We create composites with: crosslinked 
actin (Actin), crosslinked microtubules (Microtubule), crosslinkers equally forming actin-
actin and microtubule-microtubule bonds (Both), and crosslinkers binding actin to 
microtubules (Co-linked) (Fig 3.1.A). We compare these composites to a composite 
without crosslinkers (None) as well as one in which both filaments are crosslinked but R 
is doubled (Both 2x) (Fig 3.1.A). While all composites have the same crosslinker density 
R and protein concentration, the length between crosslinkers along actin filaments lc,a, 
along microtubules lc,m, and along both filaments lc (for Co-linked) vary for the different 
composites, as listed in Fig 3.1.A and described in Methods. 
To determine the steady-state mobility of actin and microtubules in each 
composite type, we analyze time series of dual-color confocal images, as described in 
Methods and previously validated 155. Briefly, for each time series we compute the 
average standard deviation of the intensity over time for all pixels <δ> and normalize by 
the corresponding average intensity of all pixels over time <I> (Fig 3.3). Higher values 
of this mobility metric indicate a more mobile network of filaments that fluctuates more 




Comparing <δ>/ <I> values for actin and microtubules in the same composite, 
we find that actin filaments in all composites fluctuate significantly more than 
microtubules with an average <δ>/ <I> value that is ~1.5x greater than that for 
microtubules (p < 0.03 using KS-Test described in Methods, Fig 3.3). This result, which 
is in line with our previous findings for composites without crosslinkers155, is not 
surprising given the ~100-fold lower bending rigidity of actin compared to microtubules. 
Comparing the mobility of the crosslinked composites to the unlinked composite (None), 
we find that all crosslinking motifs reduce the mobility of both filaments by ~1.4x (p ≤ 
0.04 and p ≤ 0.02 for actin and microtubules, respectively). This outcome corroborates 
the results of some other experiments and measurements on the mechanics of this system. 
For example, relaxation time is faster for None comparing to crosslinked composites. 
Likewise, the measured resistive force during strain for None is substantially smaller than 
for crosslinked composites, indicating it is more fluid and mobile 141.   
However, the mobilities of both actin and microtubules display minimal variation 
between the different crosslinking (p > 0.09 for actin, p > 0.07 for microtubules). 
Because the mobility we are measuring is at the submicron scale (each pixel is 0.41 μm) 
and in the steady-state (linear) regime, we expect our mobility results to more closely 
match the results of microrheology measurements at the submicron and microscopic 
scales 141. As described above, at these lengths and force scales there is little difference 
between the different crosslinking motifs, with all composites exhibiting similar force, 
stiffness and viscosity values. This effect is also seen in the relaxation data in which the 




Lastly, the steady-state mobility measurements for time series with different time 
intervals is displayed in Figure 3.4. Here, the time resolution is 62.5 ms (1 frame) 
compared to 1 s (16 frames averaged together) in Figure 3.3. As shown, the mobility 
measurements and their distributions depend on the time resolution for all of the 
composites. However, for smaller time windows the mobility values and spread in the 
mobility distributions for both actin and microtubules are enhanced due to noise. Hence, 
we use the larger time windows for the mobility analysis and comparison purposes here, 





Figure 3. 3 Differences between crosslinking motifs have minimal impact on the 
steady-state filament mobility in actin-microtubule composites.  (A) For each 
composite, a 128×128 image shows the standard deviation of intensity values for 
each pixel over time for actin (green) and microtubules (red) in a 60 s time 
series.  Scale bar is 10 µm and applies to all images. (B) Box-whisker plot of the 
steady-state mobility, determined by computing the average standard deviation of 
pixel intensities <> normalized by the overall average pixel intensity <I> for each 
time series (as described in Methods). For each composite type, <>/<I> is 
calculated separately for actin (cross-hatched) and microtubules (solid) and each 
data point is computed from 10-12 time series each collected in different regions of 
the sample chambers of two different samples. As shown, microtubules are less 
mobile than actin filaments in all composites. Further, while crosslinking reduces 







Figure 3. 4 Mobility analysis from time series with 62.5 ms time windows. Box-
whisker plot of the steady-state mobility determined by computing the average 
standard deviation of pixel intensities <δ> normalized by the overall average pixel 
intensity <I> for each time series. Here, we use a time resolution of 62.5 ms (1 
frame) compared to 1 s (16 frames averaged together) shown in Fig 3.3. As shown, 
the dependence of the mobility of both actin and microtubules on crosslinking motif 
is robust to varying time windows used for analysis. However, for smaller time 
windows the mobility values and spread in the mobility distributions for both actin 
and microtubules are enhanced due to noise. 
 
3.4.2 Steady-state mobility of varying actin crosslinking in actin-microtubule 
composite network 
To investigate the role that actin crosslinking plays in cytoskeleton composites, 
we use previously established protocols to create co-entangled actin–microtubule 
composites in which we systematically tune the density of actin crosslinking 155,161. We 
use biotin–NeutrAvidin as the crosslinker to create permanent actin-specific crosslinks 
devoid of transient unbinding/rebinding events, and we vary the actin crosslinker ratio 
from R = 0 to R = 0.08 (Fig 3.2, Methods) 45. 
To shed light on the filament fluctuations, we use dual-color confocal time series 




As described previously, we quantify the mobility as the average standard deviation of 
the intensity over time for all pixels <δ>, normalized by the average intensity of all 
pixels over time <I> (Fig 3.5). This metric could not necessarily distinguish the acquired 
signal of systems with different properties and their motions. However, given the fact that 
networks of actin and microtubule filaments are studied, and the results of the response 
force and mechanical measurement could help us to understand this metric clearer. The 
correlation between force measurement and mobility measurements using average 
standard deviation of intensity, <δ>, of this soft material indicates that the observed 
mobility of filaments here is associated with “compliance” (or inverse stiffness). 
One would expect stiffer networks to correlate with reduced filament mobility, 
and actin crosslinking to suppress actin mobility more than microtubules (which remain 
unlinked for all R). Fig 3.5, which displays the mobility term <δ>/<I> as a function of R 
for both actin and microtubules, shows that actin crosslinking reduces the magnitude and 
spread of the mobility of both filaments from that of the R = 0 case. This result is 
intuitive as permanent crosslinking leads to stiffer more uniform networks with 
suppressed filament fluctuations and less heterogeneity. However, while stiffer 
composites do in fact confer reduced mobility, it is surprisingly the mobility of 
microtubules rather than actin that correlates with stiffness. 
The mean magnitude of <δ>/<I> for microtubules decreases from R = 0 to R = 
0.01, is nearly identical for R = 0.01 and 0.02, after which it increases with R. 
Interestingly, this non-monotonic behavior is reflected in the mechanical propertied 
measurements that is carried out by our collaborators. Figure 3.6 displays the response 




crosslinkers. Average force and average composite stiffness of the composite 
demonstrate non-monotonic dependence on crosslinking with a peak at R = 0.02. This 
correlation between the dynamics and the mechanical properties suggests that the rigidity 
(i.e. reduced mobility) of the microtubules is the primary contributor to elasticity and 
stiffness. Crosslinking also reduces the mobility of actin, but surprisingly does not show 





Figure 3. 5 Microtubule mobility is tuned by actin crosslinking and dictates the non-
monotonic mechanics of composites. (A) Projection images of the standard deviation 
of pixel intensity values in actin (green) and microtubules (red) channels for a 60 s 
time series. Time series are acquired using a Nikon A1R laser scanning confocal 
microscope with 60 - 1.4 NA objective. Numbers in bottom left of each image 
correspond to crosslinking ratio R. Colors outlining images match color scheme in 
(B). Scale bar is 25 μm. (B) Box whisker plot of mobility calculated by computing 
the standard deviation of pixel intensities over time and space <δ>, normalized by 
the average pixel intensity for each time series <I> as described in Methods. As 
shown, the mobility as well as the distribution of fluctuations for microtubules 
decreases until R= 0.02 after which the mobility increases, with microtubules 






Figure 3. 6 Mesoscale force response of actin-microtubule composites shows non-
monotonic dependence of stiffness on actin crosslinking. (A) Force, F(x) composites 
exert to resist constant speed (v = 10 µm/s) microsphere displacement of 10 µm. 
Grey lines are linear fits to the data from 0.25 to 10 µm. (B) Average force over the 
full 10 µm bead displacement with error bars denoting standard error across all 
trials. Colors match the legend in A and black line and grey panel are average and 
error for R = 0. (C) Average composite stiffness <K> = <dF/dx> determined from 
slopes of the linear fits shown in A. R = 0 is the solid line 162. 
 
In fact, actin mobility shows no significant dependence on the degree to which 
actin is crosslinked, with all distributions overlapping each other. Further, the highest  
mobility and largest spread (i.e. heterogeneity) in mobility is measured for R = 0.02, 
despite this network exhibiting the stiffest nonlinear mechanical response (Fig 3.6) 162. 
Thus, while actin becomes more crosslinked as R increased, which should reduce 
its mobility, it appears that it is its ability to suppress microtubule mobility that controls 




scaffolding network interwoven with the network of microtubules. As actin crosslinking 
increases the increased rigidity of the actin scaffold reduces the mobility of microtubules.  
The robustness of the non-monotonic dependence of microtubule mobility on R, 
and its coupling to mechanics, requires a discussion of the mechanism leading to this 
surprising behavior. We suggest that as the crosslinking density increases beyond a 
critical density, actin filaments begin to form bundles, which increases the mesh size of 
the actin scaffold and reduces the connectivity between actin fibers (bundles or single 
filaments). This more loosely connected scaffold cannot as effectively suppress 
microtubule mobility as a denser network of individual crosslinked filaments. We note 
that our confocal images demonstrate that the networks at all R values remain isotropic 
and connected, without obvious signs of significant actin bundling. As such, the degree of 
bundling is likely on the order of a few filaments, such that a connected network still 
forms but with a larger mesh size and fewer connections than a network of individual 
crosslinked filaments. Our imaging methods are not sensitive enough to pick up these 
subtle microscale changes due to the high density and fluctuations of the labeled 
filaments. 
To understand the slight difference in the R value at which the minimum of 
mobility is achieved, we examine the breadth of the mobility distributions for actin and 
microtubules at R = 0.01 and 0.02, crosslinking ratios. The distribution of microtubule 
mobility values is narrowest at R = 0.01, indicating that the scaffolding network is the 
most uniform and dense, such that microtubules in all regions of the network feel the 
same surroundings. The actin mobility distribution is likewise narrower than other R 




actin and microtubules are larger than all other crosslinked (R > 0) composites, 
suggesting that the composite is the most heterogeneous at this crosslinking density. The 
actin mobility, in particular, displays a notably large spread in mobility values. A mixture 
of actin bundles and individual crosslinked actin filaments would provide the most 
heterogeneous scaffolding network, compared to scaffolds comprised solely of bundles or 
single filaments, owing to the wide distribution of actin mobility values. 
We note that one previous study examining actin networks crosslinked by 
palladin reported a similar non-monotonic dependence in which actin networks appear to 
soften for very large R (> 0.1) 142. Authors suggest that increased bundling at these high R 
values correspondingly increases the mesh size which gives rise to softer networks 142. 
However, in this study the crosslinking density required to see such an effect is an order 
of magnitude larger than what we report, and the effect is more subdued for the palladin 
result. 
3.5 Conclusion 
Actin and microtubules form interacting networks within the cytoskeleton, 
providing cells with mechanical integrity, and enabling a myriad of mechanical processes 
such as locomotion, morphogenesis, intracellular transportation, and division. Many of 
these diverse functions are mediated by crosslinking proteins that can bind actin, 
microtubules, or both proteins. Further, the role of crosslinking between actin and 
microtubules has received much recent attention and is thought to be responsible for 
maintaining cell shape and polarity, growth and structure of neurons, and spindle 
positioning in mitosis 123,131,132. The design and characterization of composites of flexible 




how crosslinking can tune the mechanical response of these composites has remained 
largely unexplored. 
Here, we characterize the mobility of composites of actin and microtubules with 
distinct crosslinking patterns. First, we create composites in which actin is crosslinked 
(Actin), microtubules are crosslinked (Microtubule), both actin and microtubules are 
crosslinked (Both), and actin and microtubules are crosslinked to each other (Co-linked). 
We use dual-color fluorescence confocal microscopy to measure the mobility of each 
composite type. The crosslinking motif has little impact on the microscopic steady-state 
filament mobility. Secondly, we study the surprising and diverse roles that actin 
crosslinking can play in the steady-state mobility of actin-microtubule composites. We 
create composites of actin and microtubules with actin crosslinker ratios of R = 0 – 0.08. 
We show that there is an unexpected and robust non-monotonic dependence of filament 
mobility on R. We show that it is the synergistic interactions between actin and 
microtubules that give rise to emergent behaviors which are largely absent in crosslinked 
only actin or crosslinked only microtubule networks. 
Our results demonstrate the unique and complex ways that components of the 
composite cytoskeleton – such as actin, microtubules, and crosslinkers – work in concert 
to tune the mechanical properties of the cell over a wide parameter space with modest 
changes to the interactions between constituents. Moreover, our platform and results 
provide design principles for biomimetic materials with physical properties that can be 






DYNAMICS OF THE 3D COMPOSITE NETWORK OF ACTIN AND 
MICROTUBULE WITH NEUTRAVIDIN & MAP65 CROSSLINKERS 
4.1 Abstract 
Actin and microtubule filaments, with their auxiliary proteins, enable the 
cytoskeleton to carry out vital processes in the cell by tuning the organizational and 
mechanical properties of the network. Despite their critical importance and interactions in 
cells, we are only beginning to uncover information about the composite network. The 
challenge is due to the high complexity of combining actin, microtubules, and their 
hundreds of known associated proteins. Here, I use fluorescence microscopy, fluctuation, 
and cross-correlation analysis to examine the role of actin and microtubules in the 
presence of an antiparallel microtubule crosslinker, MAP65, and a generic, strong actin 
crosslinker, biotin-NeutrAvidin. For a fixed ratio of actin and microtubule filaments, I 
vary the amount of each crosslinker and measure the organization and fluctuations of the 
filaments. I find that the microtubule crosslinker plays the principle role in the 
organization of the system, while, actin crosslinking dictates the mobility of the 
filaments. We have previously demonstrated that the fluctuations of filaments are related 
to the mechanics, implying that actin crosslinking controls the mechanical properties of 
the network, independent of the microtubule-driven re-organization.  
4.2 Introduction  
The cytoskeleton is composed of interacting biopolymer filaments that regulate 




composed of two protofilaments made from actin monomers, helically twisted with a 
diameter of 7 nm and a persistence length of 10 μm 16–18. Actin filaments and their actin 
binding proteins (ABPs) govern cell migration, contraction, and cell signaling 165. 
Microtubules are composed of tubulin protein dimers that form a lattice of 13 
protofilaments that roll into a tube to create a hollow cylinder structure with an outer 
diameter of 25 nm and a persistence length of 1 mm 14,36,37. Microtubules, the 
microtubule associated proteins (MAPs), and enzymes control intracellular transport, 
mitotic spindle formation, and cellular organization. The distinct structures and physical 
properties of these cytoskeletal subunits enable the cell to maintain its integrity during 
cell growth, differentiation, division, and motility 17. 
 
Characterizing the dynamics and mechanics of composite cytoskeletal networks is 
important for both biological and synthetic applications. On the biological front, 
intracellular experiments are complex and uncontrolled. Clean, reproducible in vitro 
experiments enable the elucidation of fundamental principles of cytoskeletal organization 
and mechanics 166–168. From a synthetic materials view, cellular composite networks 
inspire the design and fabrication of smart synthetic and biomimetic materials with 
tunable mechanical properties 169,170. 
  
Most of the studies of in vitro reconstitution of cytoskeletal filaments have been 
conducted in a network of either actin or microtubule filaments. The mechanics and 
dynamics of co-entangled and crosslinked actin networks have been characterized in the 
presence of various crosslinkers with different structures and strength, such as alpha-
actinin, fascin, palladin, arp 2/3, arg, filaminA, and biotin-NeutrAvidin 141,142,144–




stiffness of the network and lead to the formation of actin bundles 16,144,147,148,171. 
Microtubule network organization and mechanics have also been explored in the 
presence of MAP65, Ase1, PRC1, biotin-NeutrAvidin, and active crosslinkers like 
various types of kinesin motors with different movement direction and speed 
46,49,98,120,141,159,173–182. Viscoelasticity measurements have showed that entangled 
microtubule networks are soft elastic solids, and added crosslinkers make a stiffer gel of 
filaments 124. 
Despite their biological relevance, few studies have explored composite networks 
of actin and microtubule filaments. These studies have shown that the interactions 
between these filaments lead to unexpected emergent properties 
102,123,126,132,153,154,156,157,162,183–187. For example, we have previously shown that actin 
filaments, rather than microtubules, govern the microscale elasticity and mobility of 
actin-microtubule composite networks comprised of equal molar ratios of actin 
monomers and tubulin dimers 141,162,183. We showed that this effect was due to the smaller 
mesh size of the network of actin filaments compared to that of the microtubules in the 
composite162. Here, I sought to examine networks with more comparable mesh sizes from 
similar total filament lengths. Using a fixed ratio of actin to microtubules, I 
independently varied the actin and microtubule crosslinkers. I used biotin-NeutrAvidin to 
permanently crosslink actin filaments, and MAP65 to transiently crosslink microtubules. 
I found that actin crosslinkers tune the mobility of the composite network: actin becomes 
less mobile, while microtubules become more mobile. Microtubule crosslinkers, on the 
other hand, control the co-localization of actin and microtubule filaments in the 




4.3 Materials and Methods 
Rabbit skeletal actin, biotinylated actin, and rhodamine-labeled actin were 
purchased from Cytoskeleton (AKL99, AB07, AR05) and resuspended at 2 mg/ml, 1 
mg/ml, and 1.5 mg/ml, respectively, in Ca Buffer G (2 mM Tris pH 8.0, 0.2 mM ATP, 
0.5 mM DTT, 0.1 mM CaCl2) and stored at -80ºC. Lyophilized porcine brain tubulin, 
biotinylated tubulin, fluorescent HiLyte 488-labeled tubulin, and fluorescent HiLyte 647 
tubulin were purchased from Cytoskeleton (T240, T33P, TL488M, TL670M). Porcine 
tubulin and biotinylated tubulin were resuspended to 5 mg/ml in PEM-100 [100 mM 
PIPES (pH 6.8), 2 mM MgCl2, 2 mM EGTA] and stored at -80ºC. HiLyte 488 or 647-
labeled tubulin was resuspended to 5 mg/ml using a ratio of 1:10 fluorescent labeled 
tubulin:unlabeled-tubulin in PEM-100 and stored at -80ºC. 
Two different types of crosslinkers were used in composite networks of actin and 
microtubules. To crosslink actin filaments, biotin-NeutrAvidin crosslinker complexes 
were prepared according to previously published protocols 141,162. To crosslink 
microtubule filaments, GFP labeled and unlabeled MAP65-1 was used that was expressed 
and purified from bacteria as previously described 50,97,98.  
Composite networks were made by mixing tubulin, G-actin, and crosslinkers in 
PEM-100 solution. For visualization, biotinylated, rhodamine labeled actin filaments 
were pre-polymerized in PEM-100 and 2 mM ATP by incubation for 1 hour in room 
temperature. To visualize microtubules, all filaments were labeled with HiLyte 488 or 
HiLyte 647. Pre-polymerized, rhodamine-labeled actin filaments were prepared at 5 μM 
with 1:1 rhodamine labeled actin:unlabeled actin monomer ratio and 0, 0.04, 0.08, or 0.16 




HiLyte 647-labeled tubulin (with 3:100 labeled:unlabeled tubulin, 9.1 μM total), 
unlabeled actin monomer (1.43 μM final concentration) and pre-polymerized rhodamine 
labeled actin filaments (1.43 μM final concentration) were added to the PEM-100 buffer 
with 1 mM ATP, 1 mM GTP and 5 μM Taxol.  Oxygen scavenging agents (4.5 mg/ml 
glucose, 4.3 mg/ml glucose oxidase, 0.7 mg/ml catalase, and 0.5% β-mercaptoethanol,) 
were added to the solution to inhibit photobleaching. Additionally, 0.025% Tween was 
included to block the chamber surface from protein binding. The mixture was pipetted 
into a ~10 μL sample chamber made of a glass slide and cover slip attached via 
permanent double stick tape (3M). The ends were sealed by epoxy and the sample 
chamber incubated at 37°C for 30 minutes to form the composite network. 
At the concentrations of actin and tubulin proteins used, 1.4 μM and 9.1 μM, 
respectively, the mesh size of actin and microtubule networks are estimated as A = 
0.3/cA
1/2 = 1.22 µm and M = 0.89/cT1/2 = 0.89 µm, respectively, where cA and cT are the 
actin and tubulin concentrations in units of mg/ml 158,188,189. I can estimate the total 
polymer length in our 10 μl experimental chamber from the concentrations and known 
geometries of the filaments. For actin, I estimate that there are 27 actin monomers in a 72 
nm length of actin filament. Given the concentration of 1.4 μM, I estimate the total 
polymer length, when all actin monomers go into polymer form to be 2.4 x 104 m.  For 
microtubules, I estimate that there are 13 dimers for a 12 nm length of filament. Given 
the concentration of 9.1 μM, I estimate the total polymer length, when all tubulin dimers 
are polymerized to be 5 x 104 m. These two total polymer lengths are the same order of 
magnitude, so I conclude that the total polymer length present is approximately one-to-




fixed while the crosslinker concentrations varied. NeutrAvidin:actin molar ratios of R = 
0, 0.02, 0.04, and 0.08 were examined for actin crosslinking. For microtubules, three 
different percentages of MAP65, 0%, 3%, and 10%, were tested. The % represents the 
percentage of tubulin dimers that are bound to MAP65 crosslinkers. The percent bound 
was determined from the known equilibrium dissociation constant, as previously 
described 49. I specifically use different nomenclature for the amount of actin and 
microtubule crosslinkers because this is the nomenclature from prior literature 49,97,141,162 
and to make it less confusing about which filament crosslinker I am referring. 
I use a Nikon Ti-E inverted microscope with a 60x water immersion objective 
(NA = 1.38) with scientific-CMOS camera (Zyla). The pixel size was 108 nm/pixel and 
the diffraction limit was around 300 nm, roughly corresponding to 3 pixels. The 
microscope can record 2048x2048 images in green and red channels alternatively to 
visualize fluorescent HiLyte 488-labeled microtubules and rhodamine labeled actin 
filaments. For each experiment at a specified actin and microtubule crosslinker ratio, 5-10 
time series were recorded that were 1 to 1.5 minutes each. The exposure time was 60 ms 
and 100 ms for the green and red channels, respectively. 
To quantify the mobility of the composite network, FIJI/ImageJ was used to 
analyze each channel separately, as described previously 141,162. Briefly, the standard 
deviation and average of the intensity of an image series were measured. Then the mean 
values of each channel were measured and used to calculate <δ>/<I> where <δ> is the 
average standard deviation of intensity measurement over the entire time series and <I> 
is the average intensity mean over time series. These measurements were calculated for 




determined the mobility of actin and microtubule filaments within each composite 
network. Figure 4.1 and 4.2 show representative images for actin and microtubule 
filaments respectively, in a phase diagram. Pairs of representative images are displayed at 
R = 0, 0.2, 0.04, and 0.08 and 0%, 3%, and 10% MAP65 for actin and microtubule 
channels, separately. At each data point, a projection image of standard deviation of 
intensity (STD), and a projection image of average of intensity (AVG) are shown for a 
representative time series. Spatial average of the STD and AVG image generates <δ> 
and <I> values for the representative time series. All the images are 125.4 µm×125.4 µm 
or 1158 × 1158 pixels. 
 
 
Figure 4. 1 Image examples for actin filaments in the composite network of actin 
and microtubule with NeutrAvidin molecules and MAP65 as actin and microtubule 
crosslinkers, respectively. A pair of images is shown for each of 0%, 3%, and 10% 
MAP65 and R = 0, 0.02, 0.04, and 0.08 for NeutrAvidin molecules. The % represents 
the percentage of tubulin dimers that are bound to MAP65 crosslinkers, while R is 
NeutrAvidin:actin molar ratio.  Each pair consists of projection image of standard 
deviation of pixel intensity value (STD) and projection image of average of pixel 
intensity value (AVG). Spatial averaging of STD and AVG images generates <δ> 
and <I>, respectively. These values were used to form <δ>/<I> ratio for each time 








Figure 4. 2 Image examples for microtubule filaments in the composite network of 
actin and microtubule with NeutrAvidin molecules and MAP65 as actin and 
microtubule crosslinkers, respectively. A pair of images is shown for each of 0%, 
3%, and 10% MAP65 and R = 0, 0.02, 0.04, and 0.08 for NeutrAvidin molecules. 
The % represents the percentage of tubulin dimers that are bound to MAP65 
crosslinkers, while R is NeutrAvidin:actin molar ratio.  Each pair consists of 
projection image of standard deviation of pixel intensity value (STD) and projection 
image of average of pixel intensity value (AVG). Spatial averaging of STD and AVG 
images generates <δ> and <I>, respectively. These values were used to form <δ>/<I> 
ratio for each time series. Scale bar is 20 μm and applies to all of the images. 
 
 
To characterize the co-localization of microtubules and actin filaments, I 
calculated the cross correlation between the microtubule and actin fluorescence channels 
for the same location and time. For each image of the same region in the chamber 
recorded from the actin channel and the microtubule channel, I can calculate the local 
normalized cross-correlation value for a region of n pixels. The definition of normalized 
cross correlation is: 
 










where Ia(x,y) and Im(x,y) are the intensity values for the x and y coordinates of the 
selected, corresponding regions of interest over which the normalized cross correlation is 
calculated.  The parameters μa and μm are the mean intensity values, and σa and σm are the 
standard deviations of intensities for the same region. This definition of normalized cross 
correlation returned values between -1 and +1, where +1 values denote high correlation 
between the actin and microtubule images and were depicted in white, -1 values indicated 
anti-correlation between the actin and microtubule images and were depicted in black; 
intermediate scaled linearly in grey.  
I can use this definition of the normalized cross-correlation function to create 
correlation maps, which are images that show where the actin and microtubule images are 
highly correlation (white) or anti-correlations (black). I created these maps by sweeping a 
square window to select the region over which I calculated the normalized cross 
correlation.  The interrogation window, defined by characteristic size d, contained (2d + 
1)2 pixels. Correlation maps could be created using different window sizes, calculating 
the normalized cross correlation (Eq. 1) over the n = (2d + 1)2 pixels, and assigning the 
central pixel of the window with the correlation value. The borders of the correlation map 
were trimmed by removing d pixels from the borders as this method leaves a frame of 
uncalculated pixel values 190.  
I used different interrogation window sizes to calculate correlation maps and 
determine the optimal window size, d, based on the diffraction limitation of optical 
microscopy and the quality of the resulting image. In order to compare between 




single number for the normalized cross correlation of one set of actin and microtubule 
images.  
4.4 Results and Discussion  
To assess the dynamics of the composite network of actin and microtubule 
filaments, I co-polymerized actin filaments and microtubules so as to have similar total 
polymer length and mesh sizes. I systematically altered the actin crosslinkers:actin 
monomers ratio, R, and the percentage of tubulin dimers bound to MAP65 crosslinkers 
(%). These control parameters resulted in altered arrangements of the network structure 
and tuned the mobility of the networks.  
4.4.1 Composite network without actin crosslinkers 
I first looked at the mobility of a composite network of actin and microtubule 
filaments with no actin crosslinkers present. To crosslink microtubule filaments, I tested 
MAP65 at 0%, 3%, and 10%, and recorded fluorescence images of the actin and 
microtubules (Fig 4.3.A). At 0% MAP65, the composite network of actin and 
microtubules co-polymerized to form an entangled network, as we have previously 
examined 141,162. The microtubule filaments and tracer actin filaments showed little 
structure when imaged in wide field epi-fluorescence (Fig 4.3.A i-iii).  When MAP65 
was introduced to the system (3%), microtubule filaments formed thin, over 10 μm long, 
bundles (Fig 4.3.A iv-vi). The bright background in the microtubule channel suggests the 
presence of microtubules that remained un-crosslinked. The actin filaments were 
uniformly distributed as well, implying that they are unaffected by the microtubule 





At 10% MAP65, the microtubule bundles were denser and longer (Fig 4.3.A vii-
ix). The background in the microtubule channel was lower, implying that most 
microtubules were in bundles.  Unlike at the lower concentrations, MAP65 at 10% 
displayed actin structures. Interestingly, the actin bundles appear to be coincident with 
the microtubule structures. The co-localization of actin filaments and crosslinked 
microtubule filaments is obvious in the merged channel (Fig 4.3.A ix).  
In addition to the organization of the networks, I directly quantified the mobility of the 
composite networks, as we have previously measured 141,162. The mobility was deduced 
from the average standard deviation normalized by the average intensity, <δ>/<I>, from 
time series data of the microtubule and actin fluorescence channels, separately. These 
data were taken for several fields within a chamber to perform the averaging (N = 5 - 10 
measured time series for each chamber). Interestingly, the mobility of composite 
networks with zero actin crosslinking (R = 0) and increasing microtubule crosslinking by 
MAP65 at 0%, 3%, and 10% did not depend on the MAP65 crosslinking, despite the 






Figure 4. 3 Composite networks of microtubule and actin filaments without actin 
crosslinkers. (A) Representative images of (i, iv, vii) microtubules, (ii, v, viii) actin 
filaments, and (iii, vi, ix) merge channels with microtubules (cyan) and actin (red) 
for 0%, 3%, and 10% MAP65 without actin crosslinking (R = 0). Colors outlined 
correspond to the colors in part (B). Scale bar is 20 µm. (B) The standard deviation 
of pixel intensity over time and space, <δ>, was calculated and normalized by the 
average of pixel intensity over time and space, <I>. Box-whisker plot for <δ>/<I> 
ratio for 0%, 3%, and 10% MAP65 (N = 7, 8, 6 independent time series) is shown 
separately for actin (hashed) and microtubule (solid) networks. 
 
4.4.2 Co-localization of microtubule and actin  
I was surprised to observe that actin and microtubules co-localized at high 




amount of co-localization using a cross-correlation between the actin and microtubule 
signals in the same location (Fig 4.4, Fig 4.5). Each image was 2048×2048 pixels with a 
magnified pixel size of 108 nm; the cross-correlation value for each pixel exists between 
+1 to -1. The brightest white points corresponded to highly correlated areas with the 
magnitude of +1; the darkest black regions indicate anticorrelation between the images 
with a value of -1. Cross correlations between actin and microtubule channels were 
calculated using different interrogation window sizes, d, where d is the number of pixels 
in both directions around the central pixel (Fig 4.4.B). 
I found that the interrogation window size did impact our analysis. If the window 
size was too small (d = 1), the data was dominated by shot noise, which is uncorrelated, 
by definition (Fig 4.4.B i). Considering the diffraction limit for these images was 250 – 
325 nm or ~3 pixels, any calculation for window size below that does not carry physical 
information and would be dominated by noise, as shown for the smallest window size. 
When d = 5, there are bright patterns that correspond to the co-localized actin and 
microtubule bundles, indicating that actin and microtubule channels are highly correlated 
at those locations (Fig 4.4.B ii). These bright areas expand at window sizes of 10 and 15 
pixels (Fig 4.4.B iii-iv). However, when the window size increased, the resolution of the 
structure decreased. The signal from the bundle was smeared out over the window, and 
information was lost. Due to this empirical assessment, I chose a window size of d = 5 to 
perform all cross-correlation analysis to quantify and compare the actin-microtubule co-
localization.  
I assessed that the cross correlation was not a result of fluorescence bleed-through 




images where highly fluorescent, non-bundled regions in the microtubule channel are not 
bright in the actin channel (Fig 4.4.A, arrows, Fig 4.6). These variations in microtubule 
intensity are likely clumps of aggregated tubulin protein that are incapable of forming 
filaments. Our tubulin clarification procedure removes most of these aggregates, but 
some always remain. In this case, the aggregates were useful to demonstrate that the co-








Figure 4. 4 Cross correlation of microtubule and actin channels. (A) Representative 
image of (i) microtubule and (ii) actin networks in the same location for R = 0 and 
10% MAP65. Scale bar is 20 µm. Bright regions in the microtubule channel (arrow) 
are not observed in the actin channel, implying bleed-through is not present. (B) 
Calculated cross-correlation maps for the same microtubule and actin images from 
(A) for different window sizes, d, when d = 1, 5, 10, 15 (i-vi). Optimal window size 
was chosen to be d = 5 (n = 121 pixels) and used throughout to compare different 
experiments. (C) Box-whisker plots of the average cross correlations between 
microtubule and actin channels averaged over the entire cross-correlation map 
created with window size d = 5 pixels for networks with no actin crosslinking (R = 0) 








Figure 4. 5 Cross-correlation between actin and microtubule channels. (A) Heat 
map plot shows the mean of normalized cross-correlation values for all composite 
networks measured with various R and MAP65 percent bound. Color scale indicates 
quantitative cross-correlation. (B) Representative merged images of microtubule 
(cyan) and actin (red) for all experimental parameters with various R and MAP65 




Figure 4. 6 High intensity microtubule aggregates do not appear in the actin 
channels. Representative images of microtubules (i, iii, v, vii, ix, xi) and actin (ii, iv, 
vi, viii, x, xii) for the same region in the experimental chamber at different 
percentages of MAP65 and R. Arrows denote regions where there is high 
fluorescence in the microtubule channel, which are caused by aggregates, without 






Using the optimal window sizes, I can compare the cross correlation of the actin 
and microtubule signals as a function of MAP65 concentration. In the absence of actin 
crosslinkers, the cross correlation was an accurate reporter of what was obvious from 
images: the actin co-localization increased with MAP65 percent bound (Fig 4.4.C). Given 
the dependence on MAP65 concentration, I can think of two possible mechanisms for this 
co-localization: (1) actin can bind to MAP65 with a low affinity and is being co-
crosslinked into bundles with microtubules, or (2) microtubule bundles are sweeping up 
the actin into the large bundles of microtubules. In order to assess these two possible 
mechanisms, I performed control experiments to examine the organization of actin in the 
presence of MAP65 without microtubules present. I found that in the presence of 10% 
MAP65, actin appeared as typical entangled networks with no effect on the actin 
structure (Fig 4.7.A). In order to be sure that the MAP65 was not associating with actin 
filaments – even weakly – I repeated the measurement using a GFP-labeled MAP65 and 
imaged the network in both channels (Fig 4.7.B). I found no obvious association of the 
MAP65 with actin and no structure in the MAP65 channel to imply interaction between 
the filaments (Fig 4.7.B).  
Finally, by closely examining regions where I did observe co-localization 
between microtubules and actin, I found that particularly thick microtubule bundles in the 
presence of 10% MAP65 could show individual actin filaments within larger bundle 
structures (Fig 4.7.C). I used ImageJ/FIJI to create a temporal color code of the time 
series for the actin and microtubule channels, which overlaid successive images in 
different colors, as given by the time-color scale (Fig 4.7.D). When using a spectrum 




temporal color code image. The microtubule bundle was mostly white due to low 
fluctuations (Fig 4.7.D i). Most of the actin filaments appeared as rainbows because they 
were able to fluctuate (Fig 4.7.D ii). The actin filaments that were co-localized with the 
microtubule bundle displayed as white – implying that they did not fluctuate over time, 
likely because they were stuck inside the microtubule bundle. Prior work has shown that 
the spacing between microtubules within MAP65 driven bundles is 25 – 35 nm 47 , more 
than enough space to trap an actin filament of width of 10 nm. Together, these 
observations support a mechanism where the actin is swept up into the microtubule 
bundles and not being co-crosslinked with microtubules due to an interaction between 
MAP65 and actin.   
The mechanism for actin-microtubule co-localization mediated by MAP65 is 
different from previously reported actin-microtubule interactions mediated by proteins 
originally thought to be only actin or microtubule binding partners. In those prior reports, 
naturally occurring proteins, such as CLIP-170, mDia 101, or engineered proteins, such as 
TipAct 102 served as crosslinkers between individual growing actin or microtubules and 
surprisingly altered the growth rates as well as the organization of these filaments. 
Another exciting study used tau and fascin to co-organize actin and microtubules 185. In 
all of these examples, the experiments showed specific interactions between the filaments 
and the crosslinkers. Further, these experiments were performed in quasi-2D, which is 
distinct from the work presented here, which is specifically interested in 3D networks of 
actin-microtubule composites. Ultimately, these exciting co-crosslinkers can be utilized 






Figure 4. 7 Actin and MAP65 do not interact without microtubules. (A) Actin 
network with 10% MAP65. Scale bar is 20 µm. (B) Representative image of (i) actin 
and (ii) GFP-MAP65. Scale bar is 10 µm. (C) (i) Large, thick bundle of microtubules 
in the presence of 10% MAP65. (ii) Actin filaments co-localized within the bundle. 
(iii) Merge of microtubules (cyan) and actin (red). Scale bar is 10 µm. (D) Temporal 
color code of a 1-minute time series of (i) microtubules and (ii) actin shows that 
actin within the microtubule bundle does not fluctuate as much as actin outside of 








4.4.3 The role of actin crosslinkers in the fluctuation dynamics of actin and 
microtubules 
 
We have previously shown that actin network crosslinking has a profound effect 
on the mobility and viscoelastic nature of actin-microtubule composite networks 141,162. In 
our prior works, the microtubule network was less dense compared to the actin network, 
which may have been the reason for the actin’s control over the mechanical properties. 
To determine the impact of actin crosslinking by NeutrAvidin when actin and 
microtubule mesh sizes are comparable, I prepared co-polymerized actin and microtubule 
filaments without MAP65 crosslinkers, and with an increasing ratio of NeutrAvidin:actin 
R = 0, 0.02, 0.04, and 0.08. The actin and microtubule networks were imaged directly and 
the organization and mobility were measured for each filament type using time series. 
I found that the microtubule network of the composite did not appear to have 
gross changes in morphology as the actin crosslinking ratio was increased (Fig 4.8.A). 
Actin filaments did tend to form a mesh-like network with some clusters of filaments at 
the highest tested ratio, R = 0.08, similar to our prior results 141. NeutrAvidin molecules 
have four potential binding sites in a tetrahedral arrangement allowing the actin network 
to be oriented in a variety of angles when crosslinked. While some actin bundling can 
occur, the actin bundles are far less obvious than the microtubule bundles created by the 
antiparallel crosslinker, MAP65. 
  
For multiple locations in several chambers, the mobility <δ>/<I> was measured 
and compared for networks without microtubule crosslinking and increasing actin 
crosslinking (R = 0, 0.02, 0.04, 0.08). In general, I found that the mobility of both actin 




network mobility and viscoelastic properties were controlled by the actin network and its 
crosslinking ratio 141.   
Of interest, I found that the microtubule mobility increased, while the actin 
mobility decreased (Fig 5.8.B). Perhaps it is not surprising that actin would become less 
mobile when crosslinked. Indeed, we have shown that in our prior work 18,19,183. 
Strikingly, and distinct from our prior work, microtubule motility significantly increased 
as the actin crosslinking increased. The enhanced microtubule mobility may result from 
the increased free space when actin filaments become crosslinked, giving microtubules 
more space to fluctuate. This implied that the actin was bundling on a scale that was 
smaller than we can detect in the microscope, as we previously noted 18,19,183.  
In our prior works, the actin mobility is almost always higher than the 
microtubule mobility due to the inherent high flexibility of actin filaments compared to 
microtubule filaments 18,19,183. These prior works often had equimolar actin monomers 
and tubulin dimers, resulting in more actin filaments than microtubules. Specifically, the 
number of actin filaments was greater than the number of microtubules due to the fact 
that the microtubule requires 13 dimers to nucleate and form a filament, compared to two 
actin monomers needed for actin filaments. Here, we purposely chose an actin-
microtubule ratio to result in similar amounts of actin and microtubule polymer length 
and mesh sizes. In this study, the tubulin fraction is ~87%. In one prior work, I altered the 
relative ratio of actin and tubulin to change the network from 100% actin to 100% 
microtubules for entangled networks without crosslinkers. Significant changes in the 
mobility and mechanics of the network occurred when the actin and microtubule polymer 




low mobilities for actin and microtubules, with actin’s mobility slightly higher than 
microtubules 183. Excitingly, I show here that when actin-microtubule filament ratios are 
more similar, the mobility of actin decreases as a function of actin crosslinking, and the 










Figure 4. 8 Filament fluctuations depend on actin crosslinking. (A) Representative 
images of microtubules (i, iv, vii, x) and actin (ii, v, viii, xi). Merged images (iii, vi, ix, 
xii) display microtubules (cyan) and actin (red) networks as the actin crosslinking is 
increased R = 0, 0.02, 0.04, 0.08 in the absence of microtubule crosslinkers (N = 7, 6, 
8, 5 independent time series for increasing R). Colors outlined correspond to the 
colors in part (B). Scale bar is 20 μm. Arrows denote regions where there is high 
fluorescence in one channel without bleed-through into the other fluorescence 
channel. (B) The mobility of the networks was quantified using the <δ>/<I> ratio 
where <δ> is the standard deviation of pixel intensity that was averaged over time 
and space and then normalized by the mean of pixel intensity, <I>, for (i) 
microtubules and (ii) actin as a function of actin crosslinking ratio. 
 
 
4.4.4 High microtubule crosslinking causes co-localization of actin and 
microtubules, while actin crosslinking controls filament mobility 
 
I previously discussed the co-localization of actin and microtubule filaments in 
the absence of actin crosslinkers (R = 0) and demonstrated that it was highly correlated at 
10% MAP65 (Figs 4.3, 4.4). I wanted to test if the actin crosslinking had further effects 
to enhance or negate the actin-microtubule co-localization driven by MAP65. To 
investigate this phenomenon, I changed the NeutrAvidin:actin ratio, R, systematically 
while maintaining the MAP65 at 10% bound (Fig 4.9). For all actin crosslinker ratios (R 
= 0, 0.02, 0.04, 0.08), the microtubules displayed long bundles distributed randomly 
through the whole sample in the imaging plane as well as the depth of the experimental 
chamber (Fig 4.9.A). As for the entangled networks, actin filaments appeared to co-
localize with the microtubule bundles (Fig 4.9.A).  
I quantified the co-localization using cross-correlation maps with the optimal 
window size of d = 5 (Fig 4.9.B). All the networks had high cross correlation between 
actin and microtubules when high MAP65 (10%) was present, and there was no 




I measured the mobility of actin and microtubules in composite networks with 
high microtubule crosslinking (MAP65 at 10%) as a function of actin crosslinking ratio 
(R). As above, I determined the mobility of this crosslinked network by measuring the 
mean of standard deviation over time, <δ>, and the mean of intensity over time, <I>, 
when the actin crosslinking was R = 0, 0.02, 0.04, and 0.08. For microtubules, the 
mobility increased as more actin crosslinkers were added (Fig 4.9.C). For actin filaments, 
adding more actin crosslinkers reduced actin filament mobility. The trend for both actin 
and microtubules was similar for 10% MAP65 as shown above for 0% MAP65 (Fig 
4.8.B). These results imply that the actin crosslinkers have the most influence on network 
mobility. From our prior work with actin-microtubule composites, I also know that the 
viscoelastic properties of the networks depend on the actin network mobility, implying 











Figure 4. 9 Co-localization of microtubule and actin filaments at 10% MAP65. (A) 
Representative images of microtubules (i, iv, vii, x), actin (ii, v, viii, xi), and merge 
(iii, vi, ix, xii) with microtubules (cyan) and actin (red) composite networks created 
in the presence of 10% MAP65 with different actin crosslinking ratios: R = 0, 0.02, 
0.04, and 0.08. Bundles of microtubules and co-localization of actin are obvious for 
all networks. Color outlines correspond to the data represented in (B) and (C). Scale 
bar is 20 μm. (B) Cross correlation of microtubule and actin channels were 
computed and displayed in a box-whisker plot. There was no significant difference 
in the actin-microtubule co-localization as a function of R (N =8, 8, 10, 10). (C) The 
mobility of the (i) microtubules and (ii) actin of composite networks was quantified 
using the <δ>/<I> ratio where <δ> is the standard deviation of pixel intensity that 
was averaged over time and space and then normalized by the mean of pixel 
intensity, <I>, for networks with increasing actin crosslinkers, R (N = 6, 6, 8, 9 




I showed that microtubule bundling by MAP65 can significantly affect the 
organization of actin and microtubules, specifically causing co-localization (Figs 4.3, 4, 
9). Using the GFP-labeled MAP65 protein, I can perform three-color imaging to localize 
the microtubules, actin, and MAP65 simultaneously (Fig 4.10.A). For an example 
network with 10% MAP65 and R = 0.02 actin crosslinking, I found that the MAP65 and 
microtubules exactly correlated their organizations. The actin also correlated with the 
microtubules and MAP65, but there were additional actin filament signals outside of the 
bundles (Fig 4.10.A ii). Using the temporal color code, it is clear that the actin associated 
with the bundles is not as mobile as the actin in the background, also shown in figure 5 
(Fig 4.10.B, 4.7.D).  
Although the microtubule crosslinker had profound effects on the microtubule and 
actin organizations, it had insignificant effects on the mobility of the actin and 
microtubule filaments (Fig 4.10.C). This trend continued for all variations of Netravidin 
crosslinker (R = 0, 0.02, 0.04, 0.08) and MAP65 percentage bound (0%, 3%, 10%) (Fig 




agents. It is known that MAP65 crosslinkers reduce the flexural rigidity of microtubule 
filaments 191, but other microtubule-associated proteins, such as tau, make microtubules 
stiffer 31,37. Future studies using these crosslinking and stiffening associated proteins 
could have different results on the mobility.  
In order to ensure that these effects on mobility were not caused by inadvertent 
effects of the crosslinkers to the wrong filament within the network, I performed control 
experiments with actin in the presence of MAP65 (Fig 4.7) and microtubules in the 
presence of Neutravidin (Fig 4.11). For each of these tests, I used the higher crosslinker 
concentration (10% MAP65 and R = 0.08). The mobility of these networks were 
measured and shown as a gray bar (Fig 4.10.C).  For microtubules in the presence of 
NeutrAvidin, the median mobility is similar to that of microtubules with R = 0 (Fig 
4.10.C i-iv), implying that the control network behaves like the composite without actin 
crosslinkers (Fig 4.10). Consequently, I can conclude that microtubule filaments and 
NeurAvidin molecules do not interact in this composite network. Further, the higher 
mobility than control could be due to the increased volume compared to when the other 
part of the network is present. 
For the samples with actin in the presence of MAP65, without microtubules and 
without NeutrAvidin (R = 0), the median and the distribution of mobility exhibited higher 
mobility compared to 10% MAP and R = 0 in the presence of microtubule filaments. This 
result mirrors the imaging results (Fig 4.7) that suggest that MAP65 and actin do not 
associate to form bundles of actin. It implies that great amount of MAP65 could not form 
bundles of actin filaments and did not lower the mobility of actin network as was shown 




was significantly higher than observed with microtubules present (Fig 4.10 v-viii). This 
could be due to the increased volume to move when the microtubules were absent.  
One interesting observation was that, despite the co-localization of actin with 
microtubules when the MAP65 was 10% (Fig 4.4, 4.8), the actin mobility is not equal to 
the microtubule mobility. This result implied that these co-localized actin filaments did 
not dominate the fluctuation dynamics in the actin network. That is corroborated by the 
imaging data and the temporal color code data of the actin which shows significant 
mobility from the free actin filaments, despite a fraction being immobilized in the 
bundles (Fig 4.7.D, 4.10.B).  
I also noted that there was a relatively large jump in actin mobility when doubling 
the actin crosslinker concentration from R = 0.02 to 0.04. An additional doubling of the 
actin crosslinkers (R = 0.08) has no further effect, as if the network mobility has hit a 
saturation level (Fig 4.10). This same activity was observed in our recent publication 
examining actin crosslinking in composite networks 162.  
Unlike actin, the microtubules did not show a discrete jump in the mobility as a 
function of actin crosslinking. Instead, the trend of increasing microtubule mobility was 
gradual as a function of actin crosslinking (Fig 4.9). Comparing this data to our recent 
publication of actin crosslinking in composites without microtubule crosslinking, I see 
similar results 162. Namely, the microtubule mobility appears higher than the actin 
mobility for R = 0.04-0.08. I conjecture that the mobility changes come from actin 
bundles at a level that allows increased microtubule mobility, but is too small to observe 








Figure 4. 10 Mobility of composite networks of microtubule and actin filaments with 
varying crosslinkers. (A) Example three-color image of a network with (i) 
microtubules and (ii) actin crosslinked with (iii) 10% GFP-MAP65, and 
NeutrAvidin R = 0.02. Three-color image merge showing microtubules (blue), 
MAP65 (green), and actin (red). Scale bar is 10 μm. (B) Example mobility of the 
images from (A) using ImageJ/FIJI temporal color code function shows (i) 
microtubules, (ii) actin, and (iii) MAP65. Microtubules and act both do not move, 
which a subset of actin does move outside of the bundles. (C) All mobility 
measurements for microtubules (i – iv) and actin (v- viii) as a function of actin 
crosslinking (R) and MAP65 binding show an overall dependence on actin 
crosslinking but not on MAP65 binding (N = 5 - 10 independent time series). 





Figure 4. 11 Microtubules in the presence of actin crosslinkers. Representative 
image of microtubules in the presence of actin crosslinkers, NeutrAvidin, at R = 0.08 
does not show any structure or any evidence of crosslinking. Scale bar is 20 μm. 
 
4.5 Discussion and Conclusions 
Composite actin and microtubule networks are important regulators of 
intracellular organization and mechanics. I found here that the microtubule crosslinking 
and bundling can control the organization of actin-microtubule networks, but the actin 
crosslinking controls the dynamics of both filament types, and likely the mechanics of the 
network. This result was rather unexpected given that one of the tenants of biological and 
soft matter is a relationship between structure and function. In this composite network, 
the obvious morphological changes driven by microtubule crosslinking by MAP65 (ie. 
the large co-localized actin-microtubule bundles), are not affecting the dynamics nor the 




Despite the large structural changes, the fluctuation dynamics of the composite 
network are controlled only by the actin portion, and the extent of crosslinking of the 
actin. Reorganization of the network due to actin crosslinking is difficult to distinguish 
given the resolution of fluorescence microscopy, but I expect that the actin filaments are 
locally bundled and linked. Despite the lack of obvious change of the organization with 
actin crosslinking, the fluctuations of the actin and microtubules change significantly. Of 
particular interest is that the microtubules become the more mobile fraction of the 
network when the actin filaments are highly crosslinked (R > 0.02). I observed this effect 
in a recent publication when R = 0.04 – 0.08, but the apparent change in mobility and the 
difference between actin and microtubule mobilities were not as striking in that prior 
study as I present here (Fig 4.10). The difference could be due to the increased number of 
microtubule filaments compared to our prior work or the higher labeling of the 
microtubules revealing a more mobile population. Future work with active crosslinkers 
(motors) of either actin or microtubules could reveal exciting mechanical feedback when 











ACTIVE 3D COMPOSITE NETWORK OF ACTIN AND MICROTUBULE WITH 
MYOSIN II MOTOR PROTEINS 
5.1 Abstract 
The cytoskeleton is an active, non-equilibrium network composited of actin and 
microtubule filaments as well as their associated proteins such as motor proteins. This 
interacting composite network plays a vital role in various cell processes such as cell 
division and cell motility. Synergistic interactions of actin and microtubule filaments in 
the presence of motor proteins creates a complex system that is poorly understood. Here, 
I look at the organization of this active composite network by performing correlation 
analysis, and I use the data collected by our collaborators employing confocal 
fluorescence microscopy.  
5.2 Introduction 
 
The Cytoskeleton is a dynamic composite network of filaments that enables the 
cell to actively self-organize its interior to facilitate various essential cell functions like 
cellular morphogenesis and mechanosensing. Assemblies of biopolymers such as actin 
and microtubules driven by motor proteins underly these dynamics that leads to 
morphological changes in a living cell.  
To understand the basic mechanisms that governs the activity of motor driven 
networks of filaments, various theoretical studies explored the produced contractile or 




actin and myosin II motor proteins was explored extensively in vitro 95,201–203. These 
actomyosin networks undergo contractile motion while myosin motors slide actin 
filaments against each other 95,201–204. It has been shown that connectivity of the filaments 
in an actomyosin network is a key parameter that could control the structure and activity 
of this network 202,205,206. Actin crosslinking proteins could tune the connectivity of 
actomyosin network. In vitro studies show that long range contraction in the network 
only occurs above a threshold connectivity when actin crosslinkers provide globular 
contractility across the network 202,205,206. However, below this threshold connectivity, 
myosin activity could produce short range contraction that forms smaller clusters 202,206. 
The cooperative interaction of actin crosslinkers and myosin motor in the contractile 
actomyosin network forms large aggregates 94 as well as aster structures while myosin 
motor activity could be controlled spatiotemporally using stimulating light that inactivate 
myosin inhibitors 203,207,208. Another recent study on the actomyosin network used 
experiment accompanied with simulation to demonstrate that stiffness and connectivity of 
filament modulate the deformation of the active network. Semiflexible filaments undergo 
contraction at higher filament connectivity, while crosslinking can tune more rigid 
filaments to form extensile to contractile networks 206. These results could explain the 
fact that active assemblies of more rigid microtubule filaments with motor proteins like 
kinesin motors, exhibit either extensile 98,192,193,209–211 or contractile 98,212,213 motions. 
As it is discussed above, active actin and microtubule networks were explored 
individually, while the effect of introducing a second type of filaments in an actin 
network remained an open question. However, the unique interaction of actin and 




various biological processes such as cell migration and division. I have shown that the 
interaction of actin and microtubule filaments in the composite network can produce a 
unique network with distinct dynamics and mechanical properties. Hence, exploring the 
effect of activity in this composite network could enable us to design multifunctional 
materials.  
Here, we examine the 3D active composite network of actin, microtubule, and 
myosin II motors. Two color confocal fluorescence microscopy was used by our 
collaborators to visualize the contractile network, while myosin activity was controlled 
by light. To characterize the temporal structural changes in this contractile network, I 
used correlation length measurements. I show that active composite network exhibit more 
organized and uniform contraction in both actin and microtubule networks while the 
length over which the network is correlated decreases over time. In contrast, actin 
filaments in active actomyosin network undergo rupturing and turbulent contractions that 
is reflected in enhancement in their correlation length measurements at later times. 
5.3 Material and Method 
5.3.1 Composite network preparation 
Actin and microtubule were co-polymerized in the proper optimized buffers, each 
at the constant concentration of 2.9 μM, according to previously published protocols 
141,162. Rabbit skeletal myosin II (Cytoskeleton, #MY02) introduced to provide activity to 
this composite network at the constant concentration of 0.24 μM. Oxygen scavenging 
solution was added to prevent photo damage. Also, 50 μM blebbistatin was added to 





A Nikon A1R laser scanning confocal microscope was used to image networks 
with a 60x 1.4 NA objective (Nikon). Labeled actin and microtubule were visualized 
using two color imaging. Actin and Microtubules were imaged using 488 nm laser and 
561 nm laser, respectively. The 488 nm light also inactivated the blebbistatin and initiate 
myosin activity. Time series were taken for 6 minutes at a frame rate of 2.78 fps. Each 
frame is 256×256 pixels or 212 µm ×212 µm 214. 
5.3.3 Correlation measurements 
To quantify spatial correlation in a two-dimensional image, I used a MATLAB 
function 109. Pair autocorrelation functions were tabulated in MATLAB using Fast 
Fourier Transform, FFT, as: 
𝑔(𝑟) =  
𝐹𝐹𝑇−1( |𝐹𝐹𝑇 (𝐼)|2 )
𝑁( 𝑟)
           Eq 5.1 
 
Where FFT-1 is a reverse Fast Fourier Transform, N(𝑟) is a normalization due to finite 
size of the image. Also, the pixel intensity of the 2D image forms I matrix. To eliminate 
the artifacts formed due to periodic nature of FFT, a zero pad is added around the original 
image I.  N(𝑟) is the autocorrelation of window function W that masks the image. W has 1 
value inside the measurement area and has the same size of zero padding as the original 
image I.  
𝑁(𝑟) =  𝐹𝐹𝑇−1( |𝐹𝐹𝑇 (𝑊)|2)       Eq 5.2 





Figure 5.1 displays an example of spatial correlation measurements for an image 
of actin network. The image (Fig 5.1.A) shows the actin network in an active composite 
of actin and microtubule filaments. The size of this image is 180×180 pixel or 
149μm×149μm.  
 
Figure 5. 1 Correlation measurement. (A) A confocal microscopy image of actin 
network in an active actin-microtubule composite network. It is 180×180 pixel or 
149μm×149μm. Scale bar is 20 μm. (B) Color-coded map of 2D spatial correlation 
function, g (?⃗⃗?), obtained from the image. The spatial correlation function is depicted 
for 360×360 pixels. (C) 1D spatial correlation function calculated by angular 







  The 2D spatial correlation function, g(?⃗⃗?), is calculated using the MATLAB 
function. Figure 5.1.B displays this map for the image of actin network and it has the size 
of 360×360 pixel. The 2D spatial correlation map is expected to be symmetric for 
isotropically oriented filaments. Then, g(𝑟) was averaged over all angles for each r value 
to create 1D spatial correlation function, G(r). This function is normalized as below 
Correlation =  
G(r) − 1
𝐺𝑚𝑎𝑥(𝑟)−1
    Eq 5.3 
Where Gmax(r) is the maximum value of the G function. The correlation function is 
plotted in Fig 5.3.C for different distances, r. The shape and range of the correlation 
function could reveal information about the underlying structure of the initial image 
109,110,215. Here, the correlation function is in the range between 1 and 0, and fitted to an 
exponential function, 𝑎 × 𝑒𝑥𝑝(−𝑥/𝑏). The exponential coefficient b is considered as the 
short-range correlation length for the network of filaments.  
5.4 Result and discussion 
To evaluate the structure of dynamic composite network of actin and microtubule 
filaments, I measure the short-range correlation length of each of the actin and 
microtubule network, separately. I look at 3 different time series for active composite 
network and compare them with the result of 3 time series of active actin and myosin 
network. By starting the imaging, the 488 nm light deactivates the myosin motor 
inhibitors, blebbistatin, and initiates their activity. As a result, myosin motors slide the 
actin filaments against each other that leads to contraction in the network of filaments. To 




frames at 20, 120, 240, and 360 second for each time series. The change in the correlation 
length of a network over time could indicate the effect of activity in its structure.   
5.4.1 Correlation length measurement of a contractile composite network  
To investigate the change of correlation length over time, I look at the network of 
filaments for time series i, ii, iii, while actin and microtubule channels are analyzed 
separately. The correlation length is measured for four frames of each time series at 20, 
120, 240, and 360 second. Fig 5.1 and Fig 5.2 display the network of filaments over time 
and the calculated correlation results for actin and microtubule network, respectively.  
We examine the 3D composite network of actin and microtubule over the course of six 
minutes while myosin motors provide the activity. Although, myosin motors only bind to 
actin filaments, it is clear from the careful observation of the time series that the two 
networks remain coordinated while microtubules co-localized with actin filaments and 
move with them. Particle Image Velocimetry (PIV) analysis conducted by our 
collaborator shows similar movement patterns for actin and microtubule networks, while 
they both move toward the center of activated region 214. Here, I measure the correlation 
length of actin and microtubule networks as described in the Method. Briefly, the 2D 
spatial correlation function is calculated for each image using Fast Fourier Transform 
(FFT) in a MATLAB code. Then, 1D correlation function for different radii is computed 
after angular averaging. To find the correlation length, the normalized correlation is 
plotted vs radius and fitted to exponential decay. Here, the actin and microtubule 
filaments are randomly oriented in the network. Consequently, their 1D correlation 
functions generally show an exponential decay with minimum or no fluctuation before 





Figure 5. 2 Actin filaments in a 3D active contractile composite network. (A) Four 
different confocal microscopy images of time series i, ii, iii are displayed. The frames 
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the 
activated myosin motors initiate the contraction in the composite network. Colors 
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all 
the images. (B) Correlation length values of actin network for each of the four 
frames of time series i, ii, iii are shown. Myosin activities move and rearrange actin 
filaments and forms a denser network with smaller correlation length over the 







Figure 5. 3 Microtubule filaments in a 3D contractile composite network. (A) Four 
different confocal microscopy images of time series i, ii, iii are displayed. The frames 
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the 
activated myosin motors initiate the contraction in the composite network. Colors 
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all 
the images. (B) Correlation length values of microtubule network for each of the 
four frames of time series i, ii, iii are shown. Although, myosin only binds to actin 
filaments, the microtubule network moves accordingly. This rearrangement of 
microtubules forms a network with smaller correlation length.  
 
measurements indicate smaller correlation length for both of the actin and 
microtubule networks over time, that is in a good agreement with the PIV analysis 
results. The contraction in an active actin-microtubule composite rearrange and move the 




due to the contraction are mirrored in the correlation length measurements of both actin 
and microtubule networks. 
5.4.2 Correlation length measurement of contractile composite network  
To determine the effect of actin and microtubule interaction in the dynamics of 
this active composite network, a control experiment was designed. The microtubule 
filaments are removed in the new active actomyosin network while all of the other 
reagents and conditions remain the same. Fig 5.4 shows four different frames of this 
active actomyosin network for time series i, ii, iii. The reorganization of actin network is 
more drastic and rupturing in the control experiment and the networks undergo more 
obvious structural changes over six minutes. Myosin activity creates bright regions that 
contains bundles of actin filaments and leaves large voids in the network. As the 
filaments are not confined on a surface and the network is imaged at the middle of each 
sample, these bundles could move out of the plane of view. Thus, large bundles of actin 
filaments enter and then exit the plane of view due to myosin activity. The computed 
correlation length for active actomyosin network is displayed in Fig 5.4.B. The 
correlation length of actin network increases over time for the time series while the time 
series iii undergo significant raise. This bundle formation alters the structure of actin 
network and consequently, affects the correlation measurements. It seems that the results 
correspond to the characteristic length between the brighter areas made of bundles of 
actin rather than individual filaments. The contraction empowered by myosin motors 
shapes the denser areas of actin filaments. These aggregates grow over time and then 







Figure 5. 4 Actin filaments in a 3D active actomyosin network. (A) Four different 
confocal microscopy images of time series i, ii, iii are displayed. The frames 
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the 
activated myosin motors initiate the contraction in the actin network. Colors 
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all 
the images. (B) Correlation length values of actin network for each of the four 
frames of time series i, ii, iii are shown. Structural changes fueled by myosin activity 
forms bundles of actin filaments that enter and exit the plane of view. The 
correlation measurements correspond to the rearrangement of these bright areas, 








The comparison between the active actin-microtubule and active actomyosin 
networks indicates that composite network has a slower, controlled network-wide 
contraction. This organized contraction dynamics is reflected in the decreasing 
characteristic length of both actin and microtubule networks over time. In contrast, actin 
network contraction leads to network rupturing when the actin bundles have turbulent 
motion over time. These results show that microtubule in the active actomyosin network 
could control the organization of actin network and slow down its activity 214.  
Previous studies have shown the role of filament connectivity and stiffness in the 
actomyosin contraction 205,206. For more rigid actin bundles, increasing crosslinker 
density can cause extensile to contractile transition in the actomyosin network 206. Here, 
by introducing rigid microtubule filaments to the active actomyosin network, the 
structure and dynamics of the network is regulated, while slower and more organized 
contractile network created. This composite provides a platform to explore the interplay 








 Self-organization and dynamics of composite network of actin and microtubule 
filaments were discussed in this thesis. Interactions of these two biopolymers in the 
cytoskeleton enable the cell to fulfill various key cell functions such as cell motility and 
cell division. Hundreds of known enzymes and auxiliary proteins cooperate to regulate 
the interaction of actin and microtubules at different parts of cells and facilitate their 
functions. Studying its underlying mechanism can transform our understanding of cell 
biology and material science. In addition, it could be exploited to design multifunctional 
smart materials that can be customized accordingly.   
 Actin and microtubule filaments are the main elements in these composite 
networks. Different characteristics of these filaments such as their rigidity and median 
length could determine the mechanics and dynamics of the composite network. Using 
filaments with different persistence length would be an interesting next experiment to 
design. The density ratio of actin and microtubules filaments could also affect the 
viscoelastic properties of the composites. Moreover, various molar ratios of actin and 
microtubule can control the final median length of each filament and form a composite 
network with distinct structure. Introducing some auxiliary proteins that could regulate 
actin and microtubule filaments polymerization as well as severing enzymes also could 
enable us to control the length of these filaments in the composite.  
To tune the interaction of actin and microtubule filaments, various types of 
crosslinkers could be employed. Each type of crosslinkers has a specific size and strength 




bundles. The ratio of crosslinkers to total protein is another parameter that could be 
investigated.  
Motor proteins can provide activity to these composite networks and generate 
force by consuming energy. Different types of myosin and kinesin motors can interact 
with actin and microtubule filaments while the directional movement and the amount of 
generated force varies depending on the characteristic of certain motors. The density of 
the motors and their molar ratio could dictate the activity and structure of the active 
composite network. There are studies that investigated the cooperative role of 
crosslinkers and motor protein in the network of filaments. Here in the active composite 
network, we can introduce actin and microtubule specific crosslinkers and explore the 
interplay between them. In addition, the activity of the network could be controlled by the 
amount of ATP present in the composite network. A certain type of ATP that is called 
caped ATP, is initially inactive and being exposed to the UV light could activate it. 
Employing this ATP could allow us to locally activate the motors in the composite 
network using UV light. As a result, the motor proteins could switch from passive 
crosslinkers to force generating agents that slide the filaments along each other in a 
controlled manner in desired areas. 
To visualize the network of filaments and quantify the viscoelastic characteristic 
of actin-microtubule composite network, we can use different type of fluorescence 
microscopy and optical tweezers microrheology. Various analytical methods such as 
differential dynamic microscopy (DDM), Particle Image Velocimetry (PIV) and 
correlation measurements could be employed to assess the dynamics and the structural 




There are many different aspects that could be studied to reveal the physical 
properties of the composite network of interacting actin and microtubule filaments. 
Further research on the cytoskeletal composite networks in the presence of their associate 
proteins and motors can provide a deeper understanding of the mechanisms that cells use 











Actin Buffer 10X 
 
[Final] Formula Weight Chemical   
250mM 68.05 g/mol Imidazole 0.68g 3.4g 
250mM 74.55 g/mol KCl 0.746g 3.73g 
10mM 380.35 g/mol EGTA 0.152g 0.76g 
40mM 95.21 g/mol MgCl2 1600uL 8mL 
   pH to 7.4 pH to 7.4 
   ddH2O to 40mL ddH2O to 200mL 
 
Myosin Buffer 10X 
 
[Final] Formula Weight Chemical  
250mM 68.05 g/mol Imidazole 0.34g 
3M 74.55 g/mol KCl 4.47g 
10mM 380.35 g/mol EGTA 0.076g 
40mM 95.21 g/mol MgCl2 800uL 
   pH to 7.4 
   ddH2O to 20mL 
 
Myosin Buffer 1X      
0.5 mL of 10X Myosin Buffer Concentrate   
50 μL of 1 M DTT      
Add ddH2O to 5 mL      
 
Actin Buffer 1X        
1 mL of 10X Actin Buffer Concentrate    
100 μL of 1 M DTT     









Deadhead Myosin Spindown 
4.4 μL of 18 mg/mL myosin……………………Final 200 μg/mL of myosin stock 
17.4 μL of 2.3 mg/mL F-actin…….……Final 100 μg/mL of unlabeled actin stock 
4 μL of 0.1 M ATP……………………………………………….Final 1 mM ATP 
374.2 μL of Myosin Buffer 1X ..………………..Myosin Buffer 1X to total 400 μL 
 
Centrifuge at 95,000 rpm for 20 minutes at 4 °C to pellet deadheads. Remove supernatant 
and dilute to desired concentration. 
 
Myosin Dilution 
Spun down myosin is diluted in Myosin Buffer, usually to 200 μg/mL.  
 
Kinesin-1 
1. Take kinesin stock from -80 °C and thaw it on ice. 
2. Add PEM-100 and DTT to kinesin stock to make 580 nM solution. 
3. Centrifuge diluted myosin solution at 90,000 rmp for 10 minutes at 4 °C to 
remove aggregates! 
 
Prepare spin-coated coverslips 
1. Make the setting of the spin coater for 3500 rpm for 30 seconds 
2. Put the coverslip on the stage 
3. Pipette 50 μl of 0.1% nitrocellulose at the middle of the coverslip 
4. Press start! 
Store the coverslips in a clean lidded container and use them within 2 weeks! 
 
Methylcellulose 
To make 3% methylcellulose: 
3
100












10x   F - Buffer 
1 ml                Imidazole (1M)……………………………………….Final 100 mM 
2.5 ml                      KCl (2M)…………………………..………..……….….0.5 M 
100 µl                 MgCl2 (1M)…………………………………….….……..10 mM 
100 µl           EGTA (200mM)……………………………………….……….2 mM 
6300 µl                        ddH2O 
---------------------------------------- 
Total      10 ml   
 
 
10x    G – Buffer 
200 µl             Tris (1M)………………………………………………Final  20mM 
40 µl         CaCl2 (0.5 M)……………………………………………………..2mM 
9760 µl                ddH2O 
------------------------------------- 
Total         10 ml 
 
 
1x out of 10x G – Buffer 
5 µl            10x G – Buffer 
1 µl              DTT (10mM) 
44 µl                       ddH2O 
---------------------------------- 
Total                         50 µl 
 
 
• Final labeled actin concentration is 50 µM in this protocol. 
• Final phalloidin concentration is 16 µM in this protocol. 
• Concentration of phalloidin should be 1/3 of the concentration of actin. 
• Labeled actin to total actin concentration is typically 1/10 to 1/3 in labeled actin 
filaments. 
• Reconstitute Cytoskeleton G-actin powder to 10mg/ml. Aliquot and drop freeze, 
then store at -80 °C. (for both labeled and unlabeled G-actin). 







1.5 µl          red G-actin (220 µM)……………………………….….……Final 50 µM 
3 µl             unlabeled G-actin (220 µM)……………………………..…….… 50 µM 
3.2 µl          phalloidin in Methanol (100 µM)…………………………………16 µM 
1 µl             ATP (40 mM)………………………………………………………2 mM 
2 µl             10x F-Buffer 
9.3 µl          1x G-Buffer 
----------------------------------------------------------------- 





4.5 µl        unlabeled G-actin (220 µM) )……………………………..………Final 50 µM 
3.2 µl         phalloidin in Methanol (100 µM) )………………………..….…………16 µM 
1 µl           ATP (40 mM) )………………………………………………..…………2  mM 
2 µl           10x F-Buffer 
9.3 µl        1x G-Buffer 
----------------------------------------------------------------- 
20 µl total 
 
Add everything except the phalloidin and put it on ice for 30 minutes to polymerize. Then 
put it on room temperature for another 30 minutes. After that, add phalloidin and leave it 






Making Cytoskeleton Taxol stabilized microtubule 11% labeled 
 
Unlabeled Cytoskeleton Tubulin: The stock comes in a pellet that needs 200 µl PEM-100 
added to it to be at 5mg/ml (on ice). Aliquot and drop freeze from stock. Keep at -80 °C. 
 
Labeled Cytoskeleton Tubulin: add 4 µl PEM-100 to resuspend pellet to 5 mg/ml before 
use (on ice). Aliquot and drop freeze from stock. Keep at -80 °C. 
 
1. Turn on large Sorvall Discovery M120 centrifuge, set to °C. Make sure vacuum is 
on. 
2. Thaw/resuspend tubulin on ice. Transfer 2 µl labeled + 16 µl unlabeled = 18 µl 
total 
3. Using the small S120AT2-0449 rotor in deli fridge, centrifuge at 90,000 rmp for 
10 minutes. Thaw aliquot of 100 mM GTP for next step. 
4. Discard pellet and transfer sup to a 1.5 mL epp. Tube. Add 0.2 µl 100 mM GTP 
(1 mM GTP final). 
5. Incubate for 20 min at 37 °C. 
6. Add 0.45 µl 2 mM Taxol (50 µM Taxol final). 





Gliding assay for actin, myosin, microtubule, and kinesin: 
 
Blocking buffer 
BSA  10mg/ml        5 µl 
1x Actin buffer      95 µl 
------------------------------------ 
Total                     100 µl 
 
Diluted labeled actin filament  
Labeled actin filament   
Unlabeled actin filament         
Deoxy                     
Actin buffer 1x     
 
Diluted labeled microtubule filament 
MTs             
Taxol            
PEM-100     
 
Motility buffer 
Actin buffer 10x              10 µl 
KCl (1M)                        3.7 µl 
ATP (100mM)                   2 µl 
DTT (1M)                          1 µl 
Deoxy                                2 µl 
Methylcellulose (3%)   16.7 µl 
ddH2O                           53.6 µl  
Taxol                                  1 µl 
------------------------------------ 
Total                                 80 µl 
 
 
1. Make 10 µl chamber with nitrocellulose coated coverslip 
2. Mix 1 µl Kinesin 580 nM and 9 µl of HMM 200 µg/ml, then flow it into the 
chamber (incubate 5 min) 
3. Add 10 µl blocking buffer 
4. Add 10 µl diluted microtubule filament solution 
5. Add 10 µl diluted actin filament solution 
6. Add 10 µl motility buffer  







IMAGEJ/FIJI MACRO FOR MEASURING MEAN OF STANDARD DEVIATION 
AND AVERAGE OF PIXEL INTENSITY OVER TIME FOR TIME SERIES 
/* 
This Imagej/Fiji macro provides measurements for steady-state 
dynamics of actin microtubule filaments in a composite network.  
It splits a time series to actin(green) and red (microtubule) 
channels and analyzes each separately.  
It measures standard deviation of pixel intensity over time, 
delta, and its average over all pixels, <delta>. 
Also, it measures average of pixel intensity over time, I, and 
its average over all pixels, <I>. We use the results of each 
channel of a time series to make <delta>/<I> ratio for that 
channel. Each original time series has over 900 frames. I measure 
the above values for original time series first (*-all.tif). Then 
I make a new time series with frames that are temporal average of 
intensity of all of the frames that are in 1 sec. Here there are 
16 frames/sec so the movie (*-1sec.tif) has [# original 
frames/16] frames. "Measure" command gives the mean of intensity 
over all pixels for a time collapsed frame, then the results are 
saved as csv file.  
*/ 
 
dir1 = getDirectory("Choose Source Directory ");  
list = getFileList(dir1); 
 
for (i=1; i<=9; i++){  
 
 open("Time sequence"+i+".nd2");  
 title=getTitle(); 
 title=replace(title, ".nd2", ""); 
 
 
 selectWindow("Time sequence"+i+".nd2"); 
 run("Show Info..."); 
 saveAs("Text", dir1+"meta data "+title+".txt"); 
 
  
 //Split the channels 
 run("Enhance Contrast", "saturated=0.35"); 
 run("Enhance Contrast", "saturated=0.35"); 
 run("Split Channels"); 
 
 /* 
 Here are the measurements for "-all" time series 
 Here C1 is always green channel, C2 is red channel. 







 run("Delete Slice"); 
 run("Delete Slice"); 
 saveAs("Tiff", dir1+title+"-green-all.tif"); 
 
 selectWindow("C2-"+title+".nd2"); 
 run("Delete Slice"); 
 run("Delete Slice"); 
 saveAs("Tiff", dir1+title+"-red-all.tif"); 
 
 //find average of intensity for each time series, then save 
it 
 selectWindow(title+"-green-all.tif"); 
 run("Z Project...", "projection=[Average Intensity]"); 
 run("Enhance Contrast", "saturated=0.35"); 
 run("Select All"); 
 run("Measure"); 




 run("Z Project...", "projection=[Average Intensity]"); 
 run("Enhance Contrast", "saturated=0.35"); 
 run("Select All"); 
 run("Measure"); 
 saveAs("Tiff", dir1+"AVG_"+title+"-red-all.tif"); 
 close(); 
 
 //find standard deviation of intensity for each time 
series, then save it 
 selectWindow(title+"-green-all.tif"); 
 run("Z Project...", "projection=[Standard Deviation]"); 
 run("Enhance Contrast", "saturated=0.35"); 
 run("Select All"); 
 run("Measure"); 




 run("Z Project...", "projection=[Standard Deviation]"); 
 run("Enhance Contrast", "saturated=0.35"); 
 run("Select All"); 
 run("Measure"); 




 // Here are the measurements for "-1sec" time series 
//average each 16 frames to make 1sec frames, same it under 





run("Grouped Z Project...", "projection=[Average Intensity] 
group=16"); 
 run("Enhance Contrast", "saturated=0.35"); 
 saveAs("Tiff", dir1+"AVG_"+title+"-green-1sec.tif"); 
 
 selectWindow(title+"-red-all.tif"); 
run("Grouped Z Project...", "projection=[Average Intensity] 
group=16"); 
 run("Enhance Contrast", "saturated=0.35"); 
 saveAs("Tiff", dir1+"AVG_"+title+"-red-1sec.tif"); 
 
//now find standard deviation and average of intensity of 
//AVG_ time series that are basically 1sec time series. 
 selectWindow("AVG_"+title+"-green-1sec.tif"); 
 run("Z Project...", "projection=[Standard Deviation]"); 
 run("Enhance Contrast", "saturated=0.35"); 
 saveAs("Tiff", dir1+"STD_AVG_"+title+"-green-1sec.tif"); 
 
 selectWindow("AVG_"+title+"-green-1sec.tif"); 
 run("Z Project...", "projection=[Average Intensity]"); 
 run("Enhance Contrast", "saturated=0.35"); 




 run("Z Project...", "projection=[Standard Deviation]"); 
 run("Enhance Contrast", "saturated=0.35"); 
 saveAs("Tiff", dir1+"STD_AVG_"+title+"-red-1sec.tif"); 
  
 selectWindow("AVG_"+title+"-red-1sec.tif"); 
 run("Z Project...", "projection=[Average Intensity]"); 
 run("Enhance Contrast", "saturated=0.35"); 
 saveAs("Tiff", dir1+"AVG_AVG_"+title+"-red-1sec.tif"); 
 
//measure the mean of intensity over all pixels of the 
resulted image 
 selectWindow("STD_AVG_"+title+"-green-1sec.tif"); 


































PROTOCOL FOR CROSSLINKED ACTIN-MICROTUBULE COMPOSITE 
NETWORK WITH PRE-POLYMERIZED LABELED FILAMENTS 
 
Crosslinked Actin-Microtubule Co-Polymerization Protocol – 
Anderson Lab 
**Pre-polymerized Labeled filaments  
Shea N. Ricketts  
Updated February 22, 2019 by SNR 
 
Reagents 
Dark-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #T240, in -80°C *keep on 
ice, lasts for ~2 hrs on ice. Do not refreeze again in the -80°C. 
Rhodamine-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #TL590, in -80°C 
*keep on ice until thawing for rhodamine microtubule (R-MT)  polymerization. 
Polymerize the same day aliquot is pulled from -80°C. Do not refreeze again in the -
80°C. 
Biotin Tubulin, 45.5 µM = 5 mg/ml, from Cytoskeleton cat #T333P, in -80°C *keep on 
ice, lasts ~2 hrs if properly kept on ice Do not refreeze again in the -80°C. 
Dark Actin, 46.5 µM = 2 mg/ml, from Cytoskeleton cat #AKL99, in -80°C *keep on ice, 
last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do not refreeze 
again in the -80°C. 
488-Alexa Actin, 34.9 µM = 1.5 mg/ml, from Thermofisher cat #A12373, in -80°C 
*keep on ice, last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do 
not refreeze again. Do not refreeze again in the -80°C. 
Biotin Actin, 23.3 µM = 1 mg/ml, from Cytoskeleton cat #AB07, in -80°C  
GTP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used 
again. 
ATP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used 
again. 
Taxol 2 mM stock in DMSO, aliquot and freeze in -20°C *keep on bench after 
thawing, can be refrozen and used again. Put back in -20°C once Taxol dilutions are 
made (PEM-Taxol and 200 µM Taxol). 
Neutravidin, 83.3 µM, from Thermo Fisher cat #31000, in -20°C *keep on ice, last up 
to 1 week if properly kept on ice (as ice melts, replenish ice). However aliquot is at 5 
µl so will likely be used up within 1-2 days. Do not refreeze again in the -20°C.  
Free Biotin, 1.02 mM, from Sigma cat #B4501, in 4°C *take a 5 µl sample from the 
stock solution.Keep on ice, last up to 1 week if properly kept on ice (as ice melts, 
replenish ice). 










100 mM PIPES, pH to 6.8 with HCl 
2 mM MgCl2 
2 mM EGTA 
*Stored at room temperature and is viable for 1 years.       
 
1 x G-buffer 
2.0 mM Tris pH 8 
0.2 mM ATP 
0.5 mM DTT 
0.1 mM CaCl2   




198 μl PEM-100 
2 μl 2 mM Taxol *Thaw Taxol  
*Make fresh every time before use, keep at room temp, good for 1 day.   
 
200 uM Taxol  
18 μl DMSO 
2 μl 2 mM Taxol *Thaw Taxol  
*Make fresh every time before use, keep at room temp, good for 1 day.  
 
10 mM GTP, 1:10 dilution  
90 µl PEM-100 
10 µl 100 mM GTP   
*Keep on ice during use, store in -20°C, can freeze/thaw. 
 
10 mM ATP, 1:10 dilution  
90 µl PEM-100 
10 µl 100 mM ATP  
*Keep on ice during use, store in -20°C, can freeze/thaw. 
 
1% (v/v) Tween  
495 ul PEM 
5 µl Tween 20 
Vortex and quick spin to mix 





8.33 µM Neutravidin, 1:10 dilution 
9 µl PEM-100 
1 µl 83.3 µM Neutravidin 
*Keep on ice during use, good for the day’s use 
 
51 µM Free Biotin, 1:20 dilution 
19 µl PEM-100 
1 µl 1.02 mM (1020 µM) Neutravidin 
*Keep on ice during use, good for the day’s use 
 
PEM-100 
Fill 50 ml tube with 40 ml sterile DI water 
Measure out and add 1.893 grams of PIPES 
Qualitatively transfer to 50 ml tube 
100 µl of 1 M EGTA (final will be 2 mM) 
100 µl 1 M MgCl2 (final will be 2 mM) 
pH to 6.8 with pH meter (in 290) 
If pH is too high add HCl *typically PEM is too basic with a pH between ~7.4-8. 
Usually add 3-5 drops of HCl. Do so carefully as to not fall below 6.8 and have to add 
KOH.  
If pH is to low add KOH 
Fill remaining volume to 50 ml in 50 ml tube using sterile DI water. 
Sterile Filter into new 50 ml tube. 
Label “PEM-100 pH 6.8 yourinitials, Date” 
*Store at room temperature, in your drawer. 
 
Tubulin Storage Protocol  
Keep on ice during entire process prior to flash freezing and storage. 
Dark Unlabeled Tubulin 
Obtain unlabeled 1 mg lyophilized porcine tubulin (Cytoskeleton Cat #T240) from the 
4°C and put on ice.  
Add 200 µl PEM-100 to 1 mg lyophilized tubulin to bring up to 5 mg/ml volume. 
Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the 
fluid on the sid or lid and depositing it into the solution at the bottom of the tube. To 
avoid bubbles pipette slowly. 
Let sit on ice for 10 minutes to allow tubulin to go into solution. 
 
Rhodamine Labeled Tubulin 
Obtain Rhodamine labeled 20 µg lyophilized porcine tubulin (Cytoskeleton Cat 
#TL590) from 4°C and put on ice 





Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the 
fluid on the sid or lid and depositing it into the solution. To avoid bubbles pipette 
slowly 
Let sit on ice for 10 minutes to allow tubulin to go into solution 
 
Biotinylated Tubulin 
Obtain biotin 20 µg lyophilized porcine tubulin (Cytoskeleton Cat) from 4°C and put on 
ice 
Add 4 µl PEM-100 to 20 µg lyophilized rhodamine tubulin to bring up to 5 mg/ml 
volume 
Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the 
fluid on the sid or lid and depositing it into the solution. To avoid bubbles pipette 
slowly *Do NOT vortex 
Let sit on ice for 10 minutes to allow tubulin to go into solution  
 
Aliquots from Dark and Rhodamine Tubulin 
Mix labeled and unlabeled tubulin for desired labeling ratio. No labeling ratio has 
MT’s that are too bright. Currently we use a 1:10 ratio rhoadmine-labeled:unlabeled 
tubulin (the 1:20 ratio was too dim). 
Add 36 µl of dark tubulin directly to the 4 µl rhodamine tubulin tube to create 40 µl 
total. 
Let sit for 10 minutes on ice to allow rhodamine tubulin and dark tubulin to go into 
solution  Aliquot rhodamine tubulin into 5 µl (8 aliquots) 
Label each aliquot tube “R” *Once the rhodamine tubulin has been polymerized, add 
to label “R-MT” with the data 
Aliquot remaining volume of unlabeled tubulin into 5 µl (32 aliquots) 
Label each aliquot tube “5 mg/ml DT” DT stands for dark tubulin 
Flash Freeze with liquid nitrogen and store at -80°C *Flash freezing is absolutely 
necessary for tubulin to remain functional 
 
Aliquots from Dark, Biotinylated and Rhodamine Tubulin 
Mix labeled, unlabeled and biotinylated tubulin for desired labeling ratio and 
crosslinking ratio. Currently the labeling ratio for MT’s is 1:10 labeled:unlabeled 
tubulin. This means that we are going to keep the total tubulin volume fixed at 40 µl 
along with the 4 µl rhodamine tubulin tube. The volume of biotinylated tubulin will 
vary depending on the crosslinking ratio and so will the volume of unlabeled tubulin.  
Depending on the crosslinking ratio refer to the chart and add the correct volumes 
directly to the 4 µl rhodamine tubulin tube to create 40 µl total. 
Crosslinked Ratio “R=X” 0.005 0.01 0.02 0.04 
Unlabeled Tubulin, 5 mg/ml (µl) 35.6 35.2 34.4 32.8 




Rhodamine Tubulin, 5 mg/ml (µl) 4 4 4 4 
Total Tubulin Volume (40 µl) 40 40 40 40 
Let sit for 10 minutes on ice to allow rhodamine tubulin, dark tubulin, and biotinylated 
tubulin to go into solution  Aliquot the biotinylated rhodamine tubulin into 5 µl (8 
aliquots) 
Label each aliquot tube with the correct ratio and an R so you know that this is 
labeled tubulin. ‘R–R=0.0X” *Once the biotinylated rhodamine tubulin has been 
polymerized, add to label “R–R=0.0X MT” with the data 
Flash Freeze with liquid nitrogen and store at -80°C *Flash freezing is absolutely 
necessary for tubulin to remain functional 
 
Actin Storage Protocol  
Keep covered on ice during entire process prior to flash freezing and storage 
Dark Unlabeled Actin  
*Reconstitute to 2 mg/ml (46.6uM) 
Spin down the powder  
Add 100 ul of DI to 1 mg of actin 
This gives 10mg/ml Dark Actin 
Reconstitute to working concentration (2mg/ml) in G1 
Aliquot  into 25 ul aliquots 
Drop freeze in Liquid N2 
Store in -80°C freezer. 
  
Alexa-488-labeled Actin 
*Reconstitute 1.5 mg/ml (34.9uM) 
Alexa-488-labeled actin arrives in solution 
Measure the volume received 
Read the concentration from the data sheet 
Add appropriate amount of 1x G-buffer to reconstitute to 1.5 mg/ml  
Aliquot out the 1.5 mg/ml Alexa-488 actin into 5ul aliquots 
Flash freeze in liquid nitrogen and store at -80°C.  
  
Biotinylated Actin 
*Reconstitute to 1 mg/ml (23.3uM) 
Spin down the lyophilized biotinylated actin  
Add 2 ul of DI to lyophilize biotinylated actin  
This gives 10 mg/ml biotinylated actin.  
Then reconstitute to 1 mg/ml in GX1 buffer 
Aliquot out the 1 mg/ml biotinylated actin into 5 µl aliquots 
Flash freeze in liquid nitrogen and store in -80°C 
 




Goal is to make the 10 µl crosslinker solution with neutravidin, free biotin and 
biotinylated tubulin. 
Make sure to adjust the volume to be greater, ie 10x and 20x.  
Refer to chart to see crosslinking volumes 
Crosslinked Ratio “R=X” 0.005 0.01 0.02 0.04 
Crosslink volume adjustment 20x 20x 20x  6x 
PEM-100 (µl) 8.82 7.65 5.28 7.17 
Neutravidin, 8.33 µM 1:10 dilution (µl) 0.7 1.39 2.79 1.67 
Biotinylated Tubulin, 5 mg/ml (µl) 0.25 0.51 1.02 0.61 
Free Biotin, 51 µM 1:20 dilution (µl) 0.23 0.45 0.91 0.55 
 
Incubate in bath sonicator for 90 minutes with ice packs to keep from over-heating. 
This is added to the actin to polymerize networks with crosslinkers and the volume 
increase is taken into account in the final sample volumes 
 
Crosslinker Solution for Actin 
Goal is to make the crosslinker solution with neutravidin, free biotin and biotinylated 
actin. 
Make sure to adjust the volume to be greater, ie 10x and 20x.  
Refer to chart to see crosslinking volumes 
 
Crosslinked Ratio “R=X” 0.005 0.01 0.02 0.04 
Crosslink volume adjustment 20x 20x 20x  6x  
PEM-100 (µl) 8.58 7.16 4.31 6.59 
Neutravidin, 8.33 µM 1:10 dilution 
(µl) 
0.70 1.39 2.79 1.67 
Biotinylated Actin, 1 mg/ml (µl) 0.50 1.00 1.99 1.19 
Free Biotin, 51 µM 1:20 dilution (µl) 0.23 0.45 0.91 0.55 
Incubate in bath sonicator for 90 minutes with ice packs to keep from over-heating. 
This is added to the actin to polymerize networks with crosslinkers and the volume 
increase is taken into account in the final sample volumes 
 
Pre-polymerized 488-Alexa Labeled Actin Filaments Protocol: 
Goal is to create a 5 µM 10 µL solution with 50% dark and 50% labeled actin filaments 
that can then be diluted and added to the sample chamber for force and image 
measurements. 




0.72 µl 488-Alexa Labeled Actin 1.5 mg/ml (34.9 µM) 
0.54 µl Dark Actin 2 mg/ml (46.5 µM)   
2.00 µl 10 mM ATP (ATP in PEM-100) 
Mix by pipetting and allow to polymerize for one hour 
 
Pre-polymerized Biotinylated 488-Alexa Labeled Actin Filaments Protocol: 
Goal is to create a 5 µM 10 µL solution with dark, labeled, and biotinylated actin 
filaments that can then be diluted and added to the sample chamber for force and image 
measurements. 
Make a 1:5 dilution of Biotinylated Actin 1 mg/ml (2 µl PEM-100 and 2 µl Biotinylated 
Actin) *for all crosslinked ratios greater than or equal to R = 0.01 
Make a 1:10 dilution of Biotinylated Actin 1 mg/ml (9 µl PEM-100 and 1 µl Biotinylated 
Actin) *for all crosslinked ratios less than or equal to R = 0.01 
Depending on the crosslinking ratio refer to the chart to create a 10  µl solution. 
Crosslinked Ratio “R=X” 0.005 0.01 0.02 0.04 
PEM-100 (µl) 6.55 6.34 6.36 6.18 
488-Alexa Labeled Actin, 1.5 
mg/ml (µl) 
0.71 0.70 0.69 0.67 
Unlabeled Actin, 2 mg/ml (µl) 0.53 0.53 0.52 0.51 
Biotinylated Actin, 1 mg/ml (µl) 0.21 (1:10 dilution) 0.43 (1:10 
dilution) 
0.43 (1:5 dilution) 0.64 (1:5 dilution) 
2.00 µl 10 mM ATP (ATP in PEM-100) 
Mix by pipetting and allow to polymerize for one hour 
 
R-Tubulin pre-polymerization Protocol: 
Goal is to create a 37 µM 5 µl solutio n that can be diluted and added to the sample 
chamber for force images and measurements. *For crosslinked microtubules, to create 
biotinylated rhodamine microtubules use the same protocol just with the correct R–
R=0.0X tube. 
Thaw R-aliquot in your hand and put on ice. Once you start the rest of the protocol, the 
R-aliquot needs to be stored at room  
Add 0.55 uL 10 mM GTP to the thawed R-aliquot  (for a final concentration of 1 mM). 
Incubate in water bath at 37°C for 20-30 minutes to polymerize microtubules. (NOT 
above 37°C, slightly below is fine. 
Add 0.6 uL of 200 uM Taxol (final Taxol concentration ~20 μM). This brings the 
tubulin concentration to 37 µM  
Incubate at 37°C for 20-30 minutes to equilibrate the Taxol. Taxol is NOT a 
permanent binder, do not dilute taxol lower than 5 μM as the KD value is ~2 µM. 
Label polymerized Rhodamine tubulin “R-MT” with the date. 
*Store 5 µl stock on lab bench (room temperature) and wrap in foil. DO NOT put 




 **The 5 µl stock can be used for up to a week. Dilutions will not last and should not 
be kept after several hours. 
***If MT’s are too entangled and clumpy or too long, shear microtubules with a 
Hamilton syringe for 3 up-down passes and image again. 
 
Labeled Protein Dilutions  
Make dilutions right before adding to the sample chamber. When proteins are 
diluted, they may depolymerize if not added to more proteins. 
Labeling dilutions determined via trial and error from confocal imaging. Goal is to be 
able to see each filament without having to adjust several parameters during 
acquisition. 
488-Alexa Pre-polymerized Actin (1:2) 
2 µl PEM-100 
2 µl pre-polymerized 488-labeled actin filaments, cut tips 
*Make fresh each time immediately prior to making the final sample. 
 
488-Alexa Pre-polymerized Biotinylated Actin (1:2) 
2 µl PEM-100 
2 µl pre-polymerized biotinylated 488-labeled actin filaments, cut tips 
*Make fresh each time immediately prior to making the final sample. 
 
Rhodamine-Tubulin (R-MT’s) (1:10) 
9 µl PEM-Taxol 
1 µl R-Mt’s polymerized  
*Make fresh each time immediately prior to making the final sample. 
 
Rhodamine-Tubulin (R-MT’s) (1:10) 
9 µl PEM-Taxol 
1 µl biotinulated R–R=0.0X Mt’s polymerized 
*Make fresh each time immediately prior to making the final sample. 
 
FOR IMAGING AND FORCE MEASUREMENT:  
Make a Glu/Goc/Bead solution 
The glu/goc solution is critical to prevent photobleaching, beads are needed for force 
measurements. 
6 µl PEM-Taxol 
2 µl 488-Labeled 4.5 µm microspheres, make sure all spheres are suspended in 
buffer, vortex if not. 
1 µl Glu 
1 µl Goc 
Mix the solution by vortexing and quick spin. 
*Make fresh each time immediately prior to making the final sample. The 
glu/goc/bead solution MUST be the last solution that is made prior to making the 




**If just imaging, replace 2 µl microsphere with PEM-Taxol. 
 
Final Sample Chamber at 5.8 µM volumes for 20 uL final volume 
rough calculations on data sheet in binder “Crosslinked AMT Calculations for 5.8 µM” 
→ Crosslinked solution R=0.0X Microtubules 
→ Crosslinked solution R=0.0X Actin  
→ Polymerized 488-Alexa labeled actin filaments (takes 1 hour) 
→ Polymerized rhodamine microtubules (takes 40 min to 1 hour) 
→ Polymerized biotinylated 488-Alexa labeled actin filaments (takes 1 hour) 
→ Polymerized  biotinylated rhodamine microtubules (takes 40 min to 1 hour) 
→ Final Sample 
Make 20 µl final sample chamber, see below *For these networks, the total protein 
concentration is at 11.6 µM and a tubulin fraction of 0.5 (actin fraction of 0.5). 
Pipet to mix, gently. Cut tips when adding actin and tween to final sample.  
Pipet 20 µl into sample chamber (made via 2 layers of double sticky tape, coverslip 
and slide).  
Seal sample chamber with epoxy, label sample on slide with date and AMT ratio. 
Incubate sealed sample at 37°C  for 30 minutes. Use the oven in 292. MAKE sure 
temperature does not rise above 37°C or else your AMT network will crash and 
burn and you will be sad.  
 
AMT network, no crosslinkers: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in PEM-100 
9.6 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
1.2 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1.2 µl Dark Actin, 2 mg/ml or 46.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1 µl 1:10 R-MT dilution (in PEM-Taxol) 
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100) 
1 µl beads/glu/gloc 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
AMT network, Crosslink Actin R=0.02: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in 
PEM-100 
8.7 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
1.2 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1.1 µl Dark Actin, 2 mg/ml or 46.5 µM 
1 µl 20x Crosslinker Actin Solution  
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1 µl 1:10 R-MT dilution (in PEM-Taxol) 
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100) 




0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
AMT network, Crosslink Microtubules R=0.02: 0.5 AMT → 2.9 µM actin + 2.9 µM 
tubulin in PEM-100 
8.7 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
1.1 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1.2 µl Dark Actin, 2 mg/ml or 46.5 µM 
1 µl 20x Crosslinker Microtubule Solution  
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1 µl 1:10 R-MT dilution (in PEM-Taxol) 
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100) 
1 µl beads/glu/gloc 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
AMT network, co-crosslink R=0.02: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in PEM-
100 
*For this network the Microtubule ratio is R=0.01 and the Actin ratio is R=0.01. Here the 
crosslink solution is made separately  
7.8 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
1.1 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1.1 µl Dark Actin, 2 mg/ml or 46.5 µM 
1 µl 20x Crosslinker Microtubule Solution  
1 µl 20x Crosslinker Actin Solution  
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1 µl 1:10 R-MT dilution (in PEM-Taxol) 
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100) 
1 µl beads/glu/gloc 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
 
AMT network, co-crosslink R=0.04: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in PEM-
100 
*For this network the Microtubule ratio is R=0.02 and the Actin ratio is R=0.02. Here the 
crosslink solution is made separately  
7.8 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
1.1 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1.1 µl Dark Actin, 2 mg/ml or 46.5 µM 
1 µl 20x Crosslinker Microtubule Solution  




2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1 µl 1:10 R-MT dilution (in PEM-Taxol) 
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100) 
1 µl beads/glu/gloc 
0.5 ul 1% Tween 







PROTOCOL FOR CROSSLINKED ACTIN-MICROTUBULE COMPOSITE 
NETWORK USING MAP65 AND NEUTRAVIDIN (PRE-POLYMERIZED 
LABELED FILAMENTS) 
 
Crosslinked Actin-Microtubule Co-Polymerization Protocol – Ross Lab 
**Pre-polymerized Labeled filaments  
Leila Farhadi 
Updated Aug 5, 2019 by Leila F 
 
Reagents 
Dark-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #T240, in -80°C *keep on 
ice, lasts for ~2 hrs on ice. Do not refreeze again in the -80°C. 
HiLyte Fluor 488-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #TL488, in -80°C 
*keep on ice until thawing for HiLyte Fluor 488 microtubule (G-MT) polymerization. 
Polymerize the same day aliquot is pulled from -80°C. Do not refreeze again in the -
80°C. 
Biotin Tubulin, 45.5 µM = 5 mg/ml, from Cytoskeleton cat #T333P, in -80°C *keep on 
ice, lasts ~2 hrs if properly kept on ice Do not refreeze again in the -80°C. 
Dark Actin, 46.5 µM = 2 mg/ml, from Cytoskeleton cat #AKL99, in -80°C *keep on ice, 
last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do not refreeze 
again in the -80°C. 
Rhodamine Actin, 34.9 µM = 1.5 mg/ml, from Cytoskeleton cat #AR05, in -80°C 
*keep on ice, last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do 
not refreeze again. Do not refreeze again in the -80°C. 
Biotin Actin, 23.3 µM = 1 mg/ml, from Cytoskeleton cat #AB07, in -80°C  
GTP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used 
again. 
ATP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used 
again. 
Taxol 2 mM stock in DMSO, aliquot and freeze in -20°C *keep on bench after 
thawing, can be refrozen and used again. Put back in -20°C once Taxol dilutions are 
made (PEM-Taxol and 200 µM Taxol). 
Neutravidin, 83.3 µM, from Thermo Fisher cat #31000, in -20°C *keep on ice, last up 
to 1 week if properly kept on ice (as ice melts, replenish ice). However, aliquot is at 5 
µl so will likely be used up within 1-2 days. Do not refreeze again in the -20°C.  
Free Biotin, 1.02 mM, from Sigma cat #B4501, in 4°C *take a 5 µl sample from the 











100 mM PIPES, pH to 6.8 with HCl 
2 mM MgCl2 
2 mM EGTA 




1 x G-buffer 
2.0 mM Tris pH 8 
0.2 mM ATP 
0.5 mM DTT 
0.1 mM CaCl2   




198 μl PEM-100 
2 μl 2 mM Taxol *Thaw Taxol  
*Make fresh every time before use, keep at room temp, good for 1 day.   
 
200 uM Taxol  
18 μl DMSO 
2 μl 2 mM Taxol *Thaw Taxol  
*Make fresh every time before use, keep at room temp, good for 1 day.  
 
10 mM GTP, 1:10 dilution  
9 µl PEM-100 
1 µl 100 mM GTP   
*Keep on ice during use, store in -20°C, can freeze/thaw. 
 
10 mM ATP, 1:10 dilution  
9 µl PEM-100 
1 µl 100 mM ATP  
*Keep on ice during use, store in -20°C, can freeze/thaw. 
 
1% (v/v) Tween  
495 ul PEM 




Vortex and quick spin to mix 
*Store at room temperature and use repeatedly. Good for 1 year.  
 
8.33 µM Neutravidin, 1:10 dilution 
9 µl PEM-100 
1 µl 83.3 µM Neutravidin 
*Keep on ice during use, good for the day’s use 
 
51 µM Free Biotin, 1:20 dilution 
19 µl PEM-100 
1 µl 1.02 mM (1020 µM) Neutravidin 
*Keep on ice during use, good for the day’s use 
 
PEM-100 
Fill 50 ml tube with 40 ml sterile DI water 
Measure out and add 1.893 grams of PIPES 
Qualitatively transfer to 50 ml tube 
100 µl of 1 M EGTA (final will be 2 mM) 
100 µl 1 M MgCl2 (final will be 2 mM) 
pH to 6.8 with pH meter (in 290) 
If pH is too high add HCl *typically PEM is too basic with a pH between ~7.4-8. 
Usually add 3-5 drops of HCl. Do so carefully as to not fall below 6.8 and have to add 
KOH.  
If pH is to low add KOH 
Fill remaining volume to 50 ml in 50 ml tube using sterile DI water. 
Sterile Filter into new 50 ml tube. 
Label “PEM-100 pH 6.8 your initials, Date” 
*Store at room temperature, in your drawer. 
 
Tubulin Storage Protocol  
Keep on ice during entire process prior to flash freezing and storage. 
Dark Unlabeled Tubulin 
Obtain unlabeled 1 mg lyophilized porcine tubulin (Cytoskeleton Cat #T240) from the 
4°C and put on ice.  
Add 200 µl PEM-100 to 1 mg lyophilized tubulin to bring up to 5 mg/ml volume. 
Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the 
fluid on the sid or lid and depositing it into the solution at the bottom of the tube. To 
avoid bubbles pipette slowly. 
Let sit on ice for 10 minutes to allow tubulin to go into solution. 
 
HiLyte Fluor 488-Labeled Tubulin 
Obtain labeled 20 µg lyophilized porcine tubulin (Cytoskeleton Cat #TL488) from 4°C 
and put on ice. Add 4 µl PEM-100 to 20 µg lyophilized rhodamine tubulin to bring up 




Do so by pipetting the fluid on the sides or lid and depositing it into the solution. To 
avoid bubbles pipette slowly. Let sit on ice for 10 minutes to allow tubulin to go into 
solution. 
 
Aliquots from Dark and HiLyte Fluor 488- Tubulin 
Mix labeled and unlabeled tubulin for desired labeling ratio. No labeling ratio has 
MT’s that are too bright. Currently we use a 1:10 ratio HiLyte Fluor 488-
labeled:unlabeled tubulin (the 1:20 ratio was too dim). 
Add 36 µl of dark tubulin directly to the 4 µl HiLyte Fluor 488 tubulin tube to create 
40 µl total. 
Let sit for 10 minutes on ice to allow labeled tubulin and dark tubulin to go into 
solution.  Aliquot HiLyte Fluor 488-labeled tubulin into 5 µl (8 aliquots) 
Label each aliquot tube “G” *Once the 488 tubulin has been polymerized, add to 
label “G-MT” with the data. 
Aliquot remaining volume of unlabeled tubulin into 5 µl (32 aliquots) 
Label each aliquot tube “5 mg/ml DT” DT stands for dark tubulin. 
Flash Freeze with liquid nitrogen and store at -80°C *Flash freezing is absolutely 
necessary for tubulin to remain functional. 
 
Actin Storage Protocol  
Keep covered on ice during entire process prior to flash freezing and storage. 
Dark Unlabeled Actin  
*Reconstitute to 2 mg/ml (46.6uM) 
Spin down the powder  
Add 100 ul of DI to 1 mg of actin 
This gives 10mg/ml Dark Actin 
Reconstitute to working concentration (2mg/ml) in G1 
Aliquot into 25 ul aliquots 
Drop freeze in Liquid N2 
Store in -80°C freezer. 
  
Rhodamine-labeled Actin 
*Reconstitute 1.5 mg/ml (34.9uM) 
Spin down the powder  
Add 2 ul of DI to 20 ug of actin 
This gives 10mg/ml Dark Actin 
Reconstitute to working concentration (1.5mg/ml) in G1 
Aliquot into 5ul aliquots 
Drop freeze in Liquid N2 
Store in -80°C freezer. 
 
Biotinylated Actin 
*Reconstitute to 1 mg/ml (23.3uM) 




Add 2 ul of DI to lyophilize biotinylated actin  
This gives 10 mg/ml biotinylated actin.  
Then reconstitute to 1 mg/ml in GX1 buffer 
Aliquot out the 1 mg/ml biotinylated actin into 5 µl aliquots 





Crosslinker Solution for Actin 
Goal is to make the crosslinker solution with neutravidin, free biotin and biotinylated 
actin. 
Make sure to adjust the volume to be greater, ie 10x and 20x.  
Refer to chart to see crosslinking volumes 
 
Crosslinked Ratio “R=X” 0.02 0.04 0.08 
PEM-100 (µl) 8.60 7.20 4.39 
Neutravidin, 8.33 µM 1:10 dilution (µl) 0.69 1.37 2.75 
Biotinylated Actin, 1 mg/ml (µl) 0.49 0.98 1.96 
Free Biotin, 51 µM 1:20 dilution (µl) 0.22 0.45 0.90 
 
  Incubate in bath sonicator for 90 minutes with ice packs to keep from over-heating. 
This is added to the actin to polymerize networks with crosslinkers and the volume 
increase is taken into account in the final sample volumes 
 
Pre-polymerized Rhodamine Labeled Actin Filaments Protocol: 
Goal is to create a 5 µM 10 µL solution with 50% dark and 50% labeled actin filaments 
that can then be diluted and added to the sample chamber for force and image 
measurements. 
6.74 µl PEM-100 
0.72 µl Rhodamine Labeled Actin 1.5 mg/ml (34.9 µM) 
0.54 µl Dark Actin 2 mg/ml (46.5 µM)   
2.00 µl 10 mM ATP (ATP in PEM-100) 
Mix by pipetting and allow to polymerize for one hour 
 
Pre-polymerized Biotinylated Rhodamine Labeled Actin Filaments Protocol: 
Goal is to create a 5 µM 10 µL solution with dark, labeled, and biotinylated actin 






Crosslinked Ratio “R=X” 0 0.02 0.04 0.08 
PEM-100 (µl) 6.74 6.37 5.99 5.23 
Rhodamine Labeled Actin, 1.5 
mg/ml (µl) 
0.72 0.69 0.66 0.6 
Unlabeled Actin, 2 mg/ml (µl) 0.54 0.52 0.49 0.45 
Biotinylated Actin, 0.2 mg/ml (µl) 
(1:5 dilution) 
0 0.43 0.86 1.72 
ATP 10 mM 2.00 2.00 2.00 2.00 
Mix by pipetting and allow to polymerize for one hour 
 
 
Labeled Protein Dilutions  
Make dilutions right before adding to the sample chamber. When proteins are 
diluted, they may depolymerize if not added to more proteins. 
Labeling dilutions determined via trial and error from confocal imaging. Goal is to be 
able to see each filament without having to adjust several parameters during 
acquisition. 
Rhodamine Pre-polymerized Actin (1:2) 
2 µl PEM-100 
2 µl pre-polymerized Rhodamine actin filaments, cut tips 
*Make fresh each time immediately prior to making the final sample. 
 
Rhodamine Pre-polymerized Biotinylated Actin (1:2) 
2 µl PEM-100 
2 µl pre-polymerized biotinylated Rhodamine actin filaments, cut tips 
*Make fresh each time immediately prior to making the final sample. 
 
Make a Glu/Goc/Bead solution 
The glu/goc solution is critical to prevent photobleaching 
6 µl PEM-Taxol 
2 µl 488-Labeled 4.5 µm microspheres, make sure all spheres are suspended in 
buffer, vortex if not. 
1 µl Glu 
1 µl Goc 
Mix the solution by vortexing and quick spin. 
*Make fresh each time immediately prior to making the final sample. The 
glu/goc/bead solution MUST be the last solution that is made prior to making the 
final sample chamber as glu/goc starts reacting once mixed.  





Final Sample Chamber, volumes for 20 uL final volume 
rough calculations on data sheet in binder “Crosslinked Calculations for 1.43 µM actin, 
9.1 µM MT” 
→ Crosslinked solution R=0.0X Actin  
→ Polymerized Rhodamine labeled actin filaments (takes 1 hour) 
→ Dark actin 
→ MAP65 
→ Dark and labeled Tubulin 
→ Final Sample 
 
Make 20 µl final sample chamber, see below  
Pipet to mix, gently. Cut tips when adding actin and tween to final sample.  
Pipet 20 µl into sample chamber (made via 2 layers of double sticky tape, coverslip 
and slide).  
Seal sample chamber with epoxy, label sample on slide with date and AMT ratio. 
Incubate sealed sample at 37°C for 30 minutes. MAKE sure temperature does not 






Composite network: R=0, 0% MAP65  
8.44 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
0 µl Crosslinker Actin Solution  
0 µl MAP65, 4.66 µM 
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.56 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0, 3% MAP65  
7.11 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
0 µl Crosslinker Actin Solution  
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.33 µl MAP65, 4.66 µM 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.56 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0, 10% MAP65  
3.96 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
0 µl Crosslinker Actin Solution  
4.48 µl MAP65, 4.66 µM 
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.56 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
Composite network: R=0.02, 0% MAP65  
7.46 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 




2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl Crosslinker Actin Solution  
0 µl MAP65, 4.66 µM 
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.54 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0.02, 3% MAP65  
6.13 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1 µl Crosslinker Actin Solution  
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.33 µl MAP65, 4.66 µM 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.54 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0.02, 10% MAP65  
2.99 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl Crosslinker Actin Solution  
4.48 µl MAP65, 4.66 µM 
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.54 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
Composite network: R=0.04, 0% MAP65  
7.49 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 




1 µl Crosslinker Actin Solution  
0 µl MAP65, 4.66 µM 
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.51 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0.04, 3% MAP65  
6.16 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1 µl Crosslinker Actin Solution  
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.33 µl MAP65, 4.66 µM 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.51 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0.04, 10% MAP65  
3.01 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl Crosslinker Actin Solution  
4.48 µl MAP65, 4.66 µM 
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.51 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
Composite network: R=0.08, 0% MAP65  
7.54 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl Crosslinker Actin Solution  
0 µl MAP65, 4.66 µM 




1 µl glu/gloc 
0.46 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0.08, 3% MAP65  
6.21 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
1 µl Crosslinker Actin Solution  
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.33 µl MAP65, 4.66 µM 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.46 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
0.5 ul 200 uM Taxol (in DMSO) 
 
Composite network: R=0.08, 10% MAP65  
3.06 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL) 
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM 
2 µl 10 mM GTP (in PEM-100) 
2 µl 10 mM ATP (in PEM-100) 
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin  
1 µl Crosslinker Actin Solution  
4.48 µl MAP65, 4.66 µM 
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100) 
1 µl glu/gloc 
0.46 µl Dark Actin, 2 mg/ml or 46.5 µM 
0.5 ul 1% Tween 
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